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Polychlorinated  biphenyls (PCBs) are a class of bioactive chemical once 
used in industrial applications, but which now contaminate the world 
environment.  PCBs are lipophilic with few natural degadatory mechanisms, 
and thus they accumulate in human and animal tissues, and are passed to 
subsequent generations via transfer between mother and offspring. 
Research has shown that PCBs can interfere with brain and sexual organ 
development, and adult sexual behaviors and reproduction.  However, 
previous studies produced contradictory results based on the dose and 
method of administration, species, and the age at exposure.  The research 
detailed in this thesis elucidates the effects of prenatal exposure to low levels 
of a commercial mixture of PCBs, Aroclor (A) 1221, on female reproductive 
function.  
 The studies undertaken in this dissertation focus on three areas 
relevant to understanding long-term effects of PCBs on reproductive 
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physiology in female rats:  (1) developmental effects in two generations, (2) 
sexual behaviors in the first generation, and (3) gene expression in the first 
generation.  In the first research section of this dissertation, the sexual and 
somatic development of PCB-exposed animals is investigated in first (F1) 
and second (F2) generation females. Dose-dependent effects are observed 
in both generations, and a greater number of endpoints are significantly 
affected in the F2, including circulating hormone levels and uterine and 
ovarian weight.  The second research section of the dissertation explores 
whether sexual behaviors in the first generation of exposed animals are 
altered by A1221, using a paced mating paradigm designed to elucidate 
female-typical behaviors. Several salient behaviors are affected by PCB 
exposure, including likelihood to mate, mating trial pacing, and stress-related 
vocalizations.  The third research chapter discusses the results of a genome-
wide microarray assay performed on the preoptic area of the brain.  The 
preoptic area is a neuroendocrine control center implicated in regulation of 
reproductive physiology and behavior. Taken together, these results suggest 
that A1221 has long lasting and trans-generational effects on the 
development and behavior of exposed females, accompanied by altered 
gene expression in a neuroendocrine region of the brain.  These findings 
have implications for female reproductive health and reproductive success in 
wildlife and humans. 
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A  Aroclor 
ACTH  Adrenocorticotropic hormone 
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BCA3  breast cancer associated oncogene 3 
bp  base pair(s) 
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CRHBP corticotropin releasing hormone binding protein 
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E  embryonic day 
ECD  electron capture detector 
EDC  endocrine disrupting chemical 
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activity 
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MS  selected ion monitoring mass spectrometer  
NKXH  Nkx homeobox family of transcription factors 
NTP  nucleoside triphosphate 
NRF1  Nuclear Respiratory Family of transcription factors 
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PM  perfect match probe 
POA  preoptic area (of the brain) 
RMA  robust multichip average  
Sp1  Stimulating Proteins 1 family of transcription factors 
TRE  transcriptional response element 
TRHR  thyrotropin releasing hormone receptor 





General Information on PCBs 
HISTORY 
 Polychlorinated biphenyls (PCBs) are a class of bioactive industrial 
chemical composed of 209 possible permutations (congeners) of chlorine 
substitutions on a biphenyl frame.  Although small scale PCB production 
began in 1881 in the United States, mass commercial production in America 
was initiated in 1929 in response to a demand for safer insulating materials 
in industrial machinery.  Designed for encapsulation in closed-system 
apparatuses such as transformers and capacitors (Carpenter, 1998), PCBs 
were soon also employed in  such divergent applications as plastics, nautical 
paint, microscope oil, pesticides, copy paper, adhesives, and sealants.  
Ironically, the same chemical properties that render PCBs valuable for 
industry also contribute to their toxicity.  The chemical structure of PCBs is 
given in Figure 1. 
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Figure 1:  PCB Congeners and Classifications 
Figure 1:  PCBs contain chlorine substitutions at any of 10 available carbons, 
numbered according to convention.  These sites are similarly named 
according to their relative position to the carbon containing the biphenyl 
bond:  ortho, meta, or para.  Coplanar PCBs have a flat 3-D conformation, 
which requires ≤1 ortho substitution.  Noncoplanar PCBs have >1 ortho 
substitution, resulting in a bend in the biphenyl structure.  Some coplanar 
PCBs can bind to the aryl hydrocarbon receptor (AhR) inducing dioxin-like 
effects, while non-coplanar PCBs have steroid hormone and neurotoxic 
effects.  Lightly and heavily chlorinated PCBs have different half-lives: 
heavily chlorinated PCBs endure longer in the environment, and 
bioaccumulate at a greater rate. 
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PCBs: ENVIRONMENTAL TOXICANTS 
 In addition to the extraordinary chemical stability of PCBs, few natural 
means of degradation exist (Ohtsubo, et al., 2004).  Factories and chemical 
plants may legally dispose of PCBs via flash-incineration at temperatures of 
at least 1,200 degrees within a 2 second temperature ramp; however, failure 
to implement these conditions properly can result in the formation of sister 
compounds with potentially greater toxicity than the PCBs themselves 
(Weber and Sakurai, 2001).  Ignorance or noncompliance of PCB disposal 
methods has resulted in the improper dumping of PCB waste.  In addition, 
even legally compliant disposed waste receptacles can leak PCBs from 
landfills into the soil and water.  These conditions, compounded over the ~90 
years of PCB production, have amassed a wellspring of persistent 
environmental contamination that extends to animals and humans across the 
globe.   
 Primary environmental exposure to PCBs occurs through 
consumption of contaminated food sources, inhalation, and skin contact.  
Once inside the organism, PCBs may also be passed from mother to 
offspring in uterine or oviductal fluids, or in lactate, resulting in 
transgenerational exposures.  Furthermore, lipophilic PCBs are sequestered 
in fats and other tissues because many organisms lack an adequate 
catabolic defense against this man-made chemical.  Bioaccumulation of 
PCBs thus occurs through repeated exposure, tissue sequestration, and 
transgenerational transfer.  Although commercial PCB production was halted 
in 1977, bioaccumulation, continued dumping, and landfill leakage creates a 
pervasive toxic environment in both urban and rural landscapes across the 
world.  Biotransfer via migratory organisms and oceanic currents has 
resulted in the paradoxical finding that pristine regions far from primary 





PCBs form a diverse molecular family because they were 
manufactured in the form of commercially available isomeric mixtures, each 
distinguished by degree of chlorination and three-dimensional structure. Now 
recognized as endocrine disrupting chemicals (EDCs) that can interfere with 
hormone signaling pathways, PCBs also negatively affect a breadth of other 
biological systems, including liver metabolism, gastrointestinal function, and 
adrenal gland function.  Early developmental exposure can alter brain 
patterning, accelerate mammary gland formation, and impair gonadal 
physiology.  In addition to the varied endpoints of exposure, individual PCB 
congeners affect each endpoint with a unique dose-response curve.  Thus, 
despite the fact that PCBs served a unified purpose in industry, the 
constituent congeners have very diverse modes of action within a living 
organism.  Biological activity depends on three physical properties of the 
individual congener:  (1) Degree of chlorination, (2) Substitution pattern of 
chlorine atoms on the biphenyl shell, and (3) 3-dimensional structure of the 
molecule (Figure 1).   
Highly-chlorinated PCBs that contain at least 7 chlorine substitutions 
have a longer half-life both in the environment, and within living organisms 
(Platonow and Meads, 1975).   They tend to bioaccumulate in the food chain, 
and certain congeners appear with high frequency in measures of lactate 
and serum PCB concentrations.  Human exposure typically occurs through 
consumption of intoxicated fishes or meats, or by working directly with PCBs 
in chemical or manufacturing plants.  On the other hand, lower chlorinated 
PCB homologues are readily metabolized in vivo, and thus do not 
bioconcentrate.  These PCBs easily volatize and may be inhaled in aerosol 
form (Hermanson and Hhites, 1989), or ingested after being 
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phytoconcentrated in agricultural plant stock (Thomas, et al., 1998a).  Aroclor 
1221, the low chlorinated commercial PCB mixture employed in this 
dissertation research, is best known as an estrogenic and carcinogenic 
mixture (see section: Aroclor 1221, under “Exposure Risks”).  Low 
chlorinated PCBs, called “episodic” due to their shorter half-life (Hansen, 
2001), are underrepresented in toxicological research, presumably because 
they are not commonly detected in PCB detection studies of human tissues 
or in the environment.  However, congener-specific measurement 
methodologies for episodic PCBs have greatly improved in accuracy within 
the last ten years (Burse, et al., 1996).  In addition, recent evidence suggests 
that women may accumulate the lower chlorinated PCBs to a greater degree 
than men, either due to dietary habits or to poorer metabolic capacity 
(Schaeffer, et al., 2006). 
 
Endpoints for Biotoxicological PCB Potencies 
The body of research presented in this dissertation has as its goal to 
investigate the global effect of prenatal PCB exposure on adult female 
reproduction, focusing particularly on development across two generations, 
sexual behaviors in the first generation, and gene expression in the first 
generation.  PCBs exert their deleterious effects via a multitude of biological 
processes, rendering interpretation of these in vivo results difficult.  
Furthemore, natural exposures to EDCs, including PCBs, likely involve 
complex mixtures, the exact composition of which dependends on the route 
and site of contamination.  For PCBs in particular, multiple congeners 
originating from different commercial mixtures play a role in exposure.  
Exposure profiles consisting of individual PCBs along with other 
environmental toxicants may exhibit additive (Jensen, et al., 2000), 
synergistic or counteractive (Vettori, et al., 2006) biological effects at certain 
 
6 
concentrations. At the heart of understanding complex mechanisms involving 
non-linear additive effects of multi-toxicant interactions is a necessarily 
sophisticated comprehension of the effects of an ecologically relevant 
exposure profile, such as a single industrial mixture of PCBs.   This is the 
goal of the current series of experiments.  In addition, because mechanisms 
underlying the toxicity of PCBs may act during development to cause 
permanent alteration of physiological patterning, a thorough summary of 
PCB exposure endpoints related to this experiment is provided below. 
 
ENDOCRINE DISRUPTION 
PCBs may act through many conduits to disrupt animal physiology 
and behavior.  Perhaps the most well documented pathway is through 
endocrine disruption.  Endocrine disrupting chemicals (EDCs), such as 
PCBs, are natural or man-made chemicals that, when introduced to a natural 
biological system, disrupt endocrine signaling at the synthesis, transport, 
signal transduction, or catabolism stages of hormone activity.  Lower 
chlorinated PCBs such as Aroclor 1221, the PCB mixture used in this 
dissertation, are commonly found to be estrogenic, and higher chlorinated 
dioxin-like PCBs tend to be anti-estrogenic, however these distinctions are 
not absolute.  
The most highly studied avenue for endocrine disruption by PCBs is 
steroid hormone interference (Arcaro, et al., 1999, Carlson and Williams, 
2001, Moore, et al., 1997). The estrogenic effects of PCBs have been 
thoroughly investigated.   In many cases, the estrogenicity of the PCB 
mixture is derived from the activity of metabolic breakdown products 
characterized by hydroxylated carbon moieties (Connor, et al., 1997).  
Indeed, strong inhibition of estrogen sulfotransferase, an important enzyme 
for estradiol degradation, was exhibited following hydroxylated PCB 
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metabolite administration to a human in vitro binding assay (Kester, et al., 
2000).  Estrogenic and anti-estrogenic PCB congeners and/or their 
metabolites can bind directly to the estrogen receptor (Connor, et al., 1997, 
Machala, et al., 2004, Pillon, et al., 2005, Yoon, et al., 2001)(Petit, et al., 
1997)(Layton, et al., 2002) and to steroid binding globulin (Kato, et al., 1982), 
or were identified using an in vitro estrogen-dependent cell proliferation and 
protein expression assay (Decastro, et al., 2006, Soto, et al., 1995).  A 1996 
study examining the estrogenic effects of a tetrachlorobiphenyl congener 
demonstrated PCBs’ ability to directly bind the estrogen receptor, induce 
estrogen receptor binding to gene promoters, induce gene expression, and 
regulate cell growth in two human breast cancer cell lines (Nesaretnam, et 
al., 1996).  A mixture of a tri- and a tetrachloro-PCB was found to bind to the 
mouse uterine estrogen receptor in an in vitro binding assay, and to induce 
expression of estrogen response element (ERE) -dependent genes in a 
human HepG2 cell line (Ramamoorthy, et al., 1997).  In vivo studies of 
juvenile exposure of rats to individual congeners or the commercial PCB 
mixture A1242 resulted in increased uterine weight and enhanced pituitary 
response to GnRH, similar to the effects of estradiol administration (Jansen, 
et al., 1993).  PCBs may also act in an estrogenic manner by increasing 
release of estradiol by female gonads, such as was demonstrated in a 
porcine follicle culture (Ptak, et al., 2005). 
PCBs can alter gonadal steroidogenesis (Grabic, et al., 2006, 
Gregoraszczuk, et al., 2005, Mlynarczuk and Kotwica, 2005), adrenal 
steroidogenesis (Li, et al., 2004), gonadotropin levels (Desaulniers, et al., 
1999, Lorenzen, et al., 1999) and gonadal hormones. PCBs are also able to 
bind progesterone receptor (Connor, et al., 1997) and alter progesterone 
production (Wojtowicz, et al., 2005).  In addition to effects on gonadal 
steroids, PCBs disturb adrenal hormone production and signaling (Goldman 
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and Yawetz, 1991, Johansson, et al., 1998a, Li and Wang, 2005, 
Wassermann, et al., 1973).  These studies demonstrate that PCBs have the 
capability to interfere with numerous steroid hormone systems. 
Several non-steroid hormones are also affected by PCBs, most 
notably thyroid hormones, although like steroids, thyroid hormones are also 
members of the nuclear receptor transcription factor family.  Moreover, PCBs 
are structurally similar to the biphenyl structure of thyroid hormones. PCBs 
interfere with all levels of thyroid signaling, including transthyretin binding 
(Purkey, et al., 2004), metabolism (Bastomsky, et al., 1976), and thyroid 
physiology (Kilic, et al., 2005, Langer, et al., 2003), as well as circulating 
thyroid hormone levels (Gauger, et al., 2004).  Because thyroid hormone 
signaling is important for normal brain development, PCB depletion of 
circulating thyroid hormone may cause permanent brain abnormalities 
(Kimura-Kuroda, et al., 2005, Porterfield and Hendry, 1998, Zoeller, et al., 
2000).   
In addition to thyroid hormone, serum prolactin levels were depressed 
following PCB treatment of mice (De Krey, et al., 1994), but were stimulated 
(Khan, et al., 2002) in  rats.  Conversely, the PCB mixture A1254 had an 
inhibitory effect on the prolactin family of genes in rat uterus (Lee, et al., 
2003).  Coburn et al (2005) found a link between PCB exposure and altered 
vasopressin release (Coburn, et al., 2005).  Similarly, uterine oxytocin 
production was impaired by PCB exposure in a non-estrogen dependent 
mechanism (Mlynarczuk and Kotwica, 2005).  Thus PCBs have the potential 
to alter multiple hormone systems. 
The secondary effects of endocrine disruption by PCBs include 
marked effects on female fertility and fecundity.  The female reproductive 
organs are a common target of endocrine disruption.  Acute exposure of the 
uterus results in hypertrophy (Fielden, et al., 1997, Gellert, 1978, Hany, et 
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al., 1999, Jansen, et al., 1993) whereas developmental and long-term 
exposures  induce uterine hypotrophy (Nixon, et al., 2003, Sager and Girard, 
1994).  PCBs can alter uterine responsiveness to serum hormones (Sager 
and Girard, 1994, Tsai, et al., 1997, Wrobel and Kotwica, 2005) and increase 
the frequency of uterine contractions during pregnancy (Bae, et al., 2001, 
Loch-Caruso, 2002), which may be related to decreased gestation length in 
PCB-exposed females.  Maternal and paternal exposure to PCBs have been 
linked with altered sex ratios in humans (Del Rio Gomez, et al., 2002, Hertz-
Picciotto, et al., 2003, Mackenzie, et al., 2005, Tiido, et al., 2005, Weisskopf, 
et al., 2003), whereas wildlife exposure is positively correlated with altered 
sex ratios in mussels (Hellou, et al., 2003) and turtles (Crews, et al., 1995).  
PCB exposure in the adult or neonate can alter estrous cycle length in rats 
(Brezner, et al., 1984, Meerts, et al., 2004b, Sager and Girard, 1994) and 
alter uterine responsiveness to circulating steroid hormones (Patnode and 
Curtis, 1994, Sager and Girard, 1994, Tsai, et al., 1997).  Therefore, through 
their interference in proper hormonal communication, PCBs can negatively 
affect female fertility and fecundity. 
 
NEUROLOGICAL ENDPOINTS AND NEUROTRANSMITTER TARGETS 
 Though possible explanatory mechanisms are both diverse and poorly 
understood, PCB disruption of brain functioning is widely supported by the 
literature (Tilson, et al., 1998).  Ortho-substituted PCB congeners (those with 
a chlorine substitution on carbons 2, 2’, 6, or 6’; see Figure 1) appear to have 
greatest potency in the brain (Shain, et al., 1991).  A1221 is approximately 
59% mono-ortho substituted, the most potent isomer for brain-related PCB 
defects.  PCB-derived neurotoxicity is hypothesized to be due to any of the 
following:  altered protein kinase C activity (Shafer, et al., 1996), membrane 
disruption (Tan, et al., 2004a), free radical generation (Mariussen, et al., 
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2002), calcium dysregulation (Kodavanti, et al., 1998), or mitochondrial 
malfunction (Maier, et al., 1994).  The cerebellum is particularly sensitive to 
PCB disruption, which may be related to cerebellar dependence on 
circulating thyroid hormone during development.  Cerebellar granule and 
Purkinje cell populations are highly susceptible to PCB disruption (Gafni, et 
al., 2004, Roegge, et al., 2006, Tan, et al., 2004b).  Developmentally 
administered PCBs cause a decrease in cell density of myelinating glial cells 
in the central nervous system (Sharlin, et al., 2006).  They can change cell 
membrane fluidity and alter the functioning of transmembrane proteins (Tan, 
et al., 2004a).  
 Aside from neurotoxic effects, PCBs can alter brain function by 
changing gene and protein expression, and modulating enzyme activity.  
PCBs induce early immediate gene expression, c-Jun, in PC12 cells, 
(Shimokawa, et al., 2006). Expression of synaptic proteins associated with 
neurodegenerative conditions were affected by PCB exposure (Malkiewicz, 
et al., 2006).  Several neurotransmitter systems have proven susceptible to 
PCB disruption, notably the biogenic amines dopamine, norepinephrine, and 
serotonin, and their metabolites.  PCB exposure causes intracellular 
dopamine depletion in a non-AhR dependent manner (Seegal, et al., 1990, 
Seegal, et al., 1991), but it can also lead to increased dopamine and DOPAC 
tissue content (Roth-Harer, et al., 2001).  Disrupted nitric oxide synthase 
expression has been postulated as one source of dopaminergic deficiency 
(Kang, et al., 2002).  Decreased serotonin (Chu, et al., 1996, Khan and 
Thomas, 2000, Morse, et al., 1996b, Seegal, et al., 1986) or norepinephrine 
(Seegal, et al., 1985) levels are also observed effects of PCB exposure. 
 PCB-induced disruption of neurotransmitter production and release 
has been well-characterized for several systems, including acetylcholine, 
norepinephrine, dopamine, and serotonin. For the cholinergic system, 
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administration of Aroclor 1254 to adult rats for a 30 day period resulted in 
decreased activity of the catabolic enzyme acetylcholinesterase (Muthuvel, 
et al., 2006) due to oxidative damage that was remedied by vitamin C 
treatment (Venkataraman, et al., 2006).  Similarly, activity of choline 
acetyltransferase, an acetylcholine synthetic enzyme, was depressed in 15 
day old rats neonatally exposed to Aroclor 1254 (Juarez De Ku, et al., 1994), 
and in 30 day old rats perinatally exposed to Aroclor 1254 (Provost, et al., 
1999b).  The observed interference of PCBs with the acetylcholine system 
has been proposed to be secondary to thyroid hormone insufficiency (Juarez 
De Ku, et al., 1994). 
 Norepinephrine has not been the focus of research investigating PCB 
effects in the central nervous system. However one study found depressed 
norepinephrine levels in the hippocampus and frontal cortex of adult male 
rats exposed to a single large dose of Aroclor 1254 (Seegal, et al., 1985).   
Both coplanar and ortho-substituted PCBs can alter the dopamine 
neurotransmitter system, as reported both in vitro and in vivo.  This appears 
to be an important target for PCB effects in the brain. An in vitro striatal 
synaptosome preparation exposed to Aroclor 1254 or to individual PCB 
congeners showed increased media dopamine concentration and DOPAC 
levels and decreased synaptosomal dopamine (Bemis and Seegal, 2004). 
Exposure of the same preparation to individual ortho-substituted congeners 
significantly inhibited activity of the synthetic enzyme tyrosine dehydroxylase, 
with the strongest effect observed for 2,2’ dichlorobiphenyl (Choksi, et al., 
1997).  In a synaptic vesicle preparation, ortho-chlorinated PCBs inhibit 
uptake of dopamine into synaptic vesicles (Mariussen, et al., 2001).  Data 
from in vitro synaptosomal preparations suggests that PCBs that inhibit 
dopamine transport into vesicles may not alter transport into the 
synaptosome, potentially facilitating the accumulation of toxic levels of 
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dopamine in the cell cytoplasm in vivo (Mariussen and Fonnum, 2001). Data 
from immortalized dopaminergic cell lines suggests that susceptibility to 
neurotoxicity may also be related to reduced nitric oxide synthase activity 
(Kang, et al., 2002), or to the induced persistent activity of an enzyme 
associated with increased production of reactive oxidative species (Lee, et 
al., 2006). 
In vivo studies examining exposures to PCBs demonstrate robust 
effects on dopamine concentration and metabolism, although they must be 
considered separately in the context of either developmental or adult 
exposures. Exposure of adult non-human primates to Aroclor 1016 or 1260 
for >20 weeks resulted in decreased dopamine concentrations in the caudate 
nucleus, substantia nigra, and hypothalamus (Seegal, 1994).  Adult rats 
exposed to 30 days oral administration of Aroclor 1254 exhibited significant 
decreases in dopamine and its metabolites in the caudate nucleus (Seegal, 
1994).  A 13-week treatment of weanling rats with the individual congener 
PCB 28 resulted in depressed dopamine levels in the substantia nigra, with 
stronger effects observed in females (Caudle, et al., 2006).  A study 
administering PCB 153 to adult rats for 90 days found decreased dopamine 
content of the frontal cortex, with stronger effects in females (Chu, et al., 
1996), and a partner study using PCB 118 likewise found a decrease in 
dopamine levels of in the substantia nigra of females (Chu, et al., 1995).  
Amongst a cohort of human factory workers occupationally exposed to 
PCBs, the incidence of Parkinson’s disease, a condition associated with 
dopamine deficiency, was more prevalent in women (Steenland, et al., 
2006). Parkinson’s disease is typically more prevalent in men than in women.  
It is unclear why women were more strongly affected by Parkinson’s 
following PCB exposure, although it may be possible that expression of 
toxicant metabolism proteins may be altered by exposure to an estrogenic 
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chemical, such as PCBs (Hernandez, et al., 2006), If this were the case, 
women exposed to PCBs might exhibit impaired metabolism or increased 
susceptibility to the neurotoxic effects of PCBs. Another possible explanation 
is that the estrogenic/antiestrogenic effects of PCBs may subvert the 
neuroprotective effects of endogenous estradiol in the Parkinson’s disease 
state (Dhandapani and Brann, 2002, Sawada and Shimohama, 2003, 
Tamas, et al., 2006). 
Developmental exposures to PCBs can induce long-term changes in 
the dopamine pathway that persist through adulthood.  Prenatal exposure of 
rats to Aroclor 1254 resulted in increased dopamine metabolite levels and a 
higher metabolite : dopamine ratio in male, but not female, adults (Meerts, et 
al., 2004c). Perinatal exposure of rats to Aroclor 1016 resulted in increased 
dopamine concentrations in the substantia nigra, caudate nucleus, and 
nucleus accumbens, with greater effects in females than males (Seegal, 
1994).  Perinatal exposure of rats to individual coplanar tetrachloro- or 
hexachlorobiphenyl congeners elevated prefrontal cortex levels of dopamine 
in the adult (Roth-Harer, et al., 2001).  The effects of PCBs on the dopamine 
system are highly reliant on the age of exposure and the PCB 
congeners/mixtures encountered (Seegal, et al., 1997). 
 Finally, PCBs exert actions on the central serotonergic systems. Both 
developmental and adult exposure to PCBs can alter activity of serotonergic 
metabolic enzymes and regional brain concentrations of serotonin.  Khan 
and Thomas observed decreased dopamine and serotonin concentrations 
(Khan and Thomas, 1997) and decreased activity of tryptophan hydroxylase, 
the synthetic enzyme for serotonin production (Khan and Thomas, 2001), in 
the hypothalamus of the adult Atlantic croaker following a 30-day exposure to 
the PCB mixture Aroclor 1254.  A similar decrease in tryptophan hydroxylase 
activity was observed in the brainstem and frontal cortex of the rat following a 
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single oral dose of Aroclor 1254 (Khan and Thomas, 2001).   An increase in 
serotonin metabolism was observed in telencephalic structures of the rat 
following either developmental exposure to the coplanar congener PCB 77 
(Lilienthal, et al., 1997), or the technical mixture A1254 (Morse, et al., 
1996b), and a single oral adult exposure to Aroclors 1254 and 1260 resulted 
in similar effects (Seegal, et al., 1986). 
 Thus, PCBs can induce neurotoxic cell death, alter neuronal signaling, 
and bring about a misdistribution of biogenic signaling molecules in the brain. 
In the context of the current dissertation work, all of the neurotransmitter 
systems above play roles in regulating the neural circuits that control 
reproductive physiology and behavior. Thus, actions of PCBs on central 
neurotransmitters have direct implications for their effects on the 
hypothalamic regulation of reproduction. 
 
BEHAVIORAL ENDPOINTS 
Behavior is a fundamental endpoint in the examination of low-dose 
EDC exposures.  Because behavior derives from the coordinated 
contributions of many different neural systems, it is highly sensitive to 
chemical perturbation.  As a counterpart to molecular, cellular, and 
histopathological research, behavior can reveal new and ecologically 
relevant information regarding the social and species impact of toxic 
exposures.  The potentially damaging repercussions of PCB exposure on the 
endocrine system are likely to extend into behavioral abnormalities.  Sexual 
behaviors, in particular, are likely to be influenced by PCB exposure because 
they are mediated primarily by neuroendocrine brain regions such as the 
hypothalamus and preoptic area that strongly rely on neurotransmitter and 
hormone systems known to be targets of PCB disruption.   
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Because of the many insults exerted by PCBs on endocrine signaling, 
it is not surprising that adult sexual behaviors are affected.  Female rats 
exposed to PCBs exhibited depressed sexual receptivity (Brezner, et al., 
1984, Wang, et al., 2002) and improper timing of mating events (Chung, et 
al., 2001).  Other steroid-mediated behavior such as maternal care are also 
altered following PCB exposure (Cummings, et al., 2005, Fisher, et al., 
2005).  Motor activities are a commonly reported symptom of PCB toxicity.  
PCBs are associated with hyperactivity (Holene, et al., 1998, Lilienthal, et al., 
1990), skewed sex-linked sweet preference (Kaya, et al., 2002), and 
neurobehavioral pathologies (Chou, et al., 1979, Eriksson, et al., 1991). In 
addition, PCBs can alter sex-typical play behavior in children (Yoon, et al., 
2001). 
 
IMMUNO- AND BLOOD DEFICIENCY ENDPOINTS 
PCB exposures in humans and animals have been linked with 
decreased immune potential.  Aroclor 1242 and/or 1254, PCB mixtures 
known to pollute the Great Lakes and Hudson River, can alter ratios of T-cell 
subsets in mouse (Arena, et al., 2003) and rhesus monkey (Arnold, et al., 
1993).  Similar immunopathological results have been observed in rat 
(Sargent, et al., 1991, Smialowicz, et al., 1989).  Immune suppression may 
be coincident with, but does not result from PCB-related increase of serum 
corticosterone (De Krey, et al., 1993), as circulating corticosterone dampens 
the immune response potential.  Surveys of wild herring gull and harbor seal 
populations confirm the ecological impact of PCB exposure on immune 
disfunction (Grasman, et al., 2000, Levin, et al., 2005).  Suppression of 
cytotoxic T lymphocyte production as a measure of the immunotoxic effects 
of PCBs has been linked with activation of the aryl hydrocarbon receptor 
(Kerkvliet, et al., 1990, Silkworth, et al., 1984), an orphan nuclear receptor 
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involved in toxin metabolism. Aryl hydrocarbon receptor (AhR)-independent 
mechanisms, such as estrogenic effects, may also contribute (Lyche, et al., 
2004, Lyche, et al., 2006).  
In addition to immune defects, PCB-exposed animals have altered 
hemotology and serum biochemistry.  A1254-exposed rhesus monkeys had 
decreased erythrocytes and reticulocytes, altered platelet volume, serum 
cholesterol and total bilirubin (Arnold, et al., 1993), and also displayed 
hypocellular bone marrow and pathological erythroid precursor cell 
morphology (Tryphonas, et al., 1986) and impaired erythropoiesis 
(Tryphonas, et al., 1984).  Similar effects, including anemia characterized by 
low hemoglobin, hematocrit, and red blood cell number were observed in 
adult PCB-exposed rats (Chu, et al., 1994, Chu, et al., 1998), and low-dose 
exposures may be effective (Ross, et al., 1996).  An in vitro human platelet 
assay found direct effects of PCBs on platelet activation (Raulf and Konig, 
1991).  Paradoxical results of increased hemoglobin and red blood cell 
counts were observed in rainbow trout treated with a PCB technical mixture 
(Rehulka and Minarik, 2004).  Cardiac deformities were observed in 
passerine birds following developmental exposure to PCBs (Dewitt, et al., 
2006).   High blood pressure in PCB-exposed humans has been positively 
correlated with increased serum cholesterol and triglycerides (Stehr-Green, 
et al., 1986).  In situ rat and human whole blood assays detected PCB entry 
into serum lipoprotein reservoirs and erythrocytes, and competitive binding of 
PCBs to steroid binding globulin and serum albumin (Vomachka, et al., 
1983).  Additionally, PCBs are associated with vascular endothelial cell 
dysfunction (Toborek, et al., 1995), perhaps due to PCB-induced oxidative 
stress (Slim, et al., 1999).  Overall, PCBs have great potential to alter an 
organism’s metabolic homeostasis by decreasing the oxygen transport 





The lipophilic nature of PCBs enables them to pass through plasma 
membranes, including the cell membrane, endoplasmic reticulum, 
mitochondrial membrane, and nuclear envelope.  PCBs are thus associated 
with changes in cellular and mitochondrial membrane fluidity (Tan, et al., 
2003, Tan, et al., 2004a).  Disrupted neuronal membranes could interfere 
with maintaining ion gradients necessary for neurotransmission (Byrne and 
Sepkovic, 1987).  When this occurs in mitochondria, the phenolic moiety of 
PCBs can both uncouple and inhibit oxidative phosphorylation involved in 
energy metabolism (Nishihara and Utsumi, 1987).  Related to these cellular 
processes are PCB disruption of calcium homeostasis, which can lead to the 
induction of apoptosis; calcium is believed to be released via PCB interaction 




Acute effects of PCBs on liver microsomal activity are well described 
in toxicology literature. Altered vitamin availability is thought to be induced by 
dioxin-like PCBs via an AhR-mediated pathway: liver parenchymal cell 
enzymes are inducted following PCB binding to AhR, thereby exerting direct 
effects on vitamin metabolism and turnover. Even low-dose exposures to 
PCBs can deplete vitamin stores greatly needed for the growth and 
development of the exposed organism (Chu, et al., 1994, Chu, et al., 1998, 
Kodavanti, et al., 1998).   
Vitamin D3 (cholecalciferol) is a steroid-like molecule converted to its 
active form by the Cytochrome P450 class of enzymes, known to be affected 
by PCB exposure (Twaroski, et al., 2001).  Cholecalciferol’s active metabolite 
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is important for calcium homeostasis, especially in osteoblasts and renal 
tubule cells, but also in diverse other tissues including the brain.  During 
development, it regulates cell differentiation and proliferation, and can exert 
transcriptional effects.  Lilienthal and colleagues (2000) found that a 
commercial mixture of PCBs representing congeners found in human breast 
milk can reduce serum levels of cholecalciferol metabolites (Lilienthal, et al., 
2000).   
Vitamin A (retinol/retinoic acid) is a powerful morphogen active during 
development in the differentiation of the nervous system.  Decreased hepatic 
content of retinol is a common marker for PCB exposure, with probable 
repercussions on retinoic acid signaling (Nilsson, et al., 2000).  Liver and 
serum concentrations of vitamin A (retinol) and retinol binding protein 
(Innami, et al., 1976) are compromised following exposure.  In an example of 
adult PCB exposure, the accidental contamination of rhesus monkey holding 
pens with PCBs caused retinol deficiency-related lesions of the glandular 
stomach and colon (Mcconnell, et al., 1979).  Retinol deficiency during 
development could have repercussions on brain development. 
Finally, improper vitamin C and vitamin E levels result from PCB 
exposures.  Vitamin C (L-ascorbic acid) is a powerful antioxidant, and vitamin 
E (alpha tocopherol) can boost immune function.  Increased liver 
biosynthesis of vitamin C was observed following PCB treatment (Fujiwara 
and Kuriyama, 1977), and concomitant increased urinary secretion of vitamin 
C occurs (Horio and Yoshida, 1982).  The observed PCB-derived decreases 
in vitamin E liver content may be related to increased lipid peroxidation 





Altered gene expression has been observed for several genes 
following PCB exposure.  One mechanism for abnormal gene transcription 
could be from PCB activation or inhibition of second messenger signaling 
kinases (Li, et al., 2006, Yang and Kodavanti, 2001), which are involved in 
transcriptional signal transduction.  Some PCBs can alter the post-
transcriptional stability of mRNA transcripts (Lin, et al., 2006a), thereby 
creating a false impression of increased transcription.  In addition, PCBs are 
associated with the increased transcription factor binding of AP-1 to DNA 
(Twaroski, et al., 2001), and PCB binding to estrogen receptor, thyroid 
hormone receptor, and AhR induces a transcriptional response (Buterin, et 
al., 2006, Klinge, et al., 1999, Roelens, et al., 2005, Routledge, et al., 2000, 
Yoon, et al., 2001). Perinatal exposure to PCBs represses wnt7a 
transcription factor expression in the developing female uterus (Shimokawa, 
et al., 2006).  
 Cancer research suggests the existence of novel genotoxic PCB 
mechanisms that could play a role in the apoptotic cell death of vulnerable 
cell populations during development, or could introduce errors into germline 
stem cells.  Some PCBs may derive their carcinogenic qualities from DNA 
fractionation and the formation of PCB-DNA adducts (Howard, et al., 2003, 
Mclean, et al., 1996).  PCBs are also directly associated with the increased 
incidence of intrachromosomal recombination (Schiestl, et al., 1997). 
 
HUMAN PATHOLOGICAL RISKS 
PCB exposure has been linked to the incidence of several human 
health risks, including Parkinson’s disease, precocious puberty, breast 
cancer, and poor sperm quality. These correlative studies typically compare 
plasma concentrations of PCBs with pathological health outcomes. However, 
the causality of early life exposures to PCBs, and functional outcomes in 
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adulthood, is extremely difficult to demonstrate. Moreover, some chemical 
exposures in development may no longer be detectable in blood and/or 
urine, and results may be difficult to interpret due to non-linearity in the dose-
response curve.  Finally, many human health studies are confounded by 
small sample size, and sociological and ethnographic differences in the 
subject pools, all of which disadvantage researchers from drawing definitive 
conclusions on the strength of the relationships.  Despite these drawbacks, 
several health risks have been well studied and are generally accepted as 
relating to PCB exposure. 
Because several PCB congeners and mixtures are known to interfere 
with dopaminergic signaling, researchers investigated the link between PCB 
body burden and Parkinson’s disease, a disorder involving dopamine 
depletion.  A 1998 study found high concentrations of PCBs in dopaminergic 
brain regions of mortally afflicted Parkinson’s patients (Corrigan, et al., 
1998).  Later research found that PCB concentrations in dopaminergic brain 
nuclei are specifically associated with Parkinson’s and not with other 
neurodegenerative disorders (Corrigan, et al., 2000), and that women 
occupationally exposed to high levels of PCBs had an elevated risk of dying 
from Parkinson’s disease (Steenland, et al., 2006), although the small 
sample size precluded statistical significance.   
As an endocrine disrupting chemical, PCBs are known to affect 
female and male reproductive parameters.  Precocious puberty is a recently 
recognized epidemiological trend for girls to reach puberty at an abnormally 
young age.  PCB exposure has been linked to precocious puberty (Denham, 
et al., 2005) and in utero exposure is associated with abnormal menses 
(Yang, et al., 2005).  In men, measures of human sperm quality have been 
associated with PCB exposure (Hauser, et al., 2003, Mol, et al., 2002, 
Spano, et al., 2005, Tiido, et al., 2006).  One study including additional 
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endocrine disrupting chemicals in body burden analysis was able to draw a 
robust association between PCB exposure and poor sperm quality (Rozati, et 
al., 2002), and another study investigating the long term health effects of 
boys exposed to large levels of PCBs in utero also found a strong 
association with poor sperm quality (Guo, et al., 2000).  
Several studies have linked PCB body burden with cancer 
development. The link between PCB exposure and breast cancer is 
controversial, however recent research uncovered a clear link between 
genotype and PCB exposure in risk susceptibility for breast cancer (Li, et al., 
2005).  Additionally, a higher risk of breast cancer was found to be 
associated with high body burdens of particular PCB congeners (Liljegren, et 
al., 1998, Lucena, et al., 2001, Moysich, et al., 1998). Prostate cancer is also 
associated with high tissue levels of particular PCB congeners in vivo 
(Ritchie, et al., 2003) and in in vitro human preparations (Endo, et al., 2003).  
PCBs have well documented activity on liver toxicity and immune dysfunction 
in laboratory animals (see sections Immuno- and Blood Deficiency Endpoints 
and Hepatotoxicity), and parallel effects have recently been observed in 
humans (Prince, et al., 2006, Tsai, et al., 2007).  Additionally, PCB exposure 
has been linked with cancer of various organ systems (Pavuk, et al., 2004), 
perhaps due to its general genotoxicity.  A single developmental exposure of 
male rats to the endocrine disrupting chemical vinclozalin, a fungicidal toxin, 
can cause a multigenerational increase of susceptibility to a suite of adult-
onset diseases (Anway, et al., 2006).  More research is required 
investigating the multigenerational and developmental effects of PCB 
exposures, both in humans and in animal models.   
Large scale PCB exposures have occurred in human populations on 
two notable occasions:  a 1968 incident in Nagasaki, Japan, called “Yusho” 
in which 1860 people were exposed, and a 1978 incident in Taiwan, called 
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“Yucheng” in which 2022 people were poisoned.  In both cases, PCBs and 
their related biproducts, polychlorinated dibenzofurans (PCDFs) and 
polychlorinated quaterphenyls (PCQs), were accidentally introduced into a 
batch of rice cooking oil.  Resulting human exposures were acute and high-
dose, and studies focusing on these two unfortunate occasions have 
provided information on the longitudinal human health effects of both adult 
and in utero or developmental exposures; however, individual PCB or PCDF 
congeners often cannot be implicated in particular health outcomes.   
Both adults and perinatally exposed or postnatally exposed children of 
the Yucheng incident exhibited skin deformities known as chloracne, 
abnormal fingernails, skin allergies, goiter, weakened spinal discs, and 
dental and gum abnormalities (Guo, et al., 1999). Yusho syndrome 
encompasses chloracne, skin lesions, follicular keratosis, and abnormal 
pigmentation of the skin, as well as immunocompromised defenses and 
respiratory infections, fatigue, and headaches (Aoki, 2001).  Adults exposed 
during the Yusho poisoning exhibited chronically elevated levels of serum 
triglycerides, thyroxin, and IgG in addition to chronic fatigue and numbness 
(Masuda, 2001). Women exposed in adulthood within the Yucheng cohort 
exhibited abnormal menstrual bleeding, and high infant mortality of their 
children (Yu, et al., 2000).  Decreased birth weight of children of Yucheng 
women is hypothesized to be due to altered epidermal growth factor receptor 
binding, and is correlated specifically with high PCB tissue concentrations 
(Sunahara, et al., 1987).  Adolescent males who consumed contaminated oil 
in the Yucheng disaster later had a lower probability of producing male 
children (Del Rio Gomez, et al., 2002).  Men exposed in adulthood had a 
higher rate of mortality from chronic liver disease and cirrhosis and women 
died more frequently of systemic lupus erythematosus than control 
populations (Tsai, et al., 2007).  Finally, 35 years following the Yusho 
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poisoning, exposed individuals still exhibit abnormally high levels of oxidative 
stress believed to be caused by persistent PCB superoxide production 
(Shimizu, et al., 2007). 
Children exposed prenatally to Yucheng PCB-contaminated oils 
showed retarded behavioral development (Yu, et al., 1994), and achieved 
lower cognitive measures on standard indices until the conclusion of the 
study, age 12 (Lai, et al., 1994). In addition, prenatally exposed children were 
more susceptible to respiratory tract and ear infection, as well as influenza, 
although no differences in measured immune function were detected (Yu, et 
al., 1998).  Congenitally exposed individuals from the Yucheng poisoning 
had brittle teeth, often devoid of tooth germ and lower numbers of adult teeth 
(Wang, et al., 2003) and abnormal skull morphology (Yamashita and 
Hayashi, 1985).  In addition to skin, tooth, cognitive, and behavioral 
abnormalities, boys exposed prenatally in the Yucheng cohort had shorter 
penile length, and abnormal sperm morphology (Guo, et al., 2004)(Guo, et 
al., 2000),  Yucheng girls had irregular menstrual cycles and elevated serum 
levels of estradiol and FSH only in the follicular phase  of the estrous cycle 
(Yang, et al., 2005). 
 
Exposure Risks and Body Burden 
 Reported levels of contamination for PCBs vary with geographical 
location and microenvironment, time period, species, diet, subject age, and 
number of offspring (for females).  Estimates of PCB body burden in humans 
canunderestimate total body burden when a subset of congeners commonly 
found in human tissues is chosen to represent all PCBs.  Additionally, tissue 
levels of PCBs within organs, skin, and bone are not accounted for.  In 
human studies, plasma levels of PCBs are commonly utilized as a proxy for 
total PCB body burden.    
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Stellman et al, 1998, found that in human women 10 ng/ml total PCBs 
in blood serum corresponds to 1 mg/kg adipose tissue (Stellman, et al., 
1998) and this conversion factor will be used as an approximate measure to 
equilibrate different metrics.  Focusing on Long Island women, considered a 
high risk group for PCB exposure, Stellman et al documented adipose levels 
of PCBs ranging from 0.27 to 1.1 mg/kg.  In 1991 the FDA estimated 
average daily dietary intake of PCBs to be less than 1 ng/kg/day 
(Gunderson, 1995), although mean serum levels of PCBs in male Great 
Lakes sports fisherman with a high fish diet was 4.8 ng/ml (~0.5 mg/kg 
adipose PCBs) (Hanrahan, et al., 1999).  Inuit peoples with a diet high in fish 
and marine mammals have plasma PCB/lipid concentrations up to 1.1 ppm, 
which is equivalent to 1.1 mg/kg serum PCBs and suggests far higher levels 
of adipose PCBs (Carpenter, et al., 2005).  In the lower risk population of 
Western Germany, human neonatal babies consumed approximately 1.6 
µg/kg/day PCBs from breast milk in 2003 (Furst, 2006). 
Animals at greatest risk of toxic effects of PCB exposure typically 
inhabit marine environments, where PCBs are highly concentrated through 
bioaccumulation up the food chain, and atmospheric transport results in rain 
deposition.  PCB levels are highest in marine mammals, with recorded levels 
of 29-79 mg/kg adipose concentrations within Beluga whales of the St. 
Lawrence River (Muir, et al., 1996).  Sea birds are also exposed to high 
levels of PCBs, and are particularly sensitive to PCB toxicity; 1183 ng/g 
PCBs in plasma lipids (~1.2 mg/kg serum PCBs) was measured in Arctic 
glaucous gulls (Verreault, et al., 2007).  Farmed salmon from Maine were 
measured to have 0.15 mg/kg PCBs per lipid weight (Shaw, et al., 2006).  
Herbivorous land-locked species such as caribou provide a useful reference 
for monitoring environmental transfer of PCBs transported via volatization 
and atmospheric circulation rather than bioaccumulation.  Adipose PCB 
 
25 
concentrations in Canadian caribou populations ranged between 0.006 and 
0.032 mg/kg PCBs in 1995 (Elkin and Bethke, 1995). 
 
DEVELOPMENTAL EXPOSURE 
 Adult exposures to low doses of EDCs typically result in significant, 
time-delineated, alteration of hormonal signaling (Ahmad, et al., 2003, 
Desaulniers, et al., 1999, Khan and Thomas, 2001).  Gradual recovery 
follows removal of the aggravating chemical agent and thus the effects of 
exposure, while in some cases grave, represent transient modifications on a 
fully developed system.  In contrast, EDC exposures in the embryo or fetus 
can redirect the intended structure of the nervous system, forming a 
permanently altered network.  This is because steroid hormones play an 
organizational role in the neuroendocrine brain, and disruption of neuronal 
patterning manifests itself as a disfunction when these systems are activated 
in the mature adult. The biphenyl structure of PCBs and other EDCs 
resembles submolecular regions of hormones that are involved in receptor 
binding.  This structural similarity allows them to mimic or antagonize intrinsic 
steroid hormones in multiple systems. When hormonal disruption occurs in 
early development, EDCs have the capacity to alter formative processes, 
such as neuronal pathway formation, cell migration and survival, and 
receptor gene and protein expression, each of which may chronically affect 
brain function and/or brain sexual differentiation.   
In utero exposure to PCBs has far greater potential to induce enduring 
negative effects than adult exposure. Although exposure during adulthood 
may result in short-term perturbation of neuroendocrine systems (Richardson 
and Miller, 2004, Seegal, et al., 1985), behavior was not strongly affected 
(Chung, Nunez, Clemens, 2001).  On the other hand, perinatal exposure to 
PCBs can repattern the susceptible embryonic brain, resulting in the 
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eventual manifestation of improper sexual behaviors (Chung & Clemens 
1999: Sager, 1983) and hyper- or hypoactivity (Jacobson JL et al, 1992: 
Hany et al 1998). There may be differential vulnerability between the sexes, 
depending upon age and mode of exposure, and the type of EDC. The 
female mammalian embryo may be particularly sensitive to the estrogenic 
effects of PCBs because she is normally shielded from maternal steroidal 
hormones by alpha-feto binding protein, and produces only trace 
endogenous hormones in highly localized tissues.  By contrast, the fetal male 
testis is quite active and exposes the developing male organism to much 
higher levels of steroid hormones. It might be predicted that for some of 
these endpoints in the male, exogenous hormones may be less deleterious 
than in the female, in which endogenous hormone levels are naturally far 
lower. Circulating steroid hormones in development can effect a permanent 
repatterning of the plastic embryonic brain, and this effect is mimicked by 
endocrine disrupting chemicals.   
 
AROCLOR 1221 
This study examines the behavioral effects of transplacental and 
lactational exposure to the commercial PCB mixture Aroclor (A)1221. 
Previous studies have demonstrated the potential for Aroclor A1221, or its 
constituent congeners, to interfere with puberty and reproductive aging 
(Gellert RJ  1978), increase uterine weight (Ecobichon and MacKenzie 
1974), alter neurotransmitter signaling (Seegal et al, 1990), and interfere with 
hormone signaling (Gore et al 2002, Kilic et al 2005, Layton et al 2002, 
Woodhouse et al 2004), all of which are involved in the exhibition of mature 
sexual behaviors.   
A1221 is a low (21%) chlorinated PCB mixture believed to have a 
short half-life, high metabolic clearance, and estrogenic activity.  Its 
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estrogenic effects are likely primarily mediated by the hydroxylated or 
catechol metabolites created during enzymatic breakdown (Korach et al, 
1987, Kramer et al 1997, Kitamura et al, 2005, Garner et al, 1998, Connor et 
al 1997, Layton et al, 2002), but non-steroidal interactions may involve the 
parent molecule (Brouwer et al, 1999).  Aroclor 1221 can activate estrogen 
receptor-dependent activity in an in vitro preparation of preneoplastic breast 
epithelial cells and breast cancer cells (Shekhar, et al., 1997).  One major 
constituent of A1221, 4-chlorobiphenyl, and its metabolites, induce estrogen 
release from preovulatory ovarian follicles up to 256 fold greater than control 
levels in vitro at a 6 ng/ml concentration (Ptak A et al, 2005).  Constituent 
hydroxylated members of A1221 were shown to bind estrogen receptor alpha 
in a modified recombinant yeast estrogen assay (Layton, et al., 2002).  
A1221 inhibits the ability of aromatase enzyme to convert testosterone to 
estradiol in a commercially available microsomal fraction transfected with 
human CYP19 and P450 reductase (Woodhouse and Cooke, 2004). 
Because of its presumed short-lived tissue contamination before 
anabolic breakdown, A1221 has not recently been the focus of toxicological 
research.  However, some recent findings demonstrate the potential for 
A1221 to alter neuroendocrine gene expression (Salama, et al., 2003), and 
induce chromosomal recombination (Schiestl et al, 1997) that is linked with 
cancer and could alter germline heredity.  In addition, this mixture contains a 
major di-ortho substituted congener known to cross the blood-brain barrier 
and interfere with catecholaminergic neurotransmission (Seegal, et al., 
1991)(Frame, 1997). Furthermore, prior studies documenting relatively low 
levels of environmental contamination by A1221 should be reevaluated in 
light of novel, more refined analyses (Frame, 1997: Becker et al, 2002).  In 
all, the sum of previous research demonstrates the potential for lightly 
chlorinated PCBs such as A1221 to greatly affect normal physiology and 
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dramatically alter the neuroendocrine axis of the unborn embryo, acting 
quickly and catastrophically before being cleared from the body. 
Leakage of A1221 from waste dumps is well-documented (Agency for 
Toxic Substances and Disease Registry, 2000), and the potential for animal 
and human exposure exists from inhalation of airborne particles, in drinking 
water, and through fish consumption from intoxicated areas.  In addition, 
previous contamination analysis relied on relatively insensitive measures 
and/or used a single marker congener to represent levels of the entire PCB 
commercial mixture.  Accurate quantification of specific congeners 
comprising A1221 can be difficult and expensive, and methods quoted prior 
to 1997 are believed to have inferior resolution compared to recent, improved 
assays (Frame, 1997: Becker et al, 2002).  Human and wildlife contact with 
A1221 may be underestimated, evidenced by a paucity of peer-reviewed 
studies on low-dose exposures. 
Table 1 shows the breakdown by weight of A1221 into each of its 
constituent congeners by electron capture detector (ECD) adapted from G.M. 
Frame, 1996.  The Aroclor 1221 stock solution analyzed by Frame, 1996, is 
lot # 073-202 from Accustandard, Inc., and the stock used in the current 
dissertation research is lot # 072-202, from the same company.  As the 
Frame, 1996, study represents the most thorough reporting to date of A1221 
constituent congeners, and because Accustandard Aroclors are the industry 
standard and are accepted as highly reliable from lot to lot (personal 
communication, Dr. Richard Bopp, Rensselaer Polytechnic Institute), the 
contituent member congeners of A1221 given in Table 1 (page 31) are 
believed to represent the treatment administered in this dissertation 
research.   
The biological impact of lightly chlorinated congeners such as those 
that compose the majority of A1221, by mass, is not well-studied.  For 
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example, while PCB 1, 2-chlorobiphenyl makes up ~31% of A1221 (see 
Table 1), no data could be found on its toxicological effect.  I will begin this 
discussion on those congeners of A1221 with poorly understood effects, and 
follow in the next paragraphs with information about the better-investigated 
congeners, PCBs 3 and 4. PCB 2 and PCB 3, effects of which are not well-
documented, are associated with elevated production of reactive oxidative 
species in rat synaptosomes (Voie and Fonnum, 2000).  PCB 2 has been 
shown to quickly transfer amongst the three densities of human plasma 
lipoproteins in blood (Maliwal and Guthrie, 1982).  PCB 15, also referred to 
as 4,4’-dichlorobiphenyl, is associated with genetic recombination events 
(Butterworth, et al., 1995). PCB 18 is not well-studied, however it has 
recently been documented in higher than expected concentrations in native 
American women (Schaeffer, et al., 2006). 
PCB 3, 4-chlorobiphenyl, is one of the most well-studied constituents 
of A1221, and comprises approximately 16% of the mixture, by mass (Table 
1).  It is associated with cellular stress in a bacterial model (Agullo, et al., 
2007).  Environmentally-relevant exposures to PCB 3 induce apoptotic gene 
expression and genotoxicity (Ptak, et al., 2006a) and can increase 
aromatase activity and decrease progesterone secretion (Ptak, et al., 2006b) 
in cultured porcine ovarian granulosa cells.  Genotoxicity by PCB 3 is 
believed to be induced by the formation of DNA adducts (Mclean, et al., 
1996), although PCB 3 has also been shown to decouple and inhibit 
oxidative phosphorylation during cellular metabolism (Nishihara and Utsumi, 
1987).   
PCB 4 is an ortho-substituted PCB congener also known as 2,2’-
dichlorobiphenyl, and it makes up approximately 6% of A1221.  In vitro 
uterine explants from 10 day pregnant rats exhibited an inhibition of 
contraction amplitude and desynchronized contractions following exposure to 
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PCB 4 (Chung and Loch Caruso, 2005).  Because it is ortho-substituted, 
PCB 4 is attributed with increased permeability into the brain, and 
neurologically damaging effects, such as nitric oxide synthetase inhibition 
(Sharma and Kodavanti, 2002), induction of intracellular calcium fluctuation 
in cerebellar granular cells (Bemis and Seegal, 2000), alteration of PKC 
second messenger signaling (Yang and Kodavanti, 2001), and gross 
neurotoxicity (Shain, et al., 1991). 
 
31 
   Table 1:  % Congener content of Aroclor 1221 by weight, via high 
resolution gas chromatography (HRGC) and electron capture detection 
(ECD) adapted from (Frame, 1996) 
 
PCB IUPAC name Cl- substitutions PCB 3D shape % weight A1221 
0 Biphenyl None coplanar 12.0 
1 2-chlorobiphenyl mono-orthosubstituted coplanar 31.5 
2 3-chlorobiphenyl non-orthosubstituted coplanar 3.4 
3 4-chlorobiphenyl non-orthosubstituted coplanar 18.0 
4 2,2’-dichlorobiphenyl di-orthosubstituted non-coplanar 5.4 
5 2,3-dichlorobiphenyl mono-orthosubstituted coplanar 0.65 
6 2,3’-dichlorobiphenyl mono-orthosubstituted coplanar 3.4 
7 2,4-dichlorobiphenyl mono-orthosubstituted coplanar 1.5 
8 2,4’-dichlorobiphenyl mono-orthosubstituted coplanar 10.9 
9 2,5-dichlorobiphenyl mono-orthosubstituted coplanar 1.5 
10 2,6-dichlorobiphenyl di-orthosubstituted non-coplanar 0.7 
11 3,3’-dichlorobiphenyl non-orthosubstituted coplanar 0.1 
12 3,4-dichlorobiphenyl non-orthosubstituted coplanar 0.5 
13 3,4’-dichlorobiphenyl non-orthosubstituted coplanar 1.0 
15 4,4’-dichlorobiphenyl non-orthosubstituted coplanar 3.7 
16 2,2’,3-trichlorobiphenyl di-orthosubstituted non-coplanar 0.3 
17 2,2’,4-trichlorobiphenyl di-orthosubstituted non-coplanar 0.3 
18 2,2’,5-trichlorobiphenyl di-orthosubstituted non-coplanar 0.7 
19 2,2’,6-trichlorobiphenyl di-orthosubstituted non-coplanar 0.1 
20 2,3,3’-trichlorobiphenyl mono-orthosubstituted coplanar 0.1 
22 2,3,4’-trichlorobiphenyl mono-orthosubstituted coplanar 0.2 
25 2,3’,4-trichlorobiphenyl mono-orthosubstituted coplanar 0.1 
26 2,3’,5-trichlorobiphenyl mono-orthosubstituted coplanar 0.1 
27 2,3’,6-trichlorobiphenyl di-orthosubstituted non-coplanar 0 
28 2,4,4’-trichlorobiphenyl mono-orthosubstituted coplanar 0.5 
31 2,4’,5-trichlorobiphenyl mono-orthosubstituted coplanar 0.5 
32 2,4’,6-trichlorobiphenyl di-orthosubstituted non-coplanar 0.1 
33 2,3’,4’-trichlorobiphenyl mono-orthosubstituted coplanar 0.4 
37 3,4,4’-trichlorobiphenyl non-orthosubstituted coplanar 0.2 
42 2,2’,3,4’-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
44 2,2’,3,5’-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.2 
48 2,2’,4,5-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
49 2,2’,4,5’-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
52 2,2’,5,6’-tetrachlorobiphenyl tri-orthosubstituted non-coplanar 0.2 
56 2,3,3’,4’-tetrachlorobiphenyl mono-orthosubstituted coplanar 0.1 
60 2,3,4,4’-tetrachlorobiphenyl mono-orthosubstituted coplanar 0.1 
64 2,3,4’,6-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
65 2,3,5,6-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
66 2,3,4,4’-tetrachlorobiphenyl mono-orthosubstituted coplanar 0.2 
70 2,3’,4’,5-tetrachlorobiphenyl mono-orthosubstituted coplanar 0.2 
71 2,3’,4’,6-tetrachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
74 2,4,4’,5-tettrachlorobiphenyl mono-orthosubstituted coplanar 0.1 
101 2,2’,4,5,5’-pentachlorobiphenyl di-orthosubstituted non-coplanar 0.1 
118 2,3’,4,4’,5-pentachlorobiphenyl mono-orthosubstituted coplanar, dioxin-like 0.1 
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A large percentage of the constituent congeners of A1221 are ortho-
substituted, which endows this commercial mixture with a certain amount of 
versatility in its effects: (1) mono-ortho congeners are able to maintain a flat 
coplanar conformation (U.S. Environmental Protection Agency (EPA) Table 
of PCB Congeners & Other Species; 
http://www.epa.gov/toxteam/pcbid/table.htm#key), (2) certain hydroxylated 
metabolites can enact the bent conformation required for agonistic mimicry at 
the estrogen receptor (Layton, et al., 2002), and (3) di-orthosubstituted 
congeners are efficacious at crossing the blood-brain barrier and enacting 
neurotoxicological effects (Angus and Contreras, 1996, Maier, et al., 1994, 
Seegal, et al., 1991).  This suggests that A1221 has the potential to perturb 
both steroid hormone and neuronal systems. 
Aroclor 1221 has the lowest chlorine content of any of the commercial 
PCB mixtures made available in the United States.  Lower degrees of 
chlorination correlate with decreased longevity compared with the more 
highly chlorinated congeners.  Thus PCBs such as A1221 are quickly broken 
down into their hydroxylated and sulfylmethylated metabolites.  Despite its 
proven carcinogenicity, endocrine disrupting effects, and thryotoxicity, A1221 
is not a common choice for toxicological research.  Methodological difficulties 
arise from the fact that detection of A1221 is difficult and costly compared to 
measurements of the higher profile, more heavily chlorinated mixtures.  
Additionally, body burden of A1221 declines in a matter of days following 
exposure due to compensatory xenobiotic metabolism.   
Other PCBs, laden with chlorine substitutions, are heavy and highly 
lipophilic.  They are forced out of industrial waste sites by rainwater and 
erosion, and accumulate in the microscopic organism reservoir at the 
sediment layer of waterways, lakes and oceans.  Their lipophilicity and long 
half-life of years to decades facilitates their escalating accumulation at each 
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ream of the food chain, until they appear in measurable quantities in humans 
and upper trophic-level predators typically exposed via seafood.  A1221, 
however, tells a different story.  It is light and ephemeral, often volatile.  It 
enters a gaseous state in the air above superfund industrial dumps, or in the 
ducts of old buildings outfitted with grandfathered circulation systems.  In this 
state, it can be globally transported in the upper layers of the atmosphere 
and deposited in remote locations where it can be broken down by bacteria.  
Most importantly, however, A1221 can be inhaled or absorbed directly by 
humans and wildlife, or absorbed by agricultural plant stock and later 
consumed. 
A1221, together with its metabolites, presents a special challenge to 
epidemiological studies of environmental toxicology.  Exposure is quick, 
followed by the rapid production of arguably more toxic catabolic derivatives, 
and then within weeks tissue levels decline below measurable quantities.  To 
formulate judgements on the health impacts of PCBs, most medical doctors 
and researchers have focused on heavily chlorinated PCB congeners that 
persist in human tissues, and can be extracted from cancerous cysts or 
placental tissues.  While this approach is valuable, it largely ignores the 
dangerous effects of lower chlorinated PCBs, which at very low levels can 
create a grave disturbance in the physiology of exposed organisms – 
particularly during sensitive periods of embryonic development – and then 
practically disappear.   
 
 NON-LINEAR DOSE-RESPONSE CURVES 
Understanding the low-dose effects of environmental toxicants is crucial to 
human health and wildflife survival (Kuriyama & Chahoud, 2005).  This is 
especially true for EDCs. Because of their ability to act as, or interfere with, 
endogenous hormones, EDCs elicit a hormone-typic dose response curve 
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shaped like a “U” or “inverted U” (Calabrese and Baldwin, 2001a).  In this 
case, a median dose results in the most dramatic effects on the biological 
endpoint being measured and doses at the extremes of the dose-response 
curve have a lesser magnitude effect.  Steroid hormones such as estradiol 
often exhibit complex, non-linear dose response curves shaped by complex 
interactions with other hormones and mediated by different nodes of the 
signaling circuit.  Examples include the uterotrophic effect of estradiol 
(Barton and Andersen, 1998), estradiol-dependent down-regulation of uterine 
estrogen receptor alpha (Medlock, et al., 1991, Medlock, et al., 1994), and 
the effects of estrogen on GnRH-mediated LH release from pituitary 
gonadotrophs (Yen and Lein, 1976).  Non-linear, or U-shaped dose response 
curves might also occur on a molecular basis for transcriptionally active 
nuclear receptors, such as the estrogen receptor, when endogenous ligand 
is not present in saturating concentrations and binding by the xenobiotic 
does not produce an ideal receptor conformation for cofactor binding (Kohn 
and Melnick, 2002).  The introduction of exogenous estrogenic substances to 
a hormone-driven system produces effects that fall within the intrinsic non-
linear dose-response relationship (Sheehan, 2000). 
Another possible explanation for the non-linear curve is an effect 
known as hormesis, in which an organism or system overcompensates for 
the negative impact of a toxic insult; at the low end of the dose-response 
curve, compensation is not enough to overcome toxic effects, but at median 
levels of intoxication, overcompensation of the system results in an opposite 
magnitude of effect.  At high doses, the toxicant may again overcome the 
system, resulting in another reversal in the direction of effect.  Whereas a 
steroid hormone-like effect is mediated by interaction between a hormone 
mimic and a steroid hormone enzyme or receptor, hormesis is a more 
generalized response to overt toxicity.  The prevalence of non-linear dose-
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response curves in toxicological research underlies the need for assaying a 
range of doses in PCB research.   
 
LOW-DOSE EXPOSURES 
Many prior studies examining the effects of PCBs in vivo employed 
high doses not normally encountered by humans or animals, but low dose 
exposures during embryogenesis have the potential to induct permanent or 
long-term aberrations in the adult. For example, low doses of A1254 
administered prenatally to rats resulted in severely depressed circulating 
thyroid hormone levels in postnatal and adult offspring (Morse, et al., 1996c), 
whereas far greater levels are required for similar effects in the adult 
(Brouwer, 1989). In addition, low versus high exposures may be associated 
with unique effect profiles at the organismal level.  High levels of PCBs may 
have increased pervasiveness in less accessible tissues, such as remote 
brain regions, and could recruit cytotoxic mechanisms unique from their low-
dose counterpart (Brouwer, et al., 1999). Thus, studies reporting only 
atypically high EDC exposures may be misleading for predicting response to 
ecologically relevant exposures.  The results of high-dose toxicology 
research may therefore be largely distinct from low-dose exposures. 
 
Goals of this Research 
My dissertation studies were designed to investigate the global effects 
of PCB exposure on females during the embryonic period of brain sex 
differentiation.  Because of the expected U- or inverted-U shaped dose-
response curve, a range of dosage values encompassing typical human PCB 
tissue burdens was chosen to determine toxic exposure levels. In addition, 
previous research examining PCB effects on mating behaviors employed 
ovariectomized, hormone replaced females, a paradigm which conceals the 
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subtle effects of PCB-related alterations in circulating hormone levels by 
replacing them with standard hormone doses.  Finally, I attempted to 
elucidate some of the molecular mechanisms and molecules underlying the 
effects of PCBs on reproductive and behavior by pursuing a whole-genome 
approach with targeted gene expression follow-up.  Thus, the following work 
describes the effects of prenatal A1221 during a period of brain sexual 
differentiation on development and reproductive hormone parameters across 
two generations, adult female reproductive behaviors, and gene expression 
in a neuroendocrine region of the brain.  
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General Methods  
 To avoid redundancy, a general description of methods is provided 
here with background information, and more precise details are given in each 
of the three research sections. 
 
Animals and Husbandry 
Sprague-Dawley rats were used for all experiments. Rats were kept 
on a 12:12 hour partially-reversed light cycle (lights on at 2300H) and were 
given the low-phytoestrogen Harlan-Teklad Global Diet 2019 rat feed, and 
water, ad libitum.  One-day timed-pregnant nulliparous females (F0 
generation) were purchased from the Animal Resources Center at the 
University of Texas at Austin.  The evening of successful mating is termed 
embryonic day (E) 0.  F0 dams were housed individually, and were weighed 
on E15 to calculate treatment dosage: either vehicle (DMSO), 0.1, 1 or 10 
mg/kg PCBs with a total injection volume of 0.1 ml.  This range of PCBs was 
chosen to span ecologically relevant human and animal exposures (see 
section Exposure Risks).  Aroclor (A) 1221 PCBs were diluted in DMSO, and 
stored in a single 5 ml Falcon tube (to prevent PCB adsorption to the novel 
tube every time a new stock solution was made).  This stock solution was 
kept light-protected at room temperature.  Injections were delivered 
intraperitoneally on E16 and E18 one hour prior to lights-out.  Because 
A1221 has a low half life in vivo, and because experimental animals were 
euthanized long after exposure, we were unable to measure body burden 
and brain content of A1221, however in future experiments several neonatal 
pups will be reserved to measure these parameters.  On E20, dams were 
administered nesting materials, and were not disturbed until postnatal day 
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(P) 1 to prevent stress that may interfere with parturition or maternal 
behaviors.   
 
Developmental measures of first generation (F1) offspring 
A flow chart depicting allocation of animals to each branch of the 
study is provided in Figure 2.  P0 was counted as the day that at least one 
pup was born before lights out at 1100H.  On P1, pups in each litter were 
counted, dead pups noted, sex ratios (including dead pups) were recorded, 
and all offspring were weighed and their anogenital distance measured an 
indicator of exposure to prenatal androgens (Gray, et al., 2001).  In addition, 
nest quality was qualitatively described and the dams were checked to see if 
they fetched their pups within 5 minutes, although these qualitative 
observations of maternal behavior were not used in analysis.  Litters were 
culled to 4 females, or fewer when 4 were not available; these experimental 
females were chosen to have a median anogenital distance normalized to 
body weight, to eliminate bias caused by fetal proximity to a male, which can 
influence anogenital distance (Vom Saal, 1989).  Body weights and 
anogenital distance were taken throughout development on the following 
timepoints:  P1,3,5,7,9,13,16,20,23,27.  Pups were weaned on P22 to 3-4 
littermates/cage.  Developmental landmarks of eye opening and vaginal 
opening were recorded.  Following vaginal opening, daily vaginal smears 
were conducted to determine estrous cyclicity, and body weights were 
measured once per week.  More detailed information may be found in 








Paced mating reproductive behavior testing of F1 females 
Beginning on day P50, females were submitted to a paced mating 
protocol to test the effects of PCB exposure on female sexual behaviors.  
Paced mating cages were constructed of a 30”Lx12”Wx17”T Plexiglas 
aquarium fitted with a clear Plexiglas panel bisecting the cage lengthwise.  
Two 1.75” diameter holes at the base of this panel allow the female to pass 
between the two chambers, however, males were too large to fit.  Males 
were untreated with PCBs, and were sexually experienced.  Ultrasonic noise 
sources were located with a bat detector and removed from the vicinity of the 
experiment.  Mating trials were conducted 5 hours after lights out under dim 
red lighting, on the evening of proestrus (behavioral estrus).  Female and 
male rats were habituated to the mating cage at least three times prior to the 
experimental trial, plus for at least 10 minutes on the experimental day.  
Females were given 20 minutes to display receptivity, or else the trial was 
called “unsuccessful” and the female was returned to her cage.  Females 
were allowed 4 different attempts to mate before being eliminated from the 
experiment.  In all cases females were tested only when they had a vaginal 
smear indicating proestrous reproductive status on the morning of the mating 
trial. 
Successful mating trials consisted of at least 7 intromissions and at 
least 1 ejaculation.  Ejaculation was confirmed by the presence of sperm in 
the vaginal smear.  Successful mating trials were recorded on video camera, 
and were later reviewed and transcribed into an events log for analysis, with 
the investigator blind to treatment. The following behaviors were scored: 
mounts, intromissions, ejaculations, lordoses, lateral kicks, face-to-face’s, 
cage-crossings, and audible vocalizations.  Further methodological details 





Assignment of F1 females after mating 
The day following a successful mating trial, F1 female rats were 
divided into three groups (Figure 2).  Of the four females per litter, one was 
kept to produce a second generation; two females were decapitated for 
molecular analysis, and the final female was perfused for future protein 
expression analysis (beyond the scope of this dissertation). Euthanasia was 
performed at ~10:00 AM (1 hour prior to lights out, and approximately 20 
hours following mating).  On the day of euthanasia, vaginal smears and body 
weights were recorded.  After euthanasia, ovaries and uteri were removed, 
and their wet weights recorded (uterus alone, then both ovaries together).  
Females euthanized via decapitation also had trunk bloods taken so that the 
serum could be stored for subsequent serum hormone analyses. 
 
F2 generation: husbandry and procedures 
As stated above, one F1 female per litter was allowed to carry the 
litter to term after the paced mating trial. Thereafter, impregnated F1 females 
were submitted to identical conditions as the F0 dams, except that they did 
not receive any further administrations of the PCBs.  Following parturition, 
the F2 generation was treated identically to the neonate F1 generation with 
the exception that six female pups were kept per litter, when possible, 
instead of four.  F2 experimental females were euthanized one week 
following vaginal opening at approximately P42 for serum hormone assays 
and determination of uterine and ovarian weights.  F2 rats were virgins at the 
time of euthanasia. Further description of studies on the F2 generation is 
provided in Research Section 1. 
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Serum hormone assays 
Blood samples collected at the time of euthanasia were centrifuged at 
6000 x g for 5 minutes, and serum of F1 and F2 female rats was removed 
and stored at -80o C until analysis.  Serum hormone levels were assayed by 
radioimmunoassay (RIA) for luteinizing hormone, estradiol, and progesterone 
concentrations. Serum LH for each animal was assayed in duplicate samples 
(50 µl) by Dr. Michael J. Woller (University of Wisconsin-Whitewater), using a 
radioimmunoassay (RIA) with LH anti-serum (NICHHD R13, pool D; provided 
by Dr. G. Niswender).  Serum estradiol (E2) was measured in duplicate via 
the Diagnostic Systems Laboratories DSL-43100 estradiol RIA kit, according 
to the kit protocols across a total of five assays.  Serum progesterone (P4) 
was measured in duplicate via the DSL-3900 progesterone RIA kit, in 
accordance with kit protocols across a total of 8 assays.  Outliers were 
eliminated from analysis (see statistics section, below). 
 
RNA extraction for molecular biology procedures 
RNA was extracted using a cushion/lysis buffer method (Daftary and 
Gore, 2003, Gore and Roberts, 1994, Gore, et al., 1999):  Frozen POA 
tissues were homogenized via extrusion through a 22 gauge needle, 
proteinase K was introduced, and then RNA was extracted in phenol 
chloriform and precipitated in ethanol.  Nuclear and cytoplasmic RNA were 
separated using a two buffer system.  Namely, frozen tissues were 
homogenized in a 22 gauge needle in lysis buffer (containing Na+ 
Deoxycholate).  A centrifugation step allowed cytoplasmic RNA to remain in 
the supernatant, a high molarity solution of salts and sugars, whereas 
nuclear RNA pellets at the base of the tube.  Cytoplasmic RNA was carefully 
pipetted away from the pellet, and treated with proteinase K to eliminate 
cytoplasmic proteins.  RNA was further purified through a series of 
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phenol/chloriform extractions in which hydrophobic constituents were 
separated from the aqueous supermatant, and finally, RNA was separated 
from solution with isopropanol.  The RNA pellet was then dried and 
reconstituted with nuclease free water.  Extracted RNA was frozen at -80 
degrees prior to amplification.  The cytoplasmic RNA of 4-5 animals per 
treatment, each representing a different litter, was chosen for microarray 
analysis (For control, 0.1, 1, and 10 m/kg groups, n/treatment group were 
5,4,5, and 4, respectively).  
 
Affymetrix 230 2.0 rat whole genome array 
The Affymetrix rat 230 2.0 whole genome array is a valuable tool for 
measuring gene expression changes in pharmacogenetic studies. This 
microarray chip is composed of a grid of oligonucleotide cRNA probes (25 
base pairs (bp) each), and each “space” on the grid is occupied by multiple 
copies of identical probes.  Because it is a whole genome GeneChip, all 
known RNA transcripts from the rat genome are represented. Over 31,000 
transcripts, including isomers and splice variants, make up the array, 
representing 28,000 genes. Introduction of amplified RNA (aRNA) from an 
experimental sample causes binding at each probe location, resulting in 
formation of a fluorescent double-stranded reaction product.  Eleven to 
twenty “perfect match” (PM) probes are designed for each transcript, and to 
control for false positive results, an equal number of paired mismatch (MM) 
probes are included in parallel, which include a single incorrect bp in the 
center of the probe (bp 13).  Signal intensity from MM probes may then be 
subtracted from that of PM probes to control for nonselective binding. Each 
probe is synthesized in situ on one space of the etched photolithographic 




RNA amplification & microarray hybridization  
Cytoplasmic RNA of samples chosen for microarray was submitted to 
Ambion, Inc. (Austin, TX) for Affymetrix Rat 230 2.0 whole genome 
GeneChip hybridization. Ratio of 260/280 absorbance values as well as 
results from the Agilent Bioanalyzer 2100 confirmed that our extracted RNA 
lacked DNA contamination.  RNA was then amplified at Ambion using the 
MessageAmp II Biotin kit (Ambion, #1791).  First, oligo(dT) primers 
containing a T7 promoter sequence were introduced to the sample RNA, 
along with reverse transcriptase and nucleoside triphosphates (NTPs) to 
create single-stranded cDNA. After this, complementary strands were 
synthesized in a similar manner with DNA polymerase, and the newly formed 
double stranded DNA was used as template for RNA amplification using T7 
RNA polymerase and biotinylated NTPs.  The amplified RNA (aRNA) was 
fractionated before being introduced to the GeneChip.  RNA was allowed to 
hybridize for 16 hours, after which the array was exposed to streptavidin 
phycoerythrin conjugate, resulting in fluorescent emissions at 570 nm in 
proportion to the number of bound aRNA transcripts.  The Affymetrix 
GeneChip Scanner 3000 was used to read emissions levels for each probe 
space.  Results were subsequently quantified as a measure of gene 
expression. Further details are provided in Research Section 3. 
 
General statistical analyses 
DEVELOPMENTAL AND PHYSIOLOGICAL ENDPOINT ANALYSIS 
Data from the F1 and F2 generations were analyzed independently 
due to methodological differences between the two groups.  Serial data such 
as body weight and anogenital distance were analyzed via repeated 
measures ANOVA using Statview software and the unit of significance was 
the mean of each litter. Remaining endpoints were analyzed via linear mixed 
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model ANOVA using SAS software and the unit of significance was an 
experimental animal. Models using a fixed treatment effect, a random dam 
(treatment) effect, and a fixed categorical covariate representing day of the 
estrous cycle at time of euthanasia were fit to the data.  Significance was 
determined by a z-score or F-value for random and fixed terms, respectively.  
Non-normally distributed data were submitted to a non-parametric 
permutation test.  Tukey-Kramer adjusted post-hoc analyses were performed 
to determine the source of significance in all instances.  These statistics were 
calculated using SAS software. 
 
BEHAVIORAL ENDPOINT ANALYSIS 
Each trait was tested to determine if it was normally distributed.  SAS 
statistical software was used to perform a linear mixed model ANOVA with a 
fixed treatment effect and a random dam (treatment) effect, and a fixed 
covariate of the log transform of mating trail length to control for mating time.  
Statistical significance was determined by a z-score or an F-value for random 
and fixed terms, respectively.  Non-normally-distrbuted traits were log (1+y) 
transformed, and highly skewed traits were tested with a permutations 
procedure.  Tukey-Kramer adjusted post-hoc t-tests were used to locate the 
source of significance, when applicable. 
 
MICROARRAY ANALYSIS 
The Affymetrix Gene Chip Operating Software (GCOS) v1.3 was used 
to quantify image signal results.  Hybridization quality control measures 
including scaling factor (a measure of effective labeling), background noise 
(relates the presence of impurities), and % Present (referring to the % probe 
sets detectable, related to RNA quality and hybridization success), and 3’/5’ 
ratio of the housekeeping genes GAPDH and actin (a measure of aRNA 
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integrity) were used to confirm accurate hybridization prior to analysis.   
Microarray expression values were determined via robust multichip analysis 
(RMA) (Irizarry, et al., 2003a, Irizarry, et al., 2003b).  This probe-level 
approach normalizes the distribution of PM vs. MM signal intensity values for 
all probes within a probe set across all arrays.  The resulting values were 
expressed in log2 format, and underwent batch effect statistics to adjust for 
any variability between the two microarray runs.  Following this, data were 
submitted to ANOVA, using the Fs statistic.  Shuffling biological samples 
1000 times generated a permutations-based null hypothesis of no differential 
expression among treatments. Genes with p < 0.01 were listed in tabular 
form, and 27 neuroendocrine related genes were selected for Tukey-Kramer 
post-hoc analysis to determine significant between-group interactions.  Five 
genes from this list were chosen for quantitative real time PCR follow-up to 
be conducted following the publication of this dissertation.  Transcriptional 
response element (TRE) analysis was performed using Genomatix software.  
Functional groups were determined by gene ontology (GO) classifications in 
an online version of Multi-Protein Survey System (MPSS) software, and a 
customized neuroendocrine-specific functional categorization was performed 
through literature and sequence searches on publicly available databases.  
Cluster analysis using Adaptive Quality-Based Clustering software was 
conducted for genes in the list of significant genes (p < 0.01) and the 
resulting 11 clusters were grouped according to dose-response curve shape.  





Research Section 1:   
Prenatal exposure to PCBs in females:  development, 




Prenatal exposures to endocrine-disrupting chemicals such as 
polychlorinated biphenyls (PCBs) can cause latent effects on reproductive 
function. Here, we tested whether PCBs administered during late pregnancy 
would compromise reproductive physiology in both the fetally-exposed 
female offspring (F1 generation), as well as in their female offspring (F2 
generation). Pregnant Sprague-Dawley rats were treated with the PCB 
mixture Aroclor (A) 1221 (0, 0.1, 1 or 10 mg/kg) on embryonic days 16 and 
18. Somatic and reproductive development of F1 and their F2 female 
offspring were monitored, including ages of eye opening, pubertal landmarks, 
and serum reproductive hormones. The results showed that low doses of 
A1221 given during this critical period of neuroendocrine development 
caused differential effects of A1221 on F1 and F2 female rats. No significant 
differences were observed between treated groups and control in the F1, 
although the F2 generation showed more profound alterations.  In particular, 
on proestrus, the day of the preovulatory GnRH/LH surge, F2 females 
exhibited profoundly suppressed LH and progesterone, and correspondingly 
smaller uterine and ovarian weights on estrus. These latter physiologic 
changes suggest that the GnRH/LH surge is delayed or abolished in adult F2 
female rats whose mothers were fetally exposed to A1221. Thus, low levels 
of exposure to PCBs during late fetal development cause significant 
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consequences on the maturation and physiology of two generations of 
female offspring, and these findings have implications for reproductive health 




Polychlorinated biphenyls (PCBs) were used as non-flammable 
lubricants and insulators in industry beginning in 1929 until they were banned 
in 1977. Because of their lipophilic structures, PCBs are easily absorbed 
from the environment into the food chain, rendering human and animal 
exposure ubiquitous and persistent. As a result, a greater understanding of 
the many negative outcomes of exposure continues to be essential to human 
health, and for addressing declining wildlife fecundity and viability. 
PCB exposure has been linked with a broad spectrum of effects, both 
in vivo and in vitro, which vary depending on method/age of exposure, sex of 
the individual, and dose/duration of exposure. Fetal and early developmental 
exposure to PCBs is particularly devastating, and can have different 
outcomes from adult exposure (Crews, et al., 2000). Latent effects of early 
exposures include, but are not limited to, depressed circulating thyroid 
hormone and abnormal thyroid cytology (Bansal, et al., 2005, Chauhan, et 
al., 2000, Goldey, et al., 1995, Morse, et al., 1996c, Porterfield, 1994), 
delayed cognitive development (Chen, et al., 1992, Jacobson and Jacobson, 
1997), altered sensory and motor abilities (Bowman, et al., 1981, Lasky, et 
al., 2002, Roegge, et al., 2004), reproductive impairment (Arnold, et al., 
1995, Meerts, et al., 2004b, Sager and Girard, 1994, Yang, et al., 2005), and 
compromised neural function (Donahue, et al., 2004, Morse, et al., 1996a, 
Provost, et al., 1999a, Seegal, et al., 2005). 
Not only do PCBs and other environmental endocrine disrupting 
chemicals directly affect the exposed individual, but they can also exert 
effects on subsequent generations that may differ from those associated with 
primary exposure (Fernie, et al., 2003, Shipp, et al., 1998). One compelling 
mechanism for multigenerational effects of PCBs is via the hypothalamic-
pituitary-gonadal reproductive axis. Exposure of the first generational 
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animals can later result in aberrant reproductive physiology and behavior, 
including improper steroid hormone production during pregnancy, and 
deficiencies in parturition, lactation and maternal behavior (Boersma and 
Lanting, 2000, Takser, et al., 2005). Such alterations can potentially be 
transmitted to a second generation offspring through improper hormonal 
exposure while in utero, and altered parental care postnatally (Champagne 
and Meaney, 2001, Cummings, et al., 2005). Thus PCBs, particularly 
developmental exposures, can affect the immature organism, adult, and 
subsequent generations of offspring, although relatively little is known about 
the nature and mechanisms of these outcomes.  
The current study investigated the effects of prenatal exposure to 
PCBs on sexual and somatic development of two generations, employing 
low, ecologically relevant doses of PCBs (Zhang, et al., 2004). Aroclor 
(A)1221, a commercial PCB mixture composed of lightly-chlorinated isomers, 
was chosen for this study because of its previously reported disruption of the 
neuroendocrine system (Chung and Clemens, 1999, Chung, et al., 2001, 
Gore, 2001, Gore, et al., 2002, Salama, et al., 2003, Steinberg, et al., 2007, 
Woodhouse and Cooke, 2004).   
  
Materials and Methods  
ANIMALS AND HUSBANDRY 
Sprague-Dawley rats were fed low-phytoestrogen Harlan-Teklad 2019 
Global Diet ad libitum and were housed in a 12:12 partially reversed light 
cycle (lights on 2300 h, lights off 1100 h).  All animal procedures were 
conducted in compliance with protocols approved by IACUC at the University 
of Texas at Austin. One day timed-pregnant Sprague-Dawley rats (F0 
generation) were purchased from the Animal Resources Center at the 
University of Texas at Austin. Dams (n=11-13 per treatment) were injected 
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i.p. with Aroclor (A)1221 (0.1, 1, or 10 mg/kg; Accustandard #C-221N-50MG; 
Lot#072-202) or vehicle (0.1 ml DMSO 99.5%; Sigma, #D4540, 
Lot#122K0027) on gestational days 16 and 18, during the period of 
embryonic brain sexual differentiation (Ramaley, 1979). Intraperitoneal 
injection has been used in other studies investigating the effects of PCB 
exposure (Chung and Clemens, 1999, Gillette, et al., 1987, Murugesan, et 
al., 2005), and here it was chosen to avoid stress of gavage or possible 
variability in consumption of infused food pellets.  
PCBs are only partially conducted from dam to offspring.  To estimate 
actual exposure of each pup to the dose administered the dam, we followed 
the methods of Takagi et al, 1986 (Takagi, et al., 1986) and estimated that 
individual pups in each of the three dosed groups were exposed to 
approximately 0.2,  2, or 20 µg/kg PCBs, respectively. Because A1221 is a 
lightly chlorinated PCB mixture, it is believed to be relatively volatile 
(Thomas, et al., 1998a) with a short half life of several days (Tanabe, et al., 
1981), and its low degree of chlorination renders it difficult to detect (Frame, 
1997b).  We were thus unable to directly confirm body burden of 
experimental animals following dosage of the pregnant dam.  The doses 
used in this experiment were chosen to approximate human and wildlife 
exposures. Average PCB serum levels of full term babies in Germany have 
been measured at 0.5 µg/L (Lackmann, 2002), and from this figure, adipose 
PCB levels can be estimated at 50 µg/kg (Stellman, et al., 1998). Given 
these estimates, the doses used in this study closely approximate typical 
human exposures.   
The day of parturition, determined by the birth of at least one pup 
before lights out at 1100 h, was termed postnatal day (P) 0. On P1, live and 
dead pups were counted, sex ratio was determined, and litters were culled to 
4 females (average litter size = 12) to minimize effects of litter composition 
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on body size, physiology, and behavior. This cohort is referred to as the F1 
generation. At least one adult F1 female per litter was later allowed to 
become impregnated and produce the F2 generation. F2 litters were culled to 
6 females when possible. Although treatment groups were known to the 
experimenter in the first cohort of F1 and F2 animals (14 litters) for the 
developmental measures of body weight and anogenital distance, in 
subsequent cohorts (32 litters) experimenters were blind to treatment for 
these endpoints. The number of litters per treatment and average numbers of 
individual per litter are given in Table 2. For all hormonal and postmortem 
measures, the investigators were blind to treatments for all 46 litters.
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Table 2: The number of litters and the average number of rats per litter 
(separated by a comma) are shown. For F1 and F2 generations, numbers of 
litters are shown in the top of each cell, with the average numbers of pups 
per litter prior to culling shown at the bottom. F1 litters were culled to 4 




Litter size and sex ratios, number of dead pups, anogenital distance 
(a marker of masculinization/defeminization (Marois, 1968)), and body 
weight were recorded for F1 and F2 male and female pups on P1, prior to 
culling. After culling, the remaining females’ body weights and anogenital 
distance were recorded 2-3 times per week until P30 or vaginal opening. 
Anogenital distance was measured with digital calipers and was 
independently confirmed by a second investigator. Anogenital distance 
values were normalized to the cubed root of body weight for analysis 
(Gallavan, et al., 1999). Age at eye opening was recorded. On P22, pups 
were weaned to 3-4 littermates per cage. After P30, body weights were 
recorded once per week, and again on the day of euthanasia. Timing of 
puberty was quantified as age at vaginal opening (VO), first estrus (FE), 
and first diestrus (FD; (Salama, et al., 2003)). For both the F1 and F2 
generations, daily vaginal smears were conducted from vaginal opening 
until euthanasia, excepting pregnant or lactating F1 rats. 
 Intact F1 females were mated (~P60) on the afternoon of proestrus to 
generate a sperm-positive female for producing the second generation, 
and in conjunction with another experiment (Steinberg, et al., 2007).  
Experimental animals were euthanized by unanesthetized decapitation 
approximately 16 hours later, 1-2 hours before lights out, in random order. 
F2 experimental animals were subject to the same measures and were 
euthanized at the same time of day as the F1 generation, although they 
differed from the first generation in the following three ways: 1) F2 females 
were sexually naive, 2) they were euthanized at a younger age, on ~P42, 
and 3) they were randomly cycling at the time of euthanasia with vaginal 
cytology noted. For both generations, ovaries and uteri were dissected 
out, and wet weights were recorded. Trunk bloods were collected and 
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were centrifuged at 6000 x g for five minutes to separate serum. Serum 
was stored at -80 C until hormone analysis. 
 
SERUM HORMONE MEASUREMENTS 
Serum luteinizing hormone (LH) for each animal was assayed in duplicate 
samples (50 µl) in a single radioimmunoassay (RIA) with LH anti-serum 
(NIDDK-anti-rLH-11). The iodination preparation is NIDDK-rLH-I–9, 
iodinated with 125I. The reference preparation used for the standard curve 
is NIDDK-rLH-RP-3.  These were obtained from the National Hormone and 
Pituitary Program of NIDDK  and kindly provided by Dr. A.F. Parlow.  The 
sensitivity of the LH assay was 40 ng/ml at 90% binding, and intrassay CV 
was 2.36%. Serum estradiol was measured in duplicate (200 µl) samples 
via the Diagnostic Systems Laboratories DSL-4800 estradiol RIA kit within 
a series of five runs, according to the kit protocols.  Sensitivity is 5 pg/ml. 
Intra-assay CVs for each of the five estradiol RIA assays were 3.53, 9.54, 
4.33, 7.63, 5.42%, respectively, and inter-assay CV was 9.43%. Serum 
progesterone was measured in duplicate samples of 25 µl via the DSL-
3900 progesterone RIA kit, in accordance with kit protocols. Sensitivity is 
0.12 ng/ml.  Samples were run in a total of 8 assays, for which intra-assay 
variabilities were 3.89, 1.82, 0.69, 2.76, 8.09, 1.13, 3.06, and 1.52%, 
respectively, and inter-assay CV was 14.50%. 
 
STATISTICAL ANALYSES 
Except where noted, generation 1 and 2 were analyzed 
independently due to methodological differences between the two 
experimental generations. Repeated measures ANOVA was used to 
assess significant differences between treatment groups for serially 
recorded body weights and anogenital distances. For these endpoints the 
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unit of statistical analysis was the mean of each litter.  The remaining 
endpoints (ovarian and uterine weight and circulating hormone levels), 
which exhibited considerably more variability, were analyzed using a linear 
mixed model ANOVA approach with Proc Mixed in SAS (Cassell, 2002, 
Littell, et al., 1999, Steinberg, et al., 2007), with consultation and analyses 
kindly provided by Dr. Thomas Juenger.  Here, we fit models that included 
a fixed treatment effect, a random dam (treatment) effect, and a fixed 
categorical covariate representing estrous cycle stage of the appropriate 
category (estrus, diestrus 1, diestrus 2, or proestrus).  In addition, our 
analyses tested for significant interactions between the treatment effect 
and the estrous cycle stage.  If significant interactions were detected, we 
completed subsequent analyses splitting the data by cycle stage to more 
fully explore the biological basis of the interaction.  Models were estimated 
by restricted maximum likelihood and significance was determined by a z-
score or F-value for random and fixed terms, respectively.  Several of the 
endpoints (LH, estradiol, uterine weight, and body weight) were non-
normally distributed and therefore we utilized a non-parametric 
permutation testing approach to determine significance.  Here, phenotypes 
were randomized with respect to the experimental effects 1000 times and 
analyses were then carried out as above (Cassell, 2002).  The test 
statistics from the randomized analyses were then used to determine the 
distribution of the test statistic under the null hypothesis and to empirically 
obtain at an alpha level of 0.05.  Where significant findings were observed, 
we employed a series of post-hoc t-tests for all combinations of 
treatments, controlling for multiple tests with a Tukey-Kramer adjustment.   
LH release is pulsatile, and LH surges occurring on the evening of 
proestrus combine pulsatile release with rapidly escalating baseline levels.  
Collecting blood at a single time point makes detection of outliers difficult; 
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therefore, suspected outliers were tested with Grubb’s outliers test 
(Iglewicz and Hoaglin, 1993),, and confirmed outliers were eliminated from 
statistical analysis.  
 
Results 
F1 LITTER COMPOSITION ON P1 
A1221 did not affect litter sizes or sex ratios in the F1 generation 
(Figure 3A). Post-hoc analysis revealed no specific significant interactions 
between treatment groups, although the control vs. 0.1 mg/kg group had a 
p-value of p < 0.09 in F2 sex ratio, suggesting a trend for differences 





Figure 3: F1 & F2 litter size and litter sex ratios. A. Numbers of pups per 
litter (prior to culling) in the F1 generation group did not differ with 




F1 BODY WEIGHT AND ANOGENITAL DISTANCE ON P1 
Body weight and anogenital distance were measured for P1 male 
and female pups, as shown in Table 3. A1221 did not affect anogenital 
distance in male pups on P1, nor did it affect birth weight in pups of either 
sex (Table 3).   
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Table 3. Body weight and anogenital distance of F1 pups on P1. 
 
 
 Control 0.1 mg/kg  A1221 
1 mg/kg  
A1221 
10 mg/kg  
A1221 
P1 female body  
weight (g) 
6.10 ± 0.19 
(n=71) 
5.98 ± 0.22 
(n=78) 
6.32 ± 0.18 
(n=76) 
5.94 ± 0.18 
(n=59) 
P1 female anogenital distance  
(mm/g3) 
0.74 ± 0.03 
(n=71) 
0.81 ± 0.02a 
(n=78) 
0.71 ± 0.06 
(n=76) 
0.73 ± 0.03 
(n=59) 
P1 male body weight  
(g) 
6.36 ± 0.21 
(n=85) 
6.26 ± 0.24 
(n=67) 
6.52 ± 0.25 
(n=53) 
6.33 ± 0.18 
(n=74) 
P1 male anogenital  
distance (mm/g3) 
1.53 ± 0.04 
(n=85) 
1.58 ± 0.03 
(n=67) 
1.59 ± 0.06 
(n=53) 
1.62 ± 0.07 
(n=74) 
 
Body weights and anogenital distance were measured on P1, prior to culling 
litters. Anogenital distances are shown normalized to body weight. All data 
are shown as mean + SEM. Number of individual animals per treatment (n) is 
given .Female anogenital distance: The 0.1 mg/kg group female anogenital 
distance (normalized to body weight) tended to be larger than other groups 
(p = 0.054 vs. 1 mg/kg;  0.05 < p < 0.1 vs. 10 mg/kg). Female body weight: 
No significant differences were found on P1. Male anogenital distance, body 






F1 BODY WEIGHT AND ANOGENITAL DISTANCE DURING 
DEVELOPMENT 
After litters were culled, body weights and anogenital distance were 
recorded over time for each remaining experimental female (Figure 4). A 
repeated measures 2-way ANOVA examining the effects of age and 
treatment on body weight was performed for F1 females, revealing a 
significant effect for treatment (p < 0.01) and a treatment x age interaction (p 
< 0.0001). Post-hoc analysis revealed that interactions were attributable to 
P34. On P34, the 1 mg/kg group was significantly heavier than all other 
groups (p < 0.005 for all).  
Anogenital distance was also affected in the F1 females (Figure 4). 
Although treatment alone did not cause any effects (p = 0.126), age was 
associated with significant differences in anogenital distance (p < 0.0001). A 
trend for an interaction of age with treatment was also found (p = 0.056). 
Overall, the 0.1 mg/kg group had the largest anogenital distance, and the 10 
mg/kg A1221 group had the smallest anogenital distance. Post-hoc analysis 
confirmed differences between groups on P9 and P13, when the 0.1 mg/kg 
group had a significantly larger anogenital distance than either the control or 
10 mg/kg group (p < 0.05 for both). Anogenital distances were slightly but 
non-significantly different on P16 and P23, with a trend for a larger 
anogenital distance detected in the 0.1 mg/kg group and a smaller anogenital 






Figure 4: F1 and F2 body weight and anogenital distance.  Body weights and 
anogenital distances were analyzed by repeated measures ANOVA across 
development.  Number of individuals in the control, 0.1, 1, and 10 mg/kg 
groups were, respectively: 55, 43, 47, and 40 for the F1, and 50, 51, 41, and 
47 for the F2.  These numbers were the same for timing of developmental 
events (Table 4).   A. F1 body weights: On P34, the 1 mg/kg group was 
significantly heavier than all other treatment groups (p < 0.005 for all). B. F1 
anogenital distance: Post-hoc analysis identified differences on P9 (0.1 
mg/kg vs. control and 10 mg/kg, p < 0.05), and P13 (0.1 mg/kg vs. control 
and 10 mg/kg, p < 0.05), C. F2 body weights: On P40-42, the 1 mg/kg group 
was significantly lighter than the control or 0.1 mg/kg groups (p < 0.05). D. F2 
Anogenital Distance was unaffected by treatment.  a. 1 mg/kg vs. all other 
treatments (p < 0.005), b. 0.1 mg/kg vs. control and 10 mg/kg (p < 0.05), c. 1 
mg/kg vs. control and 0.1 mg/kg (p < 0.05).  
 
63 
F1 POSTNATAL MATURATION  
As shown in Table 4, there were no significant effects of A1221 
treatment on the developmental markers of eye opening, vaginal opening, 
first estrus, and first diestrus.   
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Table 4. F1 postnatal maturational markers. 
 
 






Eye Opening  14.9 ± 0.1 14.8 ± 0.1 15.1 ± 0.1 15.1 ± 0.1 
Vaginal Opening 33.4 ± 0.4 33.4 ± 0.4 33.6 ± 0.3 33.5 ± 0.5 
First Estrus 34.6 ± 0.7 34.4 ± 0.7 34.3 ± 0.5 33.7 ± 0.6 
First Diestrus 35.6 ± 0.4 35.3 ± 0.5 36.0 ± 0.5 35.7 ± 0.4 
 
 
Data shown are in postnatal age in days, mean + SEM. No significant 






F1 SERUM HORMONE LEVELS  
Trunk blood samples collected ~20 hours post-mating were used for 
measurement of circulating luteinizing hormone (LH), progesterone, and 
estradiol levels. No significant effects of A1221 treatment were detected for 
serum progesterone and estradiol (Figure 5A and 5B, respectively. However, 
serum LH concentrations were significantly altered (p < 0.05; Figure 5C). 
Post-hoc analyses showed that the 1 mg/kg group was significantly different 
from the 0.1 and 10 mg/kg groups (p < 0.05) and tended to be different from 
the control group (p = 0.0516). Rat estrous cyclicity was monitored by daily 
vaginal smears beginning at VO and no apparent differences were detected 





Figure 5:  F1 serum hormone 
levels. A. Serum 
progesterone; number of 
individuals in control, 0.1, 1, 
and 10 mg/kg groups were 
20, 22, 17, and 17, 
respectively. B. Serum 
Estradiol; number of 
individuals in control, 0.1, 1, 
and 10 mg/kg groups were 
19, 20 15, and 15, 
respectively. C. Serum 
luteinizing hormone (LH); 
number of individuals in 
control, 0.1, 1, and 10 mg/kg 
groups were 19, 20, 17, and 
16, respectively. No 
significant differences were 
observed for progesterone 
and estradiol. Although the 1 
mg/kg group was found to 
have significantly higher LH 
levels than either the 0.1 or 
10 mg/kg groups (p < 0.05), 
the comparison with control 
was only slightly higher than 
the 0.05 significance cutoff 
after post-hoc adjustment (p 
= 0.0516). Data are shown 
as mean + SEM.  
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F1 OVARIAN/UTERINE WEIGHTS 
The uterus and paired ovaries were carefully dissected and weighed 
after euthanasia. There was no effect of A1221 treatment on F1 uterine or 







Figure 6: F1 ovarian and uterine weights, shown normalized to body weight. 
There were no significant differences between groups. Number of individuals 
per group for control, 0.1, 1, and 10 mg/kg groups were 36, 31, 34, and 29, 
respectively.  Data are shown as mean + SEM.  
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F2 LITTER SIZE AND COMPOSITION ON P1 
Litter sizes of the F2 generation are shown in Figure 3. No significant 
differences were found.  For sex ratio, as with the first generation, no 
significant effects were observed.  
 
F2 BODY WEIGHT AND ANOGENITAL DISTANCE ON P1 
On the day after birth, body weights in F2 generation females were smallest 
in the 1 mg/kg A1221 group although this was only significantly different from 
the 10 mg/kg group which had the highest mean body weight (p < 0.05; 
Table 5). Several significant differences were found for body weight in F2 
male rats on P1. Like the females, the 1 mg/kg group had lower body 
weights and the 10mg/kg group had the highest body weights (1 mg/kg vs. 
10 mg/kg: p < 0.01). Although not significantly different from controls, a trend 
was found for differences in body weight between 1 mg/kg and control pups. 
The male control group pups were also significantly smaller than the 10 
mg/kg group (p < 0.01; Table 5). Anogenital distances were equivalent 















P1 female body weight  
(g) 
6.22 ± 0.22 
(n=57) 
6.53 ± 0.26 
(n=64) 
5.89 ± 0.23c 
(n=64) 
6.68 ± 0.16 
(n=52) 
P1 female anogenital  
distance (mm/g3) 
0.75 ± 0.04 
(n=50) 
0.79 ± 0.04 
(n=64) 
0.77 ± 0.04 
(n=64) 
0.72 ± 0.02 
(n=52) 
P1 male body weight  
(g) 
6.61 ± 0.15a 
(n=72) 
6.89 ± 0.32 
(n=50) 
6.16 ± 0.20 
(n=58) 
7.04 ± 0.15a 
(n=73) 
P1 male anogenital  
distance (mm/g3) 
1.57 ± 0.05 
(n=72) 
1.64 ± 0.06 
(n=50) 
1.60 ± 0.10 
(n=58) 




Body weights and anogenital distance were measured on P1, prior to culling 
litters. Anogenital distances are shown normalized to body weight. Number 
of individuals per treatment per endpoint are given in parentheses.  Data are 
shown as mean + SEM. Female anogenital distance: No differences were 
detected. Female body weight: The 1 mg/kg group had smaller body weights 
than the 10 mg/kg group (p < 0.05), but did not significantly differ from 
control. Male anogenital distance: No significant differences were found. 
Male body weight: The control group was significantly smaller than the 10 
mg/kg group (p < 0.01). The 1 mg/kg group was also significantly smaller 
than the 10 mg/kg group (p < 0.01). a. p < 0.01  
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F2 BODY WEIGHT AND ANOGENITAL DISTANCE DURING 
DEVELOPMENT 
Repeated measures ANOVA showed that F2 female body weights 
were significantly affected by age (p < 0.0001) but not A1221 treatment (p = 
0.28), although a significant interaction of age with treatment was detected (p 
< 0.02; Figure 4). In general, body weights were smallest in the 1 mg/kg 
group, and largest in the 10 mg/kg group. Post-hoc analysis showed 
significantly larger body weights of the 10 mg/kg group vs. the 1 mg/kg group 
on P1 and 3  (p < 0.05), and P5 (p < 0.01). On P5, the 1 mg/kg group also 
tended to be heavier than the 0.1 mg/kg group (p < 0.07). However, on P40-
42, the 1 mg/kg group was significantly lighter than the control or 0.1 mg/kg 
groups (p < 0.05). F2 female anogenital distance was similar across all 
groups as no main or interaction effects were detectable via repeated 
measures ANOVA (Figure 4). 
 
F2 POSTNATAL MATURATIONAL MARKERS 
There were no significant differences between treatment groups for 
developmental markers of EO, VO, FE, or FD (Table 6). 
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Table 6. F2 postnatal maturational markers. 
 
   Control 0.1 mg/kg      A1221 
1 mg/kg  
  A1221 
10 mg/kg  
   A1221 
Eye Opening  15.2 ± 0.2 15.2 ± 0.2 15.3 ± 0.2 15.2 ± 0.2 
Vaginal Opening 33.2 ± 0.3 33.5 ± 0.3 33.4 ± 0.6 33.0 ± 0.4 
First Estrus 33.6 ± 0.4 33.8 ± 0.3 34.0 ± 0.7 33.8 ± 0.5 
First Diestrus 35.3 ± 0.3 35.5 ± 0.3 35.0 ± 0.8 35.9 ± 0.7 
 
 
Data shown are in postnatal age in days, mean + SEM. No significant 






F2 SERUM HORMONE CONCENTRATIONS 
Serum samples were used for assays of progesterone, estradiol and 
LH concentrations (Figure 7). Uterine/ovarian wet weights were measured 
(Figure 8). Because rats were randomly cycling, data are presented 
according to different days of the estrous cycle, across which serum 
hormone and gonadal/uterine weights exhibit natural fluctuations. 
 
Progesterone:  Circulating progesterone concentrations were analyzed on 
each of the 4 estrous cycle stages: proestrus, estrus, diestrus 1 and diestrus 
2.  Analyses of interactions between cycle stage and treatment showed 
significant effects of treatment for rats that were euthanized on proestrus. At 
that cycle stage, the control group had significantly higher progesterone 
concentrations than the 0.1 mg/kg group (p < 0.005).  Control rats also had 
higher progesterone  concentrations than the 1 and 10 mg/kg A1221 groups 
(p < 0.05). On diestrus 2, significant differences were found for the 0.1 and 1 
mg/kg groups vs. the 10 mg/kg group (p < 0.05).  
The treatment x cycle stage interaction was further investigated via 
post-hoc analysis to detect differences between circulating progesterone 
levels across the estrous cycle within each treatment group.  All treatments 
showed significant interaction between estrous cycle stage and treatment: 
the control and 1 mg/kg groups at p < 0.05, and the 0.1 and 10 mg/kg groups 
at p < 0.001.  Tukey-Kramer adjusted post-hocs for the control group 
revealed significant differences between progesterone levels on estrus 
versus diestrus 1 (p < 0.01) and between diestrus 1 and proestrus (p < 0.05).  
In comparison, of the PCB treated groups, only the 10 mg/kg group exhibited 
significantly different progesterone levels between estrus and diestrus 1 (p < 
0.001), and only the 0.1 mg/kg group showed significant differences between 
diestrus 1 and proestrus (p < 0.01).  In addition, all three treatment groups 
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had significantly lower progesterone levels on proestrus versus estrus, unlike 
control (p < 0.01 for the 0.1 mg/kg group and p < 0.001 for the 1 and 10 
mg/kg groups).  The 10 mg/kg group also exhibited differences between 
estrus and diestrus 2 (p < 0.001). 
 
Estradiol: While a significant effect of cycle stage (p < 0.001) was detected 
by two-way ANOVA, no effect of treatment (p = 0.36), nor any interaction of 
treatment with cycle stage (p = 0.13) was detected.  
 
LH: LH levels were non-normally distributed, probably due to pulsatile 
release and the presence/absence of the LH surge, thus non-parametric 
permutations statistics were used.  LH levels varied significantly by estrous 
cycle stage (p = 0.01). A significant interaction of treatment with cycle stage 
was also found (p < 0.05).  Significant interactions or trends were found on 
proestrus for control vs. 0.01 mg/kg (p < 0.01), 1 mg/kg (p < 0.05) and 10 
mg/kg (p < 0.01). Because a significant treatment x estrous stage effect was 
observed, post-hoc analyses were performed on the interactions to 
determine possible differences between LH levels across the estrous cycle of 
each treatment group.  Only the control and 10 mg/kg groups showed 
significantly different LH levels across the cycle (control p < 0.05, 10 mg/kg p 
< 0.01), suggesting that the 0.1 and 1 mg/kg groups did not vary in LH levels 
at any point of the estrous cycle tested.  Control animals had significantly 
higher LH levels on proestrus than on diestrus 1 or 2 (p < 0.05 for each).  
The 10 mg/kg group shared the same pattern (p < 0.01) and additionally had 





Figure 7: F2 serum hormone 
levels across the estrous 
cycle. A. Serum 
progesterone: Significant 
differences in serum 
progesterone levels were 
found on proestrus (p < 
0.005 for control vs. 0.1 
mg/kg and p < 0.05 for 
control vs. 1 and 10 mg/kg 
groups) and are designated 
by the letter a. in the Figure.  
Number of individuals in 
control, 0.1, 1, and 10 mg/kg 
groups were : 34, 51, 34, 
and 45, respectively.  B. 
Serum Estradiol: a significant 
effect of cycle stage (p < 
0.001) was detected, but 
post-hoc analysis did not 
detect any specific 
significant differences 
between groups.  Number of 
individuals in control, 0.1, 1, 
and 10 mg/kg groups were 
31, 47, 30, and 42, 
respectively: C. Serum LH: 
Significant interactions were 
found on proestrus for 
control vs. 0.1 mg/kg and 10 
mg/kg groups (p < 0.01), and 
control vs. 1 mg/kg group (p 
< 0.05), designated by the 
letter b. on the figure. 
Number of individuals with 
LH data in control, 0.1, 1, 
and 10 mg/kg groups were :  
36, 51, 30, and 47, 
respectively.  Data are 
shown as mean + SEM.  
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F2 OVARIAN AND UTERINE WEIGHTS 
Ovarian and uterine wet weights were measured in randomly cycling 
rats on ~P42, and results herein are described as a percentage of body 
weight and presented across the estrous cycle in Figure 8. For the ovary, 
two-way ANOVA showed a significant effect of treatment (p < 0.05) and cycle 
stage (p < 0.0001), but no interaction. Post-hoc analyses of treatment 
showed differences for control vs. 0.1 mg/kg (p < 0.05), and a non-significant 
trend between control vs. 1 mg/kg (p = 0.051).  Two-way ANOVA for the 
uterus showed a non-significant treatment effect, but a significant effect of 





Figure 8: F2 0varian and uterine weights on ~P42, expressed as a 
percentage of body weight and shown here according to estrous cycle day. 
The number of individuals per per treatment group for control, 0.1, 1, and 10 
mg/kg were, respectively, 38, 51, 34, and 48.  Data shown are mean + SEM. 
A. Ovarian Weights. Although no interaction was observed between 
treatment and estrous cycle day, A1221 treatment was found to have a 
significant overall effect on the control vs. 0.1 mg/kg group (p < 0.05).  The 
control vs. 1 mg/kg group comparison also demonstrated a non-significant 
trend for a difference (p = 0.0514). B. Uterine Weights. No significance was 




 The current study was designed to test the effects of exposures to 
PCBs on female development, reproductive physiology, and fertility. 
Although aspects of such work have previously been undertaken, our study 
brings together three important features. First, we utilized low-dose, 
environmentally-relevant concentrations of PCBs (Zhang, et al., 2004), and 
employed a dose-response approach. The latter is particularly important 
because hormonally-active compounds can act via non-traditional 
mechanisms such as U- or inverted-U-shaped dose-response curves, and it 
is important to span a range of dosages to reveal these dose-response 
relationships (Calabrese and Baldwin, 2001a, De Kloet, et al., 1998, Gore, 
2001). Second, we examined effects of fetal exposure of the F1 individuals 
on adult endpoints. The model of fetal basis of adult phenotype is also 
important because the developing organism is particularly vulnerable to 
exposure during periods when organ and neural systems are being 
organized (Gore, et al., 2006a). Third, our experiments extended analyses to 
the F2 offspring, in order to assess possible transgenerational effects, 
something that has been reported for several species (Fernie, et al., 2001, 
Kaneko, et al., 1974, Mccoy, et al., 1995) and with other environmental 
toxicants (Anway, et al., 2005).  
 Direct comparison of the two generations examined within this study 
was precluded by methodological differences in the experimental protocol 
applied to each cohort.  For example, the first generation was culled to 4 
females, while the second was culled to 6, which could promote larger body 
size in the first generation due to fewer demands on resource allocation.  
Additionally, circulating hormone profiles and uterine and ovarian weight 
were likely to be affected by the advanced age and sexual experience 
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(impregnation) of rats in the first generation, compared to rats in the second 
generation.   
Several indirect mechanisms may also be a factor for differential 
effects in the first versus second generation.  Gestational delivery of PCBs 
can affect both the dam as well as the embryos.  Direct dosing can alter 
maternal response of the F0 generation dams to their pups (Simmons, et al., 
2005) whereas in utero PCB exposure of the pups can influence F0 dam 
maternal behaviors via an unknown signal (Cummings, et al., 2005), with 
implications for decreased milk let-down (Cummings, et al., 2005).  Certain 
PCBs induce hypothyroidism (Gauger, et al., 2004), which can antagonize 
lactation and decrease milk quality (Hapon, et al., 2007).  If PCB treated F0 
dams experienced altered thyroid hormone levels, they may have produced 
less lactate of a poorer quality, resulting in differential nutritional supply to 
pups in the first versus the second generation.  Finally, developmental 
exposure of mice to a similar endocrine disrupting chemical, bisphenol A, 
causes latent deficits in maternal behaviors in adulthood (Palanza, et al., 
2002), suggesting that in utero exposure to PCBs may alter adult maternal 
behaviors of the F1 generation.  Abnormal maternal behaviors or lactation 
may affect the physical development (Smart, et al., 1983) and adult 
behavioral phenotype  (Meaney, 2001) of the offspring . 
During statistical analyses, the effect of dam identity, i.e. “dam 
effects”, on each endpoint were investigated.  When significant, dam effects 
was included as a covariate for analysis; however, it is additionally 
informative to note which endpoints exhibit dam effects as a clue to 
understanding how PCB toxicity may be conducted transgenerationally.  For 
example, the effect of dam on uterine weight in the F1 (p < 0.0001) and the 
F2 (p < 0.0000) generation was highly significant.  This suggests that either 
the physiology of the F0 dam or the accuracy or exact location of the PCB 
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injection may have had a large enough impact as to set uterine weight values 
for the subsequent two generations.  There was no interaction between dam 
effects and ovarian weight in the F1, but this association was highly 
significant in the F2 (p > 0.0009) generation.  The lack of association in the 
F1 is likely due to the fact that ovaries were only harvested on the day of 
estrus, and this single time point may not be as informative as data 
representing all days of the estrous cycle, such as in the F2.   
Dam effects in the F1 and F2 were associated with different circulating 
hormones.  Whereas dam effects predicted only progesterone levels in F1 
animals (p < 0.01), dam effects were only linked to estradiol levels in the F2 
(p < 0.05).  It is likely, again that recording hormone levels across the estrous 
cycle would give more power to F1 analyses to more accurately determine 
dam effects.  Alternatively, the data as presented allow for the possibility that 
F0 and F1 gestational physiologies affected the hormone state of their 
offspring in different manners; for example, A1221 may have acted as an 
estrogen in developing F1 females, resulting in abnormal patterning of the 
neuroendocrine brain with implications for altered release of progesterone, 
estrogen, or oxytocin during their pregnancy, This might result in an F2 
generation that experienced a different, but equally detrimental, pathological 
hormonal environment during development, with different implications for 
adult reproductive physiology. 
There were no consistent trends in negative health effects of PCB-
exposed females, although one F1 female in the 1 mg/kg treatment group 
developed mammary tumors of unknown origin during her pregnancy, at 
approximately 4 months of age.  Autopsy found metastasis of the cancer to 
lungs, uterus, and ovaries, although microscopic histological analysis was 
not conducted.  In addition, one F2 litter in the 10 mg/kg group presented 
chronic eye irritation characterized by discharge and loss of fur surrounding 
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the eyes.  This was not believed attributable to PCB treatment and no 
viruses were detected in afflicted individuals. 
 
EFFECTS OF PCBS ON LITTER SIZE AND SEX RATIO IN TWO 
GENERATIONS (F1 AND F2) 
For the current study, we chose dosages of A1221 that mimic 
environmental exposures (Zhang, et al., 2004), anticipating that these low-
level exposures would not have gross morphological effects. Rather, we 
sought to investigate more subtle and long-lasting outcomes of A1221 
treatment. As predicted, A1221 had no significant effect on litter size in the 
fetally exposed F1 litters.  
 
EFFECTS OF PCBS ON BODY WEIGHT, ANOGENITAL DISTANCE, AND 
SOMATIC AND SEXUAL DEVELOPMENT ACROSS TWO GENERATIONS 
(F1 AND F2) 
We monitored body weights and measured the anogenital distance of 
all male and female pups on postnatal day 1 (P1). Body weight is a useful 
index of maternal lactational physiology or nursing behavior, and can be an 
indicator of sickly pups. Previous PCB studies have shown decreased birth 
weight and growth rate in exposed animals (Bowers, et al., 2004, Hany, et 
al., 1999, Turk and Hietman, 1976), and humans (Taylor, et al., 1984). 
Nevertheless, in our study, no effects of prenatal A1221 were found for F1 
pups on P1. Differences in body weight were detected for the F2 generation. 
Specifically, body weight in the 1 mg/kg F2 offspring was smallest in both 
male and female pups. However, we believe this is probably attributable to 
the larger litter sizes in that group (see Figure 3).  
Anogenital distance in the neonate is determined by prenatal 
androgens (Gray, et al., 1994), and can be a sensitive measure of endocrine 
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disruption. In the F1 generation, anogenital distances were only different for 
one group: in the 0.1 mg/kg female F1 pups on P1, anogenital distance was 
larger than that in all other groups, suggesting a slight masculinization of 
females. F2 rats did not differ by treatment for anogenital distance.  
After P1, the two generations of female rats were also monitored 
regularly for body weight and anogenital distance throughout the study.  For 
the F1, only one age showed significant differences between a treated and 
the control group:  P34 for the 1 mg/kg treatment group.  In the F2 
generation, the 1 mg/kg group had the lightest body weight at age P42, just 
prior to euthanasia, and future research will investigate whether consistently 
lower body weights in the F2 are associated with the 1 mg/kg treatment level 
through later time points.  The 1 mg/kg treatment group demonstrated the 
greatest number of disrupted endpoints in a related experiment testing the 
effects of A1221 on female sexual behaviors (Steinberg, Juenger, and Gore, 
2007; in press), and thus it may be significant that this difference in weight 
occurs during the pubertal period of female rats.  No effects on F2 anogenital 
distance were found.  
Despite some differences in body weight among A1221-exposed F1 
rats and their F2 offspring, the developmental landmarks of eye opening, 
vaginal opening, first estrus, and first diestrus were unaffected by PCB 
exposure. This result is not surprising considering the relatively low doses 
employed in the current study and is consistent with other reports (e.g. 
(Salama, et al., 2003)).   
 
EFFECTS OF PCBS ON SERUM HORMONES AND UTERINE/OVARIAN 
WEIGHT IN TWO GENERATIONS (F1 AND F2) 
Serum hormone and gonadal weights were measured in the F1 and 
F2 generations after euthanasia. Results for the two generations are 
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discussed separately because of experimental differences: first, F1 females 
were euthanized the day after mating whereas the F2 generation were 
euthanized one week post-puberty, were sexually naïve, and were randomly 
cycling. Second, F2 rats were slightly younger than F1 rats at the time of 
euthanasia.  
In the F1 generation, two of the three hormones measured 
(progesterone, estradiol) were unaffected by A1221, whereas serum LH 
concentrations were significantly altered by A1221, specifically in the 1 
mg/kg group. This effect of the intermediate PCB dose is similar to other 
reports on inverted U-shaped dose-response curves (Calabrese and 
Baldwin, 2003). We did not detect significant differences in ovarian or uterine 
weights among the four treatment groups. Because most serum hormones 
and organ weights were unaffected by treatment, differences in the F2 
generation discussed below are likely attributable to other mechanisms, such 
as altered maternal behaviors of F1 rats or altered pregnancy or parturition-
dependent phenotypes. Although it was beyond the scope of the present 
study to quantify maternal behavior, this is a subject of future work. 
 In the F2 generation, serum hormone data were profoundly altered by 
A1221. As a whole, the hormonal profiles of progesterone and LH across the 
estrous cycle suggest that the PCB groups lack a preovulatory gonadotropin 
surge, or that the surge was abnormally timed. On proestrus, the day of the 
surge, none of the three treatment groups exhibited the increased 
progesterone and LH concentrations characteristic of a surge, such as was 
observed in our control rats. In fact, when considered across the estrous 
cycle, the hormone profiles are consistent with a dampening and/or a shift in 
the timing and pattern of circulating hormone levels, an effect that could 
greatly interfere with fertility. Moreover, low levels of LH on proestrus in the 
absence of altered estradiol concentrations suggests a difference in the 
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positive feedback effects of estradiol on that day and are supportive of a 
hypothalamic and/or pituitary impairment. The results on ovarian and uterine 
wet weights across the estrous cycle are consistent with our hormonal 
profiles. Both ovarian and uterine weights were higher on estrus than on 
other days of the cycle for all groups, but effects were dampened in the PCB 
groups compared to the control groups. Again, this suggests a decreased 
ability of these tissues to respond to regulatory hormone signaling, 
particularly on proestrus and estrus when differences were greatest. As a 
whole, sex hormone levels and reproductive tract weights of F2 rats indicate 
a transgenerational effect of A1221 on ovulatory processes. Although we do 
not know if these same mechanisms were in play in the F1 generation as all 
rats were euthanized the day after mating, we do know that that generation 
was fertile and capable of producing the F2 generation. However, we found 
in other experiments that the F1 PCB-treated rats required additional paced 
mating trials to mate (Steinberg, et al., 2005) suggesting an uncoupling of 
reproductive physiology and behavior. In future studies we will characterize 
the full reproductive ovulatory profiles of F1 rats; however that was beyond 
the scope of the current study.  
 
POSSIBLE MECHANISMS FOR EFFECTS OF A1221 ON F1 AND F2 
FEMALE RATS 
The observed in vivo effects of PCBs, as well as most other 
endocrine-disrupting chemicals, are likely attributable to complex actions on 
multiple systems. For example, PCBs can alter any or all of the following: 
activity of enzymes involved in hormone or neurotransmitter metabolism or 
biosynthesis (Drenth, et al., 1998, Kester, et al., 2000, Liu, et al., 1995), 
mRNA stability (Lin, et al., 2006b, Pocar, et al., 2001), cell and mitochondrial 
membrane integrity (Tan, et al., 2003, Tan, et al., 2004b), serum hormone 
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binding proteins (Chauhan, et al., 2000, Hodgert Jury, et al., 2000), along 
with direct actions on nuclear receptors including the estrogen receptor, 
thyroid receptor, and aryl hydrocarbon receptor (Kafafi, et al., 1993, Moore, 
et al., 1997, Schrader and Cooke, 2003). Furthermore, neurotransmitter 
systems such as norepinephrine (Seegal, et al., 1985), dopamine (Seegal, et 
al., 1990), serotonin (Morse, et al., 1996b) and acetylcholine (Provost, et al., 
1999a) are also targets of PCBs. With particular reference to A1221, weak 
estrogenic effects (Shekhar, et al., 1997), weak anti-androgenic effects 
(Schrader and Cooke, 2003), but little or no association with aryl 
hydrocarbon receptor (Kafafi, et al., 1993) have been reported. For 
neuroendocrine systems, our laboratory reported that A1221 given 
perinatally can down-regulate estrogen receptor beta expression in the 
anteroventral periventricular nucleus (Salama, et al., 2003), a region 
implicated in female ovulatory function (Gu and Simerly, 1997). In a 
gonadotropin-releasing hormone (GnRH) GT1-7 cell line, A1221 alters GnRH 
gene expression (Gore, et al., 2002) and preliminary work from our lab 
showed a similar effect in vivo (Gore, 2001) suggesting that hypothalamic 
GnRH neurons may be targets of A1221. Finally, A1221 alters adult female 
sexual behaviors in rat (Chung and Clemens, 1999, Chung, et al., 2001), 
suggesting a link between effects of A1221 on brain physiology and 
reproductive behavior. 
It is not surprising that the current transgenerational effects of A1221 
were observed. Transgenerational effects have been observed in studies of 
diethylstilbestrol (DES), a transplacental carcinogen and endocrine disrupting 
chemical previously prescribed to pregnant women.  DES leads to 
tumorogenesis (Walker and Haven, 1997) and decreased fertility (Newbold, 
et al., 1998, Turusov, et al., 1992) in the F1 offspring of exposed pregnant 
mice, and can increase tumorogenesis although not infertility in F2 offspring 
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(Newbold, et al., 2000).  These effects were ascribed by the authors as 
potentially being due to gene imprinting (Li, et al., 1997, Newbold, et al., 
2000) although the formation of DNA adducts leading to mutation in gametic 
stem cell lines is also discussed.   A1221 impairs fertility and embryogenesis 
in a mouse in vitro fertilization model (Kholkute, et al., 1994a), and induces 
genotoxic effects via intrachromosomal recombination (Aubrecht, et al., 
1995) and deletions (Schiestl, et al., 1997) in situ and in vivo.   
We postulate four possible explanations for the transgenerational 
effects we observed, that are not mutually exclusive:  (1) A1221 exposure 
directly introduced genotoxic effects in the germline of F1 females; (2) A1221 
altered epigenetic patterning (e.g., DNA methylation/acetylation) in the F1 
embryos, which was then passed to the F2; (3) A1221 caused changes in 
the behavior of the F1 dams towards their F2 pups, which in turn modified 
neonatal hormones of the fetuses and subsequently altered steroid 
hormones; or (4) prenatal A1221 exposure altered circulating hormone levels 
during pregnancy in the F1, which exposed developing embryos to an 
improper hormonal environment.  These four possibilities are discussed 
below. 
Gross chromosomal aberration (1) caused by PCBs in the developing 
embryo’s germ cell line may have multigenerational effects.  A1221 is known 
to induce mitotic deletion events (Aubrecht, et al., 1995, Schiestl, et al., 
1997).  One of the major constituents of A1221, PCB5, can increase the 
incidence of recombination in Drosophila line used to compare 
carcinogenicity of test substances (Butterworth, et al., 1995).  When 
chromosomal damage occurs in the developing germ line, it has the potential 
to be transmitted to offspring  (Choudhury, et al., 2000).  Although A1221 
may be causing gametotoxicity in F1 offspring, it is unlikely that this gross 
chromosomal aberration would result in a uniform F1 or F2 developmental or 
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physiological phenotype.  However, chromosome damage of the germ line 
may be related to the slight, but non-significant, effects observed on sex ratio 
in the F2. 
Epigenetic alteration of the tertiary structure of DNA (2) involves the 
addition or removal of methyl or acetyl groups at specific base pair 
sequences, and causes a long-term alteration in gene expression levels.  
Epigenetic alterations normally occur at specific stages of somatic and 
reproductive development, or can be artificially induced by toxin exposure in 
the adult (Bollati, et al., 2007). Multigenerational transmission of a 
developmentally induced F1 epigenetic pheotype may be accomplished due 
to epigenetic patterning of the proto-germ cell line during development.  
Acute exposure of embryonic male rats to the anti-androgen fungicide 
vinclozolin (Anway, et al., 2005, Chang, et al., 2006) or the estrogenic 
substance methoxychlor (Anway, et al., 2005) during the period of male 
gonadal sex determination causes decreased sperm count and increased 
occurrence of infertility in the exposed generation.  The offspring of these 
male rats exhibited the same detrimental phenotype for at least three 
generations, the extent of the experiments.  In the case of vinclozolin, this 
effect was attributed to epigenetic alteration of gene methylation in at least 
15 candidate genes tested (Chang, et al., 2006).  
In addition to germ cell alteration, poor or abnormal maternal care due 
to PCB exposure during pregnancy can result in epigenetic changes in 
somatic DNA metastructure (3) of subsequent generations.  For example, rat 
pups receiving substandard maternal care from a dam undergo epigenetic 
patterning of glucocorticoid receptor (Weaver, et al., 2004).  Simultaneously, 
estrogen receptors alpha and beta in the preoptic area of the brain are 
epigenetically imprinted, leading to decreased adult expression of their 
protein products (Champagne, et al., 2006). Multigenerational transmission 
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of the epigenetic change has not been verified, however female pups raised 
by a genetically unrelated dam showing poor maternal behaviors will similarly 
exhibit poor maternal care for her offspring (Champagne and Meaney, 2001), 
suggesting the potential for multigenerational transmission of this epigenetic 
alteration.  
Certain toxicants can alter hormone signaling, and when this occurs 
during pregnancy, a second generation may be affected (4).  During the 
period of PCB administration in this experiment, on E16 and E18, circulating 
estradiol and prolactin levels are low, and circulating progesterone levels are 
high (Rosenblatt, et al., 1994).  Introduction of an endocrine active substance 
such as PCBs during this period has the potential to alter endogenous 
hormone levels.  Exposure of pregnant rats to 17α-ethinylestradiol slightly 
earlier in the gestational period, from E9-E14, can alter maternal behaviors 
and induce anxiety-like behaviors in offspring (Arabo, et al., 2005).  Prenatal 
exposures to nicotine can induce age-delayed impairment in ovarian and 
uterine steroidogenesis with implications for next-generation development 
(Holloway, et al., 2006).    
It is likely that several of these mechanisms contribute to the 
multigenerational effects of A1221 exposure.  Epigenetic patterning and 
altered maternal care of offspring can both be influenced by, or can 
themselves alter hormone signaling. Thus, while observed effects on altered 
circulating hormones and gonadal weights in second generation-exposed 
females are likely due to epigenetic patterning or an improper embryonic 
hormonal milieu, trends in litter size and sex ratio may be influenced by 





 We have demonstrated that prenatal exposure to low-levels of Aroclor 
1221, a lightly-chlorinated PCB mixture and environmental toxicant, has 
complex effects on physiology, fertility, and fecundity spanning two 
generations. The most salient results from this study include altered uterine 
weights and circulating hormone levels in the second generation consistent 
with aberrant ovulatory processes that may diminish reproductive success.   
The finding of multigenerational effects is important because it signals that 
halting production of a toxic substance such as PCBs is not sufficient to 
prevent further health risks.  Altered sex hormone regulation in the second 
generation may also negatively impact fertility and fecundity and could 
induce abnormal development of further generations. 
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Research Section 2: 
The effects of prenatal PCBs on adult female paced 
mating reproductive behaviors in rats 
 
Abstract 
Polychlorinated biphenyls (PCBs) are a family of toxicants that persist in 
measurable quantities in human and wildlife tissues, despite a ban on their 
production in 1977. Some PCB mixtures can act as endocrine disrupting 
chemicals (EDCs) by mimicking or antagonizing the actions of hormones in 
the brain and periphery. When exposure to hormonally active substances 
such as PCBs occurs during vulnerable developmental periods, particularly 
prenatally or in early postnatal life, they can disrupt sex-specific patterning of 
the brain, inducing permanent changes that can later be manifested as 
improper sexual behaviors. Here, we investigated the effects of prenatal 
exposure to the PCB mixture Aroclor (A) 1221 on adult female reproductive 
behaviors in a dose-response model in the Sprague-Dawley rat. Using a 
paced mating paradigm that permits the female to set the timing of mating 
and control contact with the male during copulation, we were able to uncover 
significant differences in female-typical sexual activities in A1221-exposed 
females. Specifically, A1221 causes significant effects on mating trial pacing, 
vocalizations, and the female’s likelihood to mate. Furthermore,  the 
intermediate treatment group has the greatest number of disrupted 
endpoints, suggestive of non-linear dose-responses to A1221. These data 
demonstrate that the behavioral phenotype in adulthood is disrupted by low, 
ecologically relevant exposures to PCBs, and the results have implications 




Polychlorinated biphenyls (PCBs) were used in industry as inflammable 
coolants and lubricants and as components of paints and plastics. Banned in 
1977 in response to dawning public awareness of their estrogenic and 
potentially toxic effects on humans and wildlife, PCBs continue to leach into 
soil, air, and groundwater via retired industrial equipment, and from old 
factories and buildings. PCBs may have variable degrees of impact 
depending on which congeners or congener mixtures are involved, the 
organism’s age at exposure, the sex of the individual, the degree of 
exposure, and the availability of compensatory diet or social buffering to 
counteract those effects. An accurate evaluation of ecologically relevant 
xenobiotic exposure depends on the close examination of PCB exposures at 
low doses (Battershill, 1994, Brouwer, et al., 1999).  
The neuroendocrine system serves as an interface between the 
central nervous system and peripheral endocrine organs, and thus 
represents a prime target for endocrine disruption by PCBs (Patisaul, et al., 
2006). PCBs and their metabolites can act at multiple nodes of the 
neuroendocrine axis: they may serve as hormone mimics (Connor, et al., 
1997), alter circulating hormone levels (Desaulniers, et al., 1999), change 
patterns of estrous cyclicity (Meerts, et al., 2004a), disrupt hormone 
metabolism (Gregoraszczuk, et al., 2005, Kester, et al., 2000, Yamane, et 
al., 1975), influence endocrine-related and hypothalamic gene expression 
(Aluru, et al., 2004, Bansal, et al., 2005, Colciago, et al., 2005, Flouriot, et al., 
1995, Gore, et al., 2002, Pravettoni, et al., 2005, Salama, et al., 2003), 
interfere with hormone binding proteins (Brouwer and Van Den Berg, 1986, 
Chauhan, et al., 2000), alter neuronal signaling to endocrine regions of the 
brain (Khan and Thomas, 2001, Morse, et al., 1996b, Seegal, et al., 1985, 
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Seegal, et al., 1990) or indirectly affect steroid receptor availability via 
molecular crosstalk (Brunnberg, et al., 2003, Pearce, et al., 2004).   
The behavioral phenotype is perhaps the most sensitive and salient 
measure of PCB disruption of the neuroendocrine system, because 
reproductive success hinges upon the normal complement of reproductive 
behaviors. Previously, PCBs and their metabolites were shown to impact 
neurotransmitter and steroid hormone systems underlying reproductive 
function (Khan and Thomas, 2001, Ptak, et al., 2005, Seegal, et al., 1985, 
Seegal, et al., 2002, Tsai, et al., 1997). These changes in turn are likely to 
have profound effects on reproductive behaviors. Moreover, the timing of 
exposure to PCBs is key to the severity of the reproductive phenotype. In 
particular, exposure during the critical period of brain sexual differentiation is 
potentially detrimental. This critical period in rats has been proposed to begin 
in the third trimester of pregnancy and end shortly after birth, from 
approximately embryonic day 16 to postnatal day (P) 5 in rats (Becu-
Villalobos, et al., 1997, Breedlove, 1992, Dohler, 1991, Rhees, et al., 1990, 
Tobet and Fox, 1989, Wagner, et al., 1998) although a revisitation of brain 
sensitivity to steroid hormones suggests that the critical period may last 
longer into postnatal life than previously thought (Primus and Kellogg, 1990, 
Romeo, 2003). Nevertheless, it is clear that late gestation, the time during 
which we administered PCBs in our current study, is an important critical 
window in the organization of sex-typical behaviors (Perakis and 
Stylianopoulou, 1986). It represents a period during which hypothalamic 
GnRH neurons are developing (Aubert, et al., 1985), hypothalamic and 
preoptic area estrogen receptor alpha expression increases (Pasterkamp, et 
al., 1996), and sexually dimorphic progesterone receptor expression is 
determined (Chung, et al., 2001, Wang, et al., 2002). 
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In the present study, we investigated the effects of prenatal exposure 
to the PCB mixture Aroclor (A) 1221 on adult female reproductive behaviors, 
using a dose-response model encompassing ecologically-relevant 
exposures, and a paced mating paradigm to uncover feminine reproductive 
behaviors in the Sprague-Dawley rat. Our results show specific impairments 
in several feminine sexual behaviors that have implications for reproductive 
success. 
 
Materials and Methods 
ANIMALS 
All experimental procedures were performed following protocols 
approved by the Institutional Animal Care and Use Committee at the 
University of Texas at Austin. Timed pregnant Sprague-Dawley rats were 
purchased from the University of Texas Animal Resources Center, and were 
housed individually under a 12:12 light cycle. Animals were fed low-
phytoestrogen rat chow (Harlan Teklad Global Diet 2019) and water ad 
libitum. Pregnant dams were intraperitoneally injected with 0.1 ml of vehicle 
(dimethyl sulfoxide, DMSO) or Aroclor 1221 (Accustandard #C-221N-50MG; 
Lot#072-202, reconstituted in DMSO) at one of three doses (0.1, 1, or 10 
mg/kg), on E16 and E18, the third trimester of pregnancy in rats. 
Intraperitoneal injection was chosen as a mode of administration to eliminate 
possible variability in gastrointestinal absorption via oral exposures, as per 
the experimental methods of other published studies of PCB effects (Chung 
and Clemens, 1999, Gillette, et al., 1987, Murugesan, et al., 2005).  
PCBs administered to the dam are not fully transferred to offspring, 
either during gestation or via lactation, and amounts transferred to each pup 
are estimated to be approximately 500x less than maternal exposure 
(Takagi, et al., 1986). Therefore, we estimate that our pups were exposed to 
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a maximum of 0.2, 2 and 20 µg/kg, in the range of estimated human 
exposures (Lackmann, 2002). Impregnated dams were handled throughout 
the first few weeks of gestation to minimize stress of handling during 
injections, and a two-person method of injection was used to ensure 
accurate localization of the injection and to decrease stress. For this method, 
one person gently held the rat and a second person administered the drug; 
rats remained calm through the procedure due to extensive handling 
experience. Nesting materials were provided on gestational day 20, and the 
day of birth was recorded as P0. Pups were not handled until P1 in order to 
reduce stress to the dams and pups, and to avoid the possibility of 
interrupting parturition.  
On P1, litters were culled to 4 female pups per litter (or fewer if litters 
had fewer females) in order to minimize inter-litter variability. Whereas culling 
to single-sex litters may impact the development of normal sociosexual 
behaviors (Moore and Morelli, 1979, Pellis and Pellis, 1997, Sharpe, 1975), 
dams show suckling and grooming preferences that differ depending upon 
sex ratio (Crews, et al., 2006, Szyf, et al., 2005). Rats were weaned on P22 
to 3-4 littermates/cage. Daily vaginal smears were conducted to determine 
estrous cyclicity following puberty. The control (vehicle), 0.1 mg/kg, 1 mg/kg, 
and 10 mg/kg A1221 treatment groups contained, respectively, 11, 11, 10, 
and 10 litters, and 3-4 females were used per litter for behavioral tests 
described below. 
 
PACED MATING CAGE 
Female sexual behaviors were tested using a paced mating protocol 
(Coopersmith and Erskine, 1994, Erskine, 1985, Paredes and Vazquez, 
1999). Paced mating cages were constructed of a 30” long x12” wide x 17” 
tall Plexiglas aquarium fitted with a clear Plexiglas panel bisecting the cage 
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lengthwise. Two 1.75” diameter openings at the base of this panel allow the 
female to pass between the two chambers, however, the males were too 
large to fit through the openings. The side of the cage that restricts the male 
is hereby referred to as the “mating chamber” and the other side is called the 
“escape chamber”.  Figure 9 shows an image of the cage. 
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Figure 9: Paced Mating Cage 
 
 
Figure 9.  The paced mating cage is a Plexiglas aquarium bifurcated by a 
clear Plexiglas divider containing two holes equally spaced from the midline.  
The female, on the right in the escape chamber, is small enough to easily 
pass through either opening. The male, shown at the far corner on the left in 




CRITERIA, PREPARATION FOR, AND ANALYSIS OF TRIALS 
Paced mating experiments commenced when the females reached 
P50. Experimental trials were conducted starting at 5 hours after lights out 
under dim red lighting, on the evening of proestrus, a time when females are 
sexually receptive (Barfield and Lisk, 1970). Sexually experienced but 
otherwise experimentally untreated males (7-11 months) were used. Rats 
were habituated to the mating cage at least twice prior to the experiment for 
20 minutes (males) or 10 minutes each (females). One hour prior to each 
experiment, activity levels (ambulation) of experimental females were tested 
by allowing the female to roam freely throughout the mating cage for 10 
minutes. The baseline ambulation rate determined by counting the number of 
times the female crossed the panel during the 10 minute period. This pretrial 
ambulation value was later used to normalize the mating trial ambulation. 
Males were placed into the mating chamber for at least 20 minutes directly 
preceding each mating trial, after which a solid opaque divider was placed 
between the chambers. The experimental female was then introduced to the 
escape chamber, and the opaque divider was lifted to begin the trial. Paced 
mating parameters were scored for statistical purposes through seven 
intromissions (Edmonds, et al., 1972, Erskine, et al., 2004). This choice was 
made because female rats receiving between 5 and 10 intromissions are 
most sensitive to mating trial pacing in the establishment of pregnancy 
(Erskine et al., 2004). As the number of intromissions to ejaculation was 
variable we chose seven as a standard number for most analyses, and it 
falls within this range of 5 to 10. In addition, trials were allowed to proceed to 
the first ejaculation so that post-ejaculatory behaviors could be recorded, but 
non-ejaculatory events following the seventh intromission were not included 
in analysis, or in calculating trial length. After each trial, the male and female 
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were placed in a housing cage and allowed to continue mating overnight to 
reinforce the behavior for the males.  
Females that did not show lordosis within 20 minutes in the presence 
of a sexually active male were permitted 3 additional mating trial 
opportunities that always occurred on the evening of proestrus. After four 
unsuccessful mating trials, females were eliminated from the experiment and 
were excluded from analyses. In order to eliminate any effect of the male, the 
same male animals were mated at different times with females from control 
and all three doses of PCB-treated groups. Males were given 2-3 day 
intervals between mating trials to prevent fatigue. The day following a 
successful mating trial, vaginal smears were conducted to determine the 
presence of sperm, and vaginal cytology was recorded. Females were then 
weighed and euthanized via decapitation.   
Trials were recorded on videotape for later review by the 
experimenter, who was blind to the rats’ identities. Following completion of 
mating trial event logs, treatments were decoded and analysis was 
performed on the following parameters (described in Table 7): Male-typical 
behaviors, mating trial pacing, avoidance/rejection behaviors, ambulation, 
and receptivity. When calculating total time for the mating trial, post-
ejaculatory refractory period was not included. Female vocalizations were 
recorded as the number of audible vocalizations per minute. When a female 
failed to vocalize during a mating trial, she was given a score of 0, which was 




 Table 7. Paced Mating Behaviors  
 
Mating Trial Pacing 
Mount-return latency Mean time between a mount and the female’s return to the 
mating chamber 
Intromission-return latency Mean time between an intromission and the female’s return 
to the mating chamber 
Ejaculation-return latency Mean time between an ejaculation and the female’s return 
to the mating chamber 
 
Avoidance and Rejection Behaviors 
% Time in escape chamber Time in the escape chamber/trial length 
 
Rejection quotient (# lateral kicks + # face-to-face’s)/# mounts 
 




Pretrial activity level # crossings of empty mating cage/10 minute period 
 
Trial activity level # crossings of mating cage/trial length 
 
Normalized activity levels Trial activity level/pretrial activity level 
 
 
Receptivity and Proximity Behaviors 
Lordosis quotient (LQ) # lordosis/# mounts 
 
Mount % leave # times female leaves mating chamber after a mount/         
# mounts 
Intromission % leave # times female leaves mating chamber after an 
intromission/# intromissions 




Mount frequency # mounts/trial length 
 






The number of animals tested in the control, 0.1, 1, and 10 mg/kg 
groups were 35, 40, 32, and 35, respectively. We first determined whether 
each endpoint was normally or non-parametrically distributed, and then 
carried out the following analysis: with the statistical analysis software SAS 
(Littel et al., 1999), we completed a simple linear mixed model ANOVA 
analysis including a fixed treatment effect and a random dam (treatment) 
effect. In addition, we included a fixed covariate of the log transform of 
mating trial length to control for mating time. These models were estimated 
using restricted maximum likelihood and statistical significance was 
determined by a z-score or an F-value for the random and fixed terms, 
respectively. A number of the phenotypes were non-normally distributed and 
so were transformed using a log (1+y) transformation. For very highly 
skewed traits, we employed a non-parametric permutation testing procedure 
(Cassell, 2002). In this case, the phenotypes were randomized with respect 
to the experimental effects 1000 times and the analyses were completed as 
above. Here, the distribution of the test statistics under the null hypothesis 
was empirically determined with alpha set at 0.05.  If significant treatment 
effects were observed, we used a series of post-hoc tests for all 
combinations of treatments. Here we controlled for multiple tests with a 
Tukey-Kramer adjustment. For data presentation, raw data are shown, and 





MATING TRIAL PACING 
Results on latencies for females to return to the mating chamber after 
mounts, intromissions, and ejaculations are shown in Figure 10. Of the 
behaviors scored, mount-return latency (F (3, 38) = 3.53, p < 0.05) and the 
post-ejaculatory interval (F (3, 38) = 3.23, p < 0.05) were significantly 
affected by A1221 treatment (p < 0.05 for both). Post-hoc analyses of mount-
return latency revealed that the 1 mg/kg group had a longer mount-return 
latency than the 0.1 mg/kg group (p < 0.05). For post-ejaculatory return 
interval, post-hoc analysis showed that the 1 mg/kg group had a longer post-
ejaculatory interval than the 10 mg/kg treatment group.  No groups were 





Figure 10. Mating Trial Pacing. A. Mount Return Latency: A significant effect 
of treatment was found (p < 0.05), with significant differences between the 1 
mg/kg and the 0.1 mg/kg group (p < 0.05), designated by (a). B. Intromission 
Return Latency: No significant differences were detected. C. Post-ejaculatory 
Return Latency: A1221 significant altered this parameter (p < 0.03), with 
post-hoc analysis confirming significance between the 1 mg/kg and 10 mg/kg 
group (p < 0.03), designated by (b). Data shown in this and subsequent 




RECEPTIVITY AND PROXIMITY BEHAVIORS 
Neither lordosis quotient (Figure 11A), nor the percentage of mounts and 
intromissions followed by the female leaving the mating chamber (percent 
exits after mount and percent exits after Intromission, respectively) differed 
between treatment groups (Figure 11B & 11C). By contrast, when effects of 
A1221 on the number of trials required for a proestrous female to exhibit 
receptivity was quantified, a highly significant effect was found (F (3, 38) = 
4.84, p < 0.005; Figure 11D). Post-hoc analyses showed that rats in the 1 
mg/kg A1221 dose required significantly more trials to mate successfully 
compared to control rats (p < 0.005). In addition, rats in both the 1 mg/kg and 
10 mg/kg groups required significantly more mating trials than the 0.1 mg/kg 











Figure 11. Receptivity. A. 
Lordosis Quotient: No 
significant effects were 
found. B. Percent exits after 
mount: No differences 
among groups were 
detected. C. Percent exits 
after intromission: There 
were no significant 
differences among groups. 
D. Number of Attempts 
Required for a Successful 
Mating Trial: There was a 
significant difference 
between groups at p < 0.01. 
Post-hoc analysis showed 
that the 1 mg/kg group 
required significantly more 
mating trials before being 
receptive to a male 
compared to control (p < 
0.005) and 0.1 mg/kg 
treated rats (p < 0.01). 
These differences are 
designated by (a). The 10 
mg/kg group also required 
more mating trials than the 
0.1 mg/kg group (p < 0.05, 




Three behaviors were evaluated as avoidance/rejection behaviors: the 
percent time the female spent away from the male in the escape chamber, 
the numbers of kicks and face-to-face behaviors, and the number of 
vocalizations in the audible range, the latter a potential index of stress (Han, 
et al., 2005). There were no significant differences between groups for the 
percentage of time in escape chamber (Figure 12A) or for rejection quotient 
(Figure 12B). A statistically significant effect was found for female audible 
vocalizations (F (3, 38) = 2.53, p < 0.05; Figure 12C), and post-hoc analysis 
found that the 1 mg/kg group vocalized significantly less than either the 





Figure 12. Avoidance/Rejection Behaviors. A. Percent Time in Escape 
Chamber: All of the treatment groups spent approximately the same 
percentage of the mating trial away from the male in the escape chamber. B. 
Rejection Quotient: The number of face-to-face and lateral kicks in a mating 
trial divided by total mounts, did not differ among groups. C. Vocalizations: 
Statistical analyses showed an overall main effect of treatment (p < 0.05). 
Post-hoc analysis demonstrated that the 1 mg/kg had significantly fewer 
vocalizations than control (p < 0.05,) and 0.1 mg/kg (p < 0.05); these 




Although pretrial ambulation levels did not differ significantly among groups 
(Figure 13A), when mating trial ambulation was normalized to pretrial levels, 
a significant difference was detected (F (3, 38) = 3.01, p < 0.05). However, 
post-hoc analyses found no significant interactions, although the 10 mg/kg 
group showed a non-significant trend for reduced activity compared to the 







Figure 13. Ambulation.  A. Pretrial ambulation: Female activity levels were 
measured at least one hour prior to mating trial commencement in a paced 
mating cage in the absence of the male. No differences were detected. B. 
Normalized Mating Trial Ambulation Level: Mating trial activity was 
normalized to pretrial values, and a significant main effect was found (p < 






The same males were rotated through mating trials across all groups of 
females to minimize any effects of inter-male variability. We observed no 
statistically significant differences between any combination of treatment 
groups for mount frequency or intromission frequency of males towards 
females among the different treatment groups (Table 8).  
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Table 8. Male-typical behaviors. 
 Control 0.1 mg/kg 1 mg/kg 10 mg/kg 
Mount Frequency 1.40 ± 0.08 1.39 ± 0.13 1.41 ± 0.16 1.28 ± 0.13 
Intromission  
Frequency 
0.68 ± 0.05 0.75 ± 0.05 0.80 ± 0.09 0.71 ± 0.06 
 
 
Mount frequency and Intromission frequency are shown as number of events 
per minute. Neither parameter varied significantly among treatment groups. 




We investigated the effects of prenatal PCB exposures on adult 
female sexual behaviors and observed several endpoints that were 
significantly altered by A1221 exposure. Overall, we observed the greatest 
number of effects of the intermediate (1 mg/kg) dosage of A1221, exposure 
to which affected adult mating trial pacing, receptivity/proximity behaviors, 
and audible vocalizations compared to control and lower or higher doses of 
A1221. This suggests the possibility of a non-linear dose response curve 
common to endocrine disruption studies (Calabrese and Baldwin, 2001a), 
wherein an intermediate dose level elicits the greatest effects. Thus, the 
paced mating paradigm reveals that small, ecologically relevant exposures at 
a precise developmental stage can permanently alter specific aspects of 
adult female-typical sexual behaviors.  
In 1999 and 2001, two papers were published reporting that perinatal 
(embryonic day (E) 14, P0 and P10; Chung and Clemens, 1999), but not 
postnatal (P1-7; Chung and Clemens, 2001) exposure of rat dams to the 
commercial PCB mixture A1221 alters sexual behaviors in the female 
offspring in adulthood. Our current study follows up upon and extends the 
work of Chung and Clemens in several novel ways. First, we focus on effects 
of prenatal A1221 administered to the dams during the third trimester of 
gestation to clarify the role of this developmental window on latent 
reproductive behaviors. Second, we use gonadally-intact as opposed to 
ovariectomized females. Third, we use a slightly lower and broader range of 
exposures (0.1, 1 and 10 mg/kg) to approximate human and wildlife 
exposure levels and to investigate the possibility of a non-linear dose 
response curve (Gore, et al., 2006b, Weltje, et al., 2005). By comparison, the 
dosages used by Clemens’ laboratory ranged from approximately 8 to 42 
mg/kg. Fourth, and most importantly, we investigated some endpoints that, to 
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our knowledge, have not been investigated by other laboratories. Our most 
robust novel findings were of significant effects of A1221 on audible 
vocalizations, a potential index of stress during mating, and on the number of 
trials required to mate successfully. These latter results and their implications 
are discussed in more detail below. 
 
PROPERTIES OF A1221 AS AN ENDOCRINE-DISRUPTING CHEMICAL 
 A1221 has previously been shown to exert actions on endocrine 
systems. It alters numbers of estrogen receptor beta immunoreactive cell 
numbers in the anteroventral periventricular nucleus of the female rat brain, a 
region important for ovulation in rats (Salama, et al., 2003). In addition, 
A1221 interferes with other endocrine systems and functions including, but 
not limited to: the thyroid neuroendocrine axis (Kilic, et al., 2005); aromatase 
activity in vitro (Woodhouse and Cooke, 2004); it acts as an androgen 
receptor antagonist in vitro (Schrader and Cooke, 2003); it is estrogenic in 
estrogen-sensitive cell preparations (Shekhar, et al., 1997); and it can inhibit 
fertilization of the mouse oocyte (Kholkute, et al., 1994b). Together, these 
data suggest the potential for a wide spectrum of A1221 actions on 
endocrine systems.  
A1221 is a very lightly chlorinated PCB mixture containing primarily 
mono- and ortho-substituted congeners. A1221 is more volatile than more 
heavily chlorinated PCB mixtures, and exerts more transient effects 
(Thomas, et al., 1998b), making it difficult to reliably measure in biological 
samples (Frame, 1997b). Although to our knowledge, tissue burden analysis 
has not been conducted specifically for the commercial mixture A1221, half-
life analysis has been conducted on other lightly chlorinated PCBs, 
supporting a positive correlation between degree of chlorination and half-life 
(Matthews and Anderson, 1975), with the shortest half lives, associated with 
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the lowest chlorinated congeners, being in the range of several days 
(Tanabe, et al., 1981). Our experimental animals were treated in utero with 
low doses of PCBs approximately 5 days prior to birth, and were euthanized 
at approximately 60 days, making it highly unlikely that detectable PCBs 
persist. Nevertheless, our results demonstrate a long-lasting effect following 
developmental exposures. This is most likely due to interference in normal 
developmental patterning during the late embryonic sensitive period for 
neuroendocrine sexual differentiation. 
As reported previously for A1221 and other PCBs, effects on 
endocrine systems are often non-linear (reviewed in Gore et al., 2006), and 
our results support such findings. For the two endpoints that differed 
between A1221 and control rats, namely, the number of opportunities 
required for successful mating, and audible vocalizations, we observed the 
greatest effect on the intermediate dose of A1221, 1 mg/kg, compared to the 
control group. In addition, we observed several other significant differences 
between treatment groups. These latter observations demonstrate how 
employing a range of dosages is informative in revealing complex effects of 
environmental endocrine-disrupting chemicals.   
 
A1221 EFFECTS ON PACED MATING BEHAVIORS 
The paced mating paradigm enables the female rather than the male 
to control the pattern of mating. Not only is this paradigm considered most 
“rewarding” for females as measured by place preference for the location 
where paced mating occurred (Paredes and Vazquez, 1999), but it also 
increases fecundity as evidenced by the average number of pups/litter 
(Coopersmith and Erskine, 1994). Here, we observed several significant 
effects of prenatal exposure to A1221 on female mating trial pacing that 
varied by dosage, with the intermediate 1 mg/kg dosage of A1221 exerting 
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the strongest effects. One of our most robust findings was that females 
exposed prenatally to A1221 at 1 mg/kg required a greater number of 
opportunities before they would mate than either the control or the 0.1 mg/kg 
groups. The 10 mg/kg treatment group was also affected, requiring more 
mating trials than the 0.1 mg/kg group to mate successfully. 
Proximity (event-return) behaviors, which measure the female’s 
choice to remain with a male after a mating event and are revealed in the 
paced mating model, were significantly affected in A1221 rats, specifically for 
mount-return and post-ejaculatory-return latencies, which were longest in the 
1 mg/kg group. Event-return latencies are believed to be a function of the 
intensity of vaginal stimulation by the male’s pelvis and penis (Erskine, 1992, 
Wersinger, et al., 1993), and PCBs can potentially alter vaginocervical 
sensation by affecting peripheral nerve conduction, as has been shown in 
humans (Chen, et al., 1985). A longer event-return latency may thus be an 
indicator of altered vaginal sensitivity in the intermediate A1221 group. Our 
results suggest that A1221 may alter the amount of time that females choose 
to spend with males after a mating event. Consistent with this, other reports 
on PCBs have shown effects on other sensory and motor parameters in 
many systems, including audition (Crofton, et al., 2000) sensory and motor 
nerve conduction velocities (Chen, et al., 1985), and vision (Kremer, et al., 
1999).  
Not all aspects of the suite of mating behaviors were significantly 
affected by early PCB treatment. We did not detect significant differences in 
lordosis quotient (LQ) among treatment groups, although there was a non-
significant trend for the highest LQ in the 1 mg/kg group. Similarly, percent 
exits after mounts and intromissions were unaffected. These results indicate 
that only specific behaviors, and presumably specific neural circuits 
underlying these behaviors, are altered by fetal A1221 exposure.  
 
115 
The sexual behaviors of females used in this study were tested 
beginning at age P50.  Female rats achieve puberty at approximately 32-38 
days of age (See Research Section 1 of this dissertation) after which they 
are sexually mature. In the wild, animals are probably impregnated very early 
in adulthood (Mcclintock, 1983).  Mating trial pacing by the female rat is 
directly related to successful impregnation (Erskine, et al., 2004), and sexual 
behaviors of aged females are comparable to those of young female rats 
(Cooper and Linnoila, 1977). To my knowledge, the effect of sexual 
experience on female paced mating parameters has not been investigated.  
Our findings that A1221 significantly alter specific aspects of the timing of 
paced mating behaviors has relevance to wildlife exposed to endocrine-
disrupting chemicals, as such animals may not get a second chance to mate 
and reproduce in order to ensure transmission of their genes to subsequent 
generations. 
 
EFFECTS OF A1221 ON AUDIBLE VOCALIZATIONS 
 Audible rat vocalizations, in the audible human frequency range and 
with a fundamental frequency of approximately 2.5 kHz, are indicative of 
stress or pain, especially at increased temporal frequencies (Han, et al., 
2005). Audible rat vocalizations, in the human frequency range, are 
indicative of stress or pain, especially at increased temporal frequencies 
(Han, et al., 2005). Audible vocalizations, but not ultrasonic vocalizations 
were recorded in the methodology of this experiment.  Rat audible 
vocalizations are commonly studied as a response to Pavlovian conditioned 
stress, or pain anticipation (Borszcz, 1995).  Rat ultrasound vocalizations at 
22 KHz are similarly associated with stressful or noxious stimulation 
(Calvino, et al., 1996, Kaltwasser, 1990, Vivian and Miczek, 1993), however 
we did not record this type of vocalization for the current study.  The 
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production of the 22 Khz call is specific to only a subset of noxious/stressful 
situations (Jourdan, et al., 1995, Wallace, et al., 2005) and there is no 
temporal correlation between vocalization at this frequency and stimulus 
presentation (Jourdan, et al., 1995).  In one study directly comparing audible 
vocalizations with 22 KHz calls, analgesic administration during the 
application of nociceptive tail shocks reduced the intensity of only audible 
vocalizations, whereas ultrasonic 22Khz vocalizations were not affected 
(Jourdan, et al., 1998).  This body of research suggests that audible 
vocalizations are an appropriate and sufficient vocal measure of pain or 
stress in experimental situations.   
An unexpected outcome of our study was that the 1 mg/kg PCB group 
vocalized significantly less than the control and 0.1 mg/kg groups, suggestive 
of a decreased stress response. Although to our knowledge no studies have 
reported on another ethological relevance for rat audible vocalizations aside 
from the pain/stress response, we cannot eliminate the possibility that 
audible vocalizations during mating serve a previously undocumented social 
function.  Furthermore, the female rats employed in this experiment, although 
sexually mature, were younger than those typically employed in studies of 
female sexual behaviors, and their vocalization pattern may differ from the 
adult; whether or not this is the case, it does not undermine the relevance of 
PCB exposural effects on this endpoint.  PCBs are associated with 
decreased glucocorticoid levels in rat (Durham and Brouwer, 1990), a human 
in situ system (Li and Wang, 2005), an avian model (American Kestrel) 
(Love, et al., 2003), polar bears (Oskam, et al., 2004) and rainbow trout 
(Aluru and Vijayan, 2006). Our results suggest that A1221 may be 
decreasing stress responsiveness in the 1 mg/kg exposed females. 
Interestingly, this is the same group that required more trials to successfully 
mate. The two apparently divergent effects of A1221 on the decreased 
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likelihood to mate and decreased stress response of the female are likely not 
part of a cause-effect relationship, but rather, due to differential effects of 
PCBs on the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-
adrenal neuroendocrine axes.  
 
A1221 EFFECTS ON OTHER BEHAVIORS 
We tested ambulation in the mating cage, both prior to mating and 
during mating trials. This variable relates possible neurodevelopmental 
effects of prenatal PCB exposure on hyper/hypoactivity. Although treatment 
did not affect activity prior to the mating trial, activity during the trial itself was 
significantly different between groups; post hoc analyses did not reveal 
specific differences between groups, although there was a trend for 
increased activity in the 0.1 mg/kg group. The overall effect of treatment on 
activity is consistent with previous reports on PCB exposure in rhesus 
monkey and rats (Bowman, et al., 1981, Holene, et al., 1995, Kuriyama and 
Chahoud, 2004, Lilienthal, et al., 1990). Effects of A1221 on time spent in the 
escape chamber did not differ among groups, nor was there any effect on 
rejection quotient. Thus, again, effects of A1221 appear to be specific to 
subsets of behaviors. 
 
Conclusion 
Studies in humans and wildlife reveal that environmental exposures to 
polychlorinated biphenyls continue to be ubiquitous across a broad 
geographical range. This study on Sprague-Dawley female rats 
demonstrates that exposure to low levels of A1221 during a prenatal 
developmental window of brain sexual differentiation is sufficient to induce 
latent changes in a subset of adult reproductive behaviors. Specifically, at 
PCB exposures approximating those of wildlife and humans, the number of 
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trials required for successful mating was compromised. In addition, abnormal 
audible vocalization behavior during mating may suggest that the stress 
system may be affected in PCB-exposed females. These results have 




Research Section 3: 
The effects of prenatal PCBs on adult female gene 
expression in the preoptic area of the brain 
 
Abstract 
The production and commercial use of novel chemicals over the past century 
has introduced toxicants into the environment for which few natural 
degradatory mechanisms exist.  One class of environmental toxicants, 
polychlorinated biphenyls (PCBs), can alter a multitude of physiological 
processes when encountered by humans and wildlife.  The specific 
biotoxicological effects of PCBs vary depending upon developmental or adult 
exposure, and with the amount and duration of chemical exposure.  The 
present study investigated the effects of low, ecologically-relevant exposure 
of the PCB mixture Aroclor (A)1221, given prenatally, on adult gene 
expression in the preoptic area (POA) of the brain, a region involved in 
reproductive neuroendocrine physiology and behavior.  By using the whole 
genome Affymetrix 230 2.0 rat GeneChip Array, we were able to test our 
hypothesis of a primarily estrogenic effect of A1221 on gene expression, as 
well as to investigate other possible avenues of disruption.  Our results 
reveal that low levels of A1221 during development primarily alter 
intracellular and intercellular signaling pathways in the brain, and that this 






 Polychlorinated biphenyls (PCBs) are a species of endocrine 
disrupting chemical (EDC) constituted of linked biphenyl-ring molecules with 
chloride substitutions at any combination of 10 available carbons.  An 
industrial product used primarily in capacitors and transformers, PCB 
production was halted in 1978 in response to growing public recognition of 
their dangerous impact on human health. However, PCBs continue to enter 
the environment due to improper disposal and the gradual leaching of 
landfills.   After infiltrating the body, PCBs enter storage reservoirs in blood 
serum, brain, adipose tissue, and organs, from whence they disrupt a 
multitude of physiological processes.  The developing brain is particularly 
sensitive to PCB disruption during gestation, when the embryo’s blood-brain 
barrier is weak and open to invasive substances, especially in heavily 
vascularized regions such as the hormone-concentrated region of the 
median eminence which lies under the hypothalamus and preoptic area 
(Johansson, et al., 2006, Peruzzo, et al., 2000). In addition, the nervous and 
endocrine systems undergo many of their greatest changes during 
embryonic and early postnatal development, and disruption of these systems 
by PCBs have been shown to cause permanent dysfunction in adulthood 
(Brevini, et al., 2005, Salama, et al., 2003, Seegal, et al., 2005). 
 In an effort to better understand the many systems affected by PCB 
exposure and resulting interactions between disrupted signaling pathways, 
the toxicology research community has endeavored to document the varied 
endpoints of PCB exposure using multiple dose levels and ages of exposure.  
Recent discoveries have contributed to this goal by highlighting a novel role 
of PCBs in altering gene expression.  PCBs can activate expression of 
immediate early gene c-jun, (Shimokawa, et al., 2006) and intracellular 
signaling cascades mediated by c-src (Eum, et al., 2006), as well as alter 
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DNA binding of transcription factors Sp1 AP1 and NF kappa B (Basha, et al., 
2006), all of which can mediate downstream transcriptional events.  Altered 
gene expression following toxicant exposure may predispose an individual to 
adult disease.  For example, prenatal exposure to hydroxylated PCB 
metabolites can increase adult expression of genes implicated in mammary 
carcinogenesis (Wakui, et al., 2006).  Additionally, adult brain mRNA of 
genes involved in Parkinson’s Disease, including parkin and alpha synuclein, 
exhibited altered expression following PCB exposure, particularly in the 
hypothalamus (Malkiewicz, et al., 2006). 
Aroclor (A) 1221 is a lightly-chlorinated commercial PCB mixture 
composed mostly of mono-ortho-substituted and co-planar congeners 
(Frame, 1997a).  The chemical fingerprint of A1221 and its metabolites has 
been characterized as estrogenic (Layton, et al., 2002, Petit, et al., 1997, 
Ptak, et al., 2005, Shekhar, et al., 1997), and  A1221 or its constituent 
congeners can alter the ability of aromatase enzyme to convert testosterone 
to estradiol (Ptak, et al., 2006b, Woodhouse and Cooke, 2004).  In addition 
to perturbation of the steroid hormones, A1221 exposure can mimic 
thyrotoxicosis and alter circulating thyroid hormone levels (Kilic, et al., 2005).  
In previous work from our laboratory, A1221 was shown to increase the 
number of cells expressing estrogen receptor beta protein in the preoptic 
area of the rat brain after prenatal exposure (Salama, et al., 2003), and to 
increase GnRH gene expression in immortalized GnRH cell cultures (Gore, 
et al., 2002).   
Here, we investigate the whole genome effects of prenatal A1221 
exposure on adult female gene expression in the preoptic area, a 
neuroendocrine control center adjacent to the hypothalamus. Whole genome 
microarray analysis is valuable because the immense amount of data 
produced can be approached in many different ways in order to extract 
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information that contributes to the formation of new hypotheses. For 
example, like other environmental toxicants with known endocrine disrupting 
effects, PCBs often evince a non-linear dose-response curve, an effect 
known as hormesis (Calabrese and Baldwin, 2001b).  By examining gene 
expression across multiple treatment groups, we can infer whether A1221 is 
affecting transcription via a hormetic, steroid hormone-like pathway, or via 
another mechanism, such as disruption of second messenger signaling or 
direct interference with transcription factor binding at response elements.  
Functional group analysis and promoter analysis results further 
characterizeed the genes most affected by exposure.  Because of A1221’s 
known endocrine disrupting effects, and the potential for perturbation of 
downstream transcriptional signaling, we hypothesized that in utero exposure 
during the sensitive period of brain sexual differentiation causes long-lasting 
alterations of gene transcription into adulthood.  
 
Materials and Methods 
ANIMAL CARE 
Sprague-Dawley rats were kept on a partially reversed 12:12 hour light cycle 
(lights on at 23:00 hours) and were fed Harlan-Teklad low phytoestrogen diet 
(#2019) and given water ad libitum. Timed pregnant nulliparous females 
were given an intraperitoneal injection of 0.1, 1, or 10 mg/kg A1221 or 
vehicle (98% DMSO) in a volume of 0.1 ml 2 hours prior to lights out on 
gestational days 16 and 18.  The day of parturition, postnatal day (P) 0, was 
defined as the birth of at least one pup prior to lights-out.  On P1, litters were 
culled to 4 females.  Following vaginal opening, female estrous cycles were 
monitored daily by recording vaginal cytology.  Beginning on day P50, 
females in behavioral estrus, determined by vaginal smears, were allowed to 
mate with males according to the protocol of a related experiment (Steinberg, 
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et al., 2007).  Experimental animals were euthanized by decapitation 
approximately 20 hours following a successful mating, 1-2 hours prior to 
lights-out.  The brain was carefully removed from the skull and quickly chilled 
in crushed ice for 1-2 minutes, after which the preoptic area (POA) was 
dissected out using an adult rat brain matrix with 1 mm divisions (Ted Pella, 
model #15007), following anatomical landmarks.  Specifically, the brain was 
placed ventral side up in the matrix, and the insertion place of the optic nerve 
into the lateral borders of the tuber cinereum was used as the rostro-caudal 
location of the first coronal cut.  Using the brain matrix, the second blade was 
placed 4 mm rostral to this landmark, and the entire coronal section was 
removed and placed rostral side up on a clean, chilled glass plate.  Then, 
two parallel cuts were made from just under the midline of the corpus 
calosum, passing through each lateral branch of the anterior commissure, 
resulting in an isosceles triangle-shaped section containing the preoptic area.  
A rat brain atlas was used to confirm accurate dissection (The Rat Brain in 
Stereotaxic Coordinates, 2nd Edition. George Paxinos and Charles Watson.  
Academic Press, 1986).  The preoptic area was then flash frozen on dry ice 
prior to storage at -80o C until RNA extraction.  
 
RNA EXTRACTION FOR MICROARRAY 
RNA was extracted using a long-established in-house protocol (Daftary and 
Gore, 2003, Gore and Roberts, 1994, Gore, et al., 1999).  Briefly, frozen 
POA tissues were homogenized via extrusion through a 22 gauge needle, 
proteinase K was introduced, and RNA was extracted in phenol chloriform 
and precipitated in ethanol.  Nuclear and cytoplasmic RNA were separated 
using a two buffer system. Extracted RNA was frozen at -80 degrees prior to 
amplification.  The cytoplasmic RNA of three animals per treatment, each 
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representing a different litter, was chosen for microarray analysis (n = 5, 4, 5, 
4 rats in the control, 0.1, 1, and 10 mg/kg treatment groups, respectively).  
 
RNA AMPLIFICATION & HYBRIDIZATION FOR MICROARRAY 
Extracted RNA was run on an Agilent Bioanalyzer 2100 to confirm integrity 
and purity of samples. It was then amplified by Ambion, Inc. (Austin, TX), 
using the MessageAmp II Biotin kit (Ambion #1791).  Amplification products 
were assessed using the Agilent Bioanalyzer 2100.  Product sizes were 
between 200 and 5000 bases with an average length of 1200 bases.  
Hybridization of samples to the rat 230 2.0 BioChip, and image capture, were 
carried out according to Affymetrix protocols.  The Affymetrix Statistical 
Algorithm software GCOSv1.3 was used to quantify image signal results.  
Hybridization quality control measures including scaling factor (a measure of 
effective labeling), background noise (relates sample purity), and % Present 
(referring to the % probe sets detectable, related to sample type and tissue 
source) were used to confirm accurate hybridization prior to analysis. 
 
ANALYSIS & STATISTICS 
Transcripts affected by Treatment 
We used the R software environment and a mixed linear model 
ANOVA with the Maanova package for analyzing the expression data (Kerr, 
et al., 2000, Kerr and Churchill, 2001, Wolfinger, et al., 2001).  Raw data 
were compiled as expression values using the RMA (Robust Multichip 
Average) expression measure for Affymetrix GeneChip® arrays (Bolstad, et 
al., 2003).  Data were run in a series of 2 iterations, thus batch effects were 
accounted for with Batch Model Statistics. Our analysis focused on an 
ANOVA model testing for a fixed effect of the treatment (control, 0.1 mg/kg, 
1mg/kg, or 10 mg/kg).  
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Although false-discovery rates (FDR) were calculated from 
permutation based P-values using the q-value software implemented in the R 
statistical package (Storey and Tibshirani, 2003), no significantly differentially 
expressed genes were detected under a reasonable threshold.  Because of 
this, transcript expression results were analyzed via ANOVA using the Fs 
statistic.  We tested for significance of the treatment with distribution free 
significance levels obtained through 1000 permutations of the data, shuffling 
biological samples to generate the distribution of the test statistic under the 
null hypothesis of no differential expression among treatments.  
These statistics resulted in 1513 gene transcripts with p < 0.05. All 
genes with a p-value < 0.01 were tabulated for analysis.  Genes with p < 
0.01 of known identity are given in Table 9. Of the transcripts with the lowest 
p-values, suggesting the strongest effects of PCB treatment, a hypothesis-
driven list of 27 genes were selected for further statistical scrutiny and of 
these 6 were selected as suggested candidates for follow-up study via real 
time PCR.  Expression values of those genes were submitted to ANOVA, for 
parametrically distributed data, or permutations analysis for skewed, non-
normal data.  A Tukey-Kramer post-hoc comparison was used to determine 
significant differences between treatment groups following a significant 
treatment effect (Table 10).  This approach increases statistical power by 
requiring post-hoc p-value correction for a sublist of only 27 genes, instead of 
a correction for 30,000 tests as was required for analyzing the entire 
GeneChip.  It furthermore allowed more accurate selection of 6 follow-up 
genes for real time PCR. 
 
Functional Group Analysis 
Gene transcripts found to be most affected by A1221 exposure were 
categorized according to gene product function to infer whether any 
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functional groups were strongly represented in the results. The top 405 
genes, with a p-value < 0.01, were submitted to Gene Ontology 
(GOfunctional grouping analysis using Multi-Protein Survey System (MPSS) 
online (http://www.scbit.org/mpss/) (Hao, et al., 2005).  GO charts are a 
standardized and widely accepted method of representation for classifying a 
large list of genes according to the function of the protein products. Results 
were organized into the three primary GO categories of Cellular Component 
(Table 11), Biological Process (Table 12), and Molecular Function (Table 
13).  Many of the 405 genes with p < 0.01 have no known function, and 
several of them are non-identical transcripts of the same protein.  Because of 
this, only 98 genes were recognized by the MPSS software, of which 50, 66, 
and 82 were matched within each of the primary GO categories, respectively.  
In addition, GO terminology permits unique proteins to be assigned to 
multiple functional categories. 
To supplement the GO results and to provide a tissue-specific 
analysis of affected genes, we additionally applied literature research to each 
significant Affymetrix transcript (p < 0.01) to determine its gene identity and 
the function of its protein product.  Information was collected from any or all 
of the following sources, depending on the availability of information for each 
particular gene:  the NetAffx web search engine 
(http://www.affymetrix.com/analysis/index.affx), BLAST 
(http://www.ncbi.nlm.nih.gov/BLAST/) searches of transcript sequences, 
and/or RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) searches for highly 
homologous genes in other species (> 98.5 % homology).   In addition, 
PubMed (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) literature searches 
were conducted to accurately determine functional roles of each protein 
product within the brain, and Information Hyperlinked Over Proteins (ihop) 
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(http://www.ihop-net.org/UniPub/iHOP/) and Online Mendelian Inheritance in 
Man (OMIM)  
(http://www.ncbi.nlm.nih.gov.content.lib.utexas.edu:2048/entrez/query.fcgi?d
b=OMIM) databases were consulted for additional, cross-species 
information.  In the instances where a protein product has multiple functions 
dependent upon source tissue, only brain-specific functions were recorded 
because all RNA originated in the preoptic area of the brain.  In total, 48% of 
transcripts significantly affected by treatment have no known identity or 
function, including proteins of known function that are not currently 
understood to be expressed within the brain.  Each transcript was assigned 
to only one category.  These results were then organized into broad gene 
functional categories that may be viewed in Table 14.   
 
Transcriptional Response Element Analysis 
Transcriptional response elements (TREs) for transcripts with p < 0.01 were 
extracted via Gene2Promoter software release 4.3 ( Genomatix Software 
GmbH) (Cartharius, et al., 2005, Kramer-Hammerle, et al., 2005, Quandt, et 
al., 1995) using recommended Genomatix-prescribed promoter sequence 
length.  Genes were submitted for analysis in groups of five using Affymetrix 
ID or selected gene search terms, and results were subsequently compiled. 
The most significant 50 genes were submitted because 50 is the 
recommended maximum number to include in a single comparative analysis 
(Genomatix Software GmbH guidelines).  The average numbers of TRE 
repeats per gene are plotted in Figure 16 and TREs common to the greatest 







Clustering analysis provides a non-subjective approach to grouping data by 
gene expression profile.  This method is especially useful for assessing 
relative frequencies of dose-response curves when non-linear relationships 
are expected, as with U-shaped or inverted U-shaped dose-response curves 
that often accompany endocrine disrupting chemicals in toxicological 
research (Weltje, et al., 2005).  Adaptive Quality-Based Clustering software 
(De Smet, et al., 2002) was used to generate dose-response clusters across 
treatment groups of genes with a p-value < 0.01, with the following 
parameters: 60% probability of genes belonging to a cluster, and a minimum 




ANOVA results revealed 1512 transcripts with a nominal p-value  < 0.05, and 
405 transcripts having a nominal p-value <  0.01, of which 215 are non-
redundant genes of known identity.  The list of genes with p < 0.01 was 
tabulated and referenced for further analysis.  The number of genes from this 
list were grouped according to chromosomal location, and normalized to the 
overall number of genes on the microarray belonging to the same 
chromosome.  No bias was observed in the chromosomal location of affected 
genes (3.5 to 6.7 % of genes on each chromosome were represented). 
Identifiable genes are listed in Table 9, grouped categorically by p-value.
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Table 9.  Transcripts Used in Analysis.  Transcripts with no assigned name 
(ESTs or unknown genes) and multiple transcripts from the same gene are 
not included in this list, leaving 215 genes in Table 9.  These are grouped by 




Table 9: Affected Transcripts (nominal p < 0.01) 
Nominal p < 0.0005 
hemoglobin beta chain complex (appears twice) 
similar to heterogeneous nuclear ribonucleoprotein G – human 
hemoglobin alpha, adult chain 1 or alpha 2 chain (appears twice) 
glucocorticoid modulatory element binding protein 2 
C1q and tumor necrosis factor related protein 4 (predicted 
Similar to NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 (predicted) 
MAM domain containing glycosylphosphatidylinositol anchor 1 (predicted) 
cytochrome P450, family 7, subfamily a, polypeptide 1 
similar to Unconventional myosin-9b /// similar to spermatogenesis associated glutamate (E)-rich protein 4d 
lumican 
T-box 2 (predicted) 
cathepsin L 
opioid binding protein/cell adhesion molecule-like 
similar to inositol 1,3,4-triphosphate 5/6 kinase 
F-box only protein 32 
Churchill domain containing 1 (predicted) 
gap junction membrane channel protein alpha 5 
 
Table 9 continues on the following page 
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Table 9 Continued 
Nominal p-value:  0.0005 < p < 0.005  
Kruppel-like factor 12 (predicted) similar to C11orf17 protein (predicted) 
Similar to breast cancer membrane protein 101  CD5 antigen-like 
phospholipase A2, group IIA (platelets, synovial fluid) insulin receptor-related receptor 
talin 1 upstream transcription factor 2 
mitogen-activated protein kinase 15 prohibitin 2 
Crystallin, gamma S XK-related protein 5 
similar to CREBBP/EP300 inhibitory protein 1  ubiquitin D 
intraflagellar transport 74 homolog (Chlamydomonas) aminolevulinic acid synthase 2 
extracellular link domain-containing 1 (predicted) RT1 class Ib, locus S3 
solute carrier family 22 (organic cation transporter), member 2 ADP-ribosyltransferase 5 
stimulated by retinoic acid gene 6 homolog (mouse) cut-like 2 (Drosophila) (predicted) 
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1  
(Hu antigen R) (predicted) (appears twice) 
selenium binding protein 2 
Enthoprotin neuregulin 1 
Similar to [Ascaris lumbricoides mRNA sequence.] osteoglycin (predicted) 
FK506 binding protein 9 syntaxin binding protein 1 
reproductive homeobox on X chromosome, 9 Ankyrin 3, epithelial 
integrin beta 3 binding protein (beta3-endonexin) triadin 
reproductive homeobox on X chromosome, 9 splicing factor 3a, subunit 1 (predicted) 
nicotinamide N-methyltransferase (predicted) similar to C14orf25 protein (predicted) 
gap junction membrane channel protein beta 3 Syntaxin 8 
Cyclin M1 (predicted) 2,3-bisphosphoglycerate mutase 
nudix (nucleotide diphosphate linked moiety X)-type motif 3 casein kinase II, alpha 1 polypeptide 
SH2 domain binding protein 1 (tetratricopeptide repeat containing) chloride channel K1 
mitogen-activated protein kinase 8 interacting protein 3 guanine nucleotide binding protein, alpha 14 
G protein-coupled receptor 39 ADP-ribosyltransferase 1 (predicted) 
Similar to Zinc finger protein 184 (predicted) Notch gene homolog 2 (Drosophila) 
Low density lipoprotein receptor-related protein 1 vimentin 
Retinoic acid induced 1 (predicted) similar to C11orf17 protein (predicted) 
insulin-like growth factor binding protein 7 C-reactive protein, pentraxin-related 
v-ets erythroblastosis virus E26 oncogene like (avian) adenylate cyclase 6 
cytochrome P450, subfamily 2G, polypeptide 1 Insulin related protein 2 (islet 2) 
Similar to neurobeachin (predicted) CD24 antigen 
Similar to WAC (predicted) DEAD (Asp-Glu-Ala-Asp) box polypeptide 19 
melanocortin 5 receptor Corticotropin releasing hormone receptor 2 
kinesin light chain 3 similar to Ras-related protein Rab-1B 
laminin, alpha 2 (predicted) Upstream binding protein 1 (predicted) 
complement component 1, q subcomponent, gamma polypeptide similar to cDNA sequence BC020002  
glutamyl aminopeptidase homer homolog 1 (Drosophila) 
Prolylcarboxypeptidase (angiotensinase C) (predicted) Unknown (protein for MGC:72614) 
Smg-7 homolog, nonsense mediated mRNA decay factor  Noggin 
natriuretic peptide precursor type C Similar to nemo like kinase (predicted) 
Hairy/enhancer-of-split related with YRPW motif-like  Grainyhead-like 1 (Drosophila) (predicted) 
AHNAK nucleoprotein (desmoyokin) Zinc finger protein 503 (predicted) 
Chondroitin sulfate proteoglycan 4 tocopherol (alpha) transfer protein 
thyroid hormone receptor associated protein 1 (predicted) nuclear receptor coactivator 6 
CCAAT/enhancer binding protein , epsilon glutathione S-transferase A3 
chemokine (C-C motif) ligand 22 osteoglycin (predicted) 
interferon induced transmembrane protein 1 (predicted) Similar to AP2 associated kinase 1 (predicted) 
SAM domain, SH3 domain and nuclear localization signals, 1 similar to ovostatin-2 (predicted) 
interleukin 2 receptor, gamma (severe combined immuno- 
deficiency) protein kinase C, alpha 
gap junction membrane channel protein beta 2 PRKC, apoptosis, WT1, regulator 
cyclin-dependent kinase (CDC2-like) 10  
Table 9 continues on the following page  
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Table 9 Continued 
Nominal p-value:  0.005 < p < 0.01  
potassium inwardly-rectifying channel, subfamily J, member 5 Solute carrier family 9, member 1 
adrenergic receptor, alpha 2b neurobeachin-like 2 (predicted) 
paired-like homeodomain transcription factor 1 interleukin 24 
PREDICTED: similar to lipocalin-interacting membrane receptor  ciliary neurotrophic factor 
gastric inhibitory polypeptide neuregulin 2 
X transporter protein 3 annexin A1 
hydroxysteroid (17-beta) dehydrogenase 9 ribosomal protein L17 
similar to brain carcinoembryonic antigen pregnancy-induced growth inhibitor 
Anterior pharynx defective 1b homolog (C. elegans) ribonucleotide reductase M1 (mapped) 
PREDICTED: similar to PHD finger protein 20-like 1 isoform1 fibrinogen, alpha polypeptide 
coatomer protein complex, subunit beta 2 (beta prime) melanoma cell adhesion molecule 
proteosome (prosome, macropain) subunit, beta type 9 allograft inflammatory factor 1 
zinc finger protein 213 (predicted) Cyclin G2 (predicted) 
beta heavy chain of outer-arm axonemal dynein ATPase defensin beta 1 
similar to replication protein-binding trans-activator RBT1 chemokine (C-C motif) ligand 4 
G protein-coupled receptor 23 (predicted) fibroblast growth factor 21 
Mitochondrial tumor suppressor 1 interferon beta 1, fibroblast 
Centaurin, beta 5 (predicted) troponin I type 3 (cardiac) 
Toll interacting protein (predicted) Reticulocalbin 1 (predicted) 
zinc finger, FYVE domain containing 9 (predicted) Spondin 1 
citrate lyase beta like Complement component 3 
Deiodinase, iodothyronine, type II crystallin, beta B3 
similar to mKIAA0159 protein (predicted) zinc finger protein 96 
Similar to RNA (guanine-9-) methyltransferase domain containing 2 valyl-tRNA synthetase 2 
Moloney leukemia virus 10-like 1 (predicted) secretin 
potassium inwardly-rectifying channel, subfamily J, member 3 paraoxonase 1 
nudix (nucleoside diphosphate linked moiety X)-type motif 6 cathepsin W 
procollagen, type VI, alpha 3 (predicted) ras homolog gene family, member V 
calcium channel, voltage-dependent, L type, alpha 1C subunit transgelin 2 
Similar to microtubule associated serine/threonine kinase 2  RT1 class I, CE16 
polymerase (RNA) II (DNA directed) polypeptide H (predicted) Pbx/knotted 1 homeobox 
Similar to RAP2A, member of RAS oncogene family (predicted) Similar to Ab2-095 
ring finger protein 190 Roundabout homolog 2 (Drosophila) 
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog,  
Drosophila); translocated to, 11 Similar to Protein C20orf129 homolog  
nsulin responsive sequence DNA binding protein-1 Similar to IQ motif and WD repeats 1  
Regulator of nonsense transcripts 1 (predicted) myosin IG 
DNA cross-link repair 1B, PSO2 homolog (S. cerevisiae) similar to KIAA0339 protein 
phospholipase A2, group IVA (cytosolic, calcium-dependent) Phospholipase C, beta 4 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase  
activation protein, eta polypeptide vacuolar protein sorting 37C (predicted) 
solute carrier family 39 (iron-regulated transporter), member 1 interleukin 17B 
purinergic receptor P2X, ligand-gated ion channel, 5 regulator of G-protein signaling 6 
RAB5B, member RAS oncogene family (predicted) nephroblastoma overexpressed gene 









Because of previously documented effects of A1221 exposure on female 
reproductive behaviors and fertility, the authors hypothesize an endocrine-
disruption-mediated mechanism.  Predicting that the genes most strongly 
affected by PCB exposure would be hormone and neurotransmitter-related 
genes common to the preoptic area, we extracted a list of 27 genes 
suspected of being involved in PCB-mediated altered transcription from 
amongst the genes with a nominal p-value < 0.05.  These genes, shown in 
Table 10, were selected based on documented PCB effects in vivo and in 
vitro.  Transcript expression levels were submitted to Tukey-Kramer post-hoc 
analysis to determine possible significant differences between treatment 
groups. Significant differences between treated groups and control are 
indicated in the final column of Table 10.   
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Table 10:  Candidate Gene List 
27 candidate genes were selected from the list of genes with a p-value < 
0.01.  These genes underwent Tukey-Kramer post-hoc analysis to determine 
significant differences between groups.  Genes found to have a significant 
difference between a treatment group and control (p < 0.05), and the 
direction of the effect, are indicated in the final column. Results are shown in 











Control (p < 0.05) 
0.019 1381606_at 
stimulated by retinoic acid gene 6  
homolog  
0.001 1382202_at cut-like 2 (Drosophila) (predicted)  
0.003 1371142_at 
cytochrome P450, subfamily 2G,  
polypeptide 1  
0.004 1389931_at 
corticotropin releasing hormone  
receptor 2 1 mg/kg < Control 
0.004 1372176_at protein kinase C, alpha  
0.005 1371072_at nuclear receptor coactivator 6 1 mg/kg < Control 
0.005 1386156_at 
thyroid hormone receptor associated  
protein 1  1 mg/kg > Control 
0.005 1370567_at adrenergic receptor, alpha 2b  
0.005 1369898_a_at gastric inhibitory polypeptide  
0.005 1387994_at 
hydroxysteroid (17-beta)  
dehydrogenase 9 1 & 10 mg/kg < Control 
0.007 1391033_s_at neuregulin 2  
0.011 1369908_at 
corticotropin releasing hormone  
binding protein 1 & 10 mg/kg < Control 
0.011 1381449_s_at transforming growth factor alpha  
0.015 1370566_at retinol dehydrogenase 2  
0.016 1369533_a_at 
5-hydroxytryptamine (serotonin)  
receptor 4 0.1 mg/kg < Control 
0.024 1384868_at estrogen receptor alpha 10 mg/kg > Control 
0.024 1388260_a_at leptin receptor  
0.025 1398289_a_at 
corticotropin releasing hormone  
receptor 1 0.1 mg/kg < Control 
0.030 1388009_at thyrotropin releasing hormone receptor 2 10 mg/kg > Control 
0.030 1367851_at prostaglandin D2 synthase  
0.036 1371762_at retinol binding protein 4, plasma  
0.037 1368285_at sex hormone binding globulin  
0.038 1369760_a_at estrogen receptor beta 10 mg/kg > Control 
0.038 1388239_at period homolog 3   
0.038 1382916_at thyroid hormone receptor beta  
0.041 1371120_s_at bradykinin receptor, beta 2  
0.043 1375720_at 
gamma-aminobutyric acid (GABA) B  
receptor 1  
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In addition to those effects, several significant differences between 
treated groups were observed (Figure 14).  Specifically, for estrogen receptor 
alpha (ER-alpha) and beta (ER-beta) the 10 mg/kg group had significantly 
higher expression than the 1 mg/kg group (Figure 14B).  The 1 mg/kg group 
had significantly higher expression than the 10 mg/kg group for thyroid 
hormone receptor associated protein 1 (Figure 14A).  The 10 mg/kg group 
had significantly higher expression than the 0.1 or 1 mg/kg groups for 
“stimulated by retinoic acid gene 6 homolog” and the 10 mg/kg group had 
higher expression than the 0.1 mg/kg group for retinol dehydrogenase 2.  
The 10 mg/kg also had significantly higher expression of corticotropin 
releasing hormone receptor 1 (CRHR1) whereas the 1 mg/kg group had 
significantly lower expression of CRHR2 (Figure 14C) and nuclear receptor 
coactivator 6 than all other groups. 
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Figure 14: Expression profiles for estrogen-, corticotropin releasing hormone-










Figure 14:  RMA results in 
log2 format were adjusted 
for batch effect and gene 
expression profiles are 
plotted here.  Magnitude of 
expression differences may 
appear smaller here due to 
transformation of the data.   
A.  Thyroid hormone-
related genes.  B. Estrogen 
receptors alpha and beta.  
C.  Corticotropin releasing 
hormone-related genes.  
a.  p < 0.05 vs. Control 
(significant differences 




GENE ONTOLOGY (GO) FUNCTIONAL GROUP ANALYSIS 
SwisProt identifiers provided by Affymetrix annotation files for the list 
of genes with a p-value < 0.01 were submitted to GeneOntology (GO) 
analysis via Multi-Protein Service System (MPSS) algorithms.  One GO tree 
was generated for each of three overall categories:  Cellular Component 
(Table 11), Biological Process (Table 12), and Molecular Function (Table 
13).  A total of 98 proteins were recognized from the list of 405 genes (p < 
0.01), which included 215 non-redundant identified genes.  Of these 98 
proteins, 50 were associated with a cellular component, 66 with a biological 
process, and 82 with a molecular function.  
Of the 50 gene products with documented cellular location, 23 are 
localized to a membrane, and 24 are intracellular.  The membrane proteins 
are best described as integral to the plasma membrane.  Intracellularly 
located proteins are found primarily in the cytoplasm (16 of 24 gene 




Table 11.  Gene Ontology (GO) results: Cellular Component (50 genes 
matched) 
The number of gene products per category are given in parentheses.  Gene products may be assigned 
multiple functions. 
 
1) Unlocalized (2) 
A) Protein kinase CK2 complex (1) 
B) Ribonucleoside-diphosphate reductase complex (1) 
2) Extracellular (5) 
A) Extracellular space (1) 
3) Cell (44) 
A) Membrane (23) 
i) Plasma Membrane (10) 
ii) Endomembrane system (2) 
iii) Extrinsic to membrane (1) 
iv) Inner membrane (1) 
v) Integral to membrane (11) 
vi) Mitochondrial membrane (1) 
B) Cell Body (1) 
C) Cell Fraction (2) 
D) Cell projection (1) 
i) Neuronal cell projection (1) 
E) Cell surface (2) 
F) Intracellular (24) 
i) Ubiquitin ligase complex (1) 
ii) Nucleus (10) 
(1) Nucleoplasm (1) 
(2) Proteasome complex (sensu Eukarya) (1) 
iii) Cytoplasm (16) 
(1) Sarcoplasm (1) 
(2) Vacuole (1) 
(3) Muscle fiber (1) 
(4) Golgi apparatus (2) 
(5) Mitochondrion (1) 
(6) Cytoskeleton (4) 
(7) Cytosol (3) 
(8) Endoplasmic reticulum (2) 
(9) Citrate lyase complex (1) 
(10) Cytoplasmic ubiquitin ligase complex (1) 




In the Biological Process category, most of the affected gene products 
(54 of 66) are assigned a physiological process role, primarily in cellular 
metabolism (28 of 54 gene products).  The majority of remaining gene 
products are split evenly between response to stress or external stimuli, or 
development (primarily morphogenesis) (13 of 54 gene products, each).  
Results are given in Table 12. 
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Table 12.  Gene Ontology (GO) results: Biological Process (66 Genes 
matched) 
The number of gene products per category are given in parentheses.  Gene products may be assigned 
multiple functions. 
 
1) Regulation of biological process (15) 
A) Regulation of enzyme activity (1) 
i) Positive regulation of enzyme activity 
B) Regulation of physiological process (8) 
i) Regulation of secretion (1) 
ii) Regulation of vascular permeability (1) 
iii) Regulation of metabolism (6) 
C) Regulation of development (5) 
i) Regulation of growth (3) 
ii) Regulation of cell differentiation (2) 
D) Regulation of cellular process (7) 
i) Regulation of cell proliferation (4) 
ii) Regulation of cell size (4) 
iii) Regulation of cell volume (1) 
iv) Regulation of membrane potential (1) 
v) Regulation of programmed cell death (2) 
vi) Regulation of growth (3) 
vii) Regulation of cell differentiation (2) 
viii) Regulation of signal transduction (2) 
2) Physiological process (54) 
A) Secretion (3) 
i) Regulation of secretion (1) 
ii) Fluid secretion (1) 
iii) Hormone secretion (2) 
B) Regulation of physiological process (8) 
i) Regulation of secretion (1) 
ii) Regulation of vascular permeability (1) 
iii) Regulation of metabolism (6)  
C) Response to stimulus (13) 
i) Response to stress (7) 
ii) Response to external stimulus (12) 
iii) Response to endogenous stimulus (1) 
D) Organismal physiological process (7) 
i) Regulation of body fluids (2) 
ii) Circulation (1) 
iii) Excretion (1) 
iv) Immune response (5) 
E) Coagulation (1) 
i) Blood coagulation (1) 
F) Death (2) 
i) Cell death (2) 
G) Homeostasis (2) 
i) Ion homeostasis (1) 
ii) Cell homeostasis (2) 
 
iii) (Table 12 continues on the following page)
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Table 12 Continued 
H) Metabolism (28) 
i) Regulation of metabolism (6) 
ii) Protein metabolism (12) 
iii) Organic acid metabolism (2) 
iv) Oxygen and reactive oxygen species metabolism (1) 
v) Phosphorus metabolism (4) 
vi) Nucleobase, nucleoside, nucleotide and nucleic acid metabolism (8) 
vii) Energy pathways (1) 
viii) Hormone metabolism (2) 
ix) Lipid metabolism (5) 
x) Catabolism (6) 
xi) Carbohydrate metabolism (1) 
xii) Biosynthesis (3) 
xiii) Aromatic compound  metabolism (1) 
xiv) Amino acid derivative metabolism (1) 
xv) Amine metabolism (1) 
xvi) Alcohol metabolism (1) 
I) Cellular physiological process (17) 
i) Cell motility (2) 
ii) Cell growth and/or maintenance (15) 
iii) Cell death (2) 
3) Development (13)  
A) Regulation of development (5) 
i) Regulation of growth (3) 
ii) Regulation of cell differentiation (2) 
B) Morphogenesis (11) 
i) Organogenesis (7) 
ii) Appendage morphogenesis (1) 
iii) Embryonic morphogenesis (1) 
iv) Cellular morphogenesis (4) 
C) Growth (6) 
i) Regulation of growth (3) 
ii) Tissue regeneration (2) 
iii) Cell growth (4) 
D) Embryonic development (1) 
i) Embryonic morphogenesis (1) 
E) Cell differentiation (4) 
i) Neuron differentiation (2) 
ii) Regulation of cell differentiation (2) 
iii) Myeloid blood cell differentiation (1) 
F) Cell fate commitment (1) 
i) Cell fate determination (1) 
4) Cellular process (31) 
A) Regulation of cellular process (7) 
i) Regulation of cell proliferation (4) 
ii) Regulation of cell size (4) 
iii) Regulation of cell volume (1) 
iv) Regulation of membrane potential (1) 
v) Regulation of programmed cell death (2) 
vi) Regulation of cell growth (3) 
vii) Regulation of cell differentiation (2) 
viii) Regulation of signal transduction (2) 
 
ix) Table 12 continues on the following page
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Table 12 Continued 
B) Cellular physiological process (17) 
i) Cell motility (2) 
ii) Cell growth and/or maintenance (15) 
iii) Cell death (2) 
C) Cell differentiation (4) 
i) Neuron differentiation (2) 
ii) Regulation of cell differentiation (2) 
iii) Myeloid blood cell differentiation (1) 
iv) Cell fate commitment (1) 
D) Cell communication (16) 
i) Signal transduction (11) 
ii) Cell-cell signaling (4) 
iii) Cell adhesion (3) 
5) Behavior (1) 




In the Molecular Function category, 44 of 82 gene products are 
implicated in binding, most of which bind proteins, nucleotides, and nucleic 
acids.  The second most common category is catalytically active gene 
products, primarily hydrolases (29 of 82), and finally 19 of 82 gene products 
are involved in signal transduction (again, mostly hydrolase-based 
intracellular signal transduction).  Results are shown in Table 13. 
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Table 13.  Gene Ontology (GO) results: Molecular Function (82 Genes 
matched) 
 
1) Structural molecule activity (4) 
A) Structural constituent of cytoskeleton (2) 
B) Structural constituent of eye lens (1) 
2) Transcription regulator activity (7) 
A) RNA polymerase II transcription factor activity (1) 
B) Transcription cofactor activity (1) 
C) Transcription factor activity (5) 
3) Transporter activity (8) 
A) Drug transporter activity (1) 
B) Ion transporter activity (2) 
C) Channel/pore class transporter activity (4) 
D) Carrier activity (2) 
E) Auxiliary transport protein activity (1) 
F) Amine/polyamine transporter activity (1) 
4) Signal transducer activity (19) 
A) Receptor signaling protein activity (1) 
B) Receptor activity (9) 
C) Receptor binding (8) 
5) Motor activity (1) 
6) Enzyme regulator activity (1) 
7) Catalytic activity (29) 
A) Transferase activity (8) 
B) Oxidoreductase activity (6) 
C) Lyase activity (1) 
D) Ligase activity (2) 
E) Kinase activity (4) 
F) Isomerase activity (1) 
G) Helicase activity (2) 
H) Hydrolase activity (12) 
8) Binding (44) 
A) Selenium binding (1) 
B) Vitamin binding (1) 
C) Receptor binding (8) 
D) Nucleotide binding (10) 
E) Peptide binding (1) 
F) Protein binding (13) 
G) Lipid binding (1) 
H) Metal ion binding (3) 
I) Nucleic acid binding (10) 
J) Carbohydrate binding (1) 
K) Hormone binding (1) 
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CUSTOM FUNCTIONAL GROUP ANALYSIS 
In addition to software-driven functional group derivation, we 
conducted a publications-based information compendium to determine likely 
tissue-specific roles for affected gene products (p < 0.01).  Genes from this 
list were individually researched using published studies and reputable 
databases, and were categorized according to protein function. No 
identifying information (or no brain-specific role) was found for 189 
transcripts (47.6%), which were labeled “unknown”.  Of recognized 
transcripts, the most common functional groups are:  blood-based proteins 
(13.9%), transcription factors (13.0%), intercellular signaling (11.5%) and 
intracellular signaling (11.1%).  The hormone signaling functional category 
contained only 8.2% of recognized gene products.  Results are presented in 
Table 14, along with a more detailed explanation of inclusive gene functions 




Table 14: Custom Functional Group Analysis 
Literature searches and information from publicly available databases were 
used to generate custom brain-specific functional groups for the gene list 
with a p-value < 0.01 (n = 405 genes).  Gene products were assigned to only 
a single functional group.  Gene products with no known function or no 
known brain function are not included in this table.  Results are given as 
number of genes per category or as % of known gene products from the list 
p < 0.01.  
functional group description # genes % known genes 
toxin metabolism xenobiotic degratory proteins 2 1.0% 
cell metabolism mitochondrial proteins 3 1.4% 
cell cycle and DNA  
replication DNA synthesis related proteins 10 4.8% 
blood-brain barrier &  
brain vesicles 
proteins associated with the blood-brain  
barrier or brain vesicle wall 5 2.4% 
post-transcriptional  
modification RNA modification and RNA editing proteins 5 2.4% 
transcription RNA synthesis related proteins 6 2.9% 
translation protein synthesis related proteins 7 3.4% 
cytoskeletal element 
gap junctions, cytoplasmic structural  
proteins, and anchoring proteins 9 4.3% 
cell surface protein extracellular matrix and cell adhesion proteins 10 4.8% 
ion regulation 
ion channels involved in neuronal excitability and cell  
homeostasis  10 4.8% 
vesicle trafficking proteins involved in endo- and exocytosis 10 4.8% 
post-translational  
modification 
ribosylation, sialyltransferase, and  
ubiquitination proteins as well as peptidases  11 5.3% 
hormone signaling hormones, receptors, and associated proteins 17 8.2% 
intracellular signaling 
phosphatases, kinases, phospholipases, and  
second messenger systems 23 11.1% 
intercellular signaling 
cytokines/growth factors and receptors, 
neurotransmitter receptors, and associated proteins 24 11.5% 
transcription factor Transcription factors and coregulatory proteins 27 13.0% 
blood 
Blood-specific cells & proteins, blood vessels, and  
Immune cells 29 13.9% 
Total Known Genes  209 100% 
 
146 
TRANSCRIPTIONAL RESPONSE ELEMENT (TRE) ANALYSIS 
 Transcriptional response elements (TREs) for the 50 recognized 
transcripts with the lowest p-value were determined via Gene2Promoter, a 
software accessory in the Genomatix analysis package.  Gene promoters 
were extracted by Gene2Promoter according to intrinsic software guidelines, 
and potential TREs were searched using likelihood probability matrices.  
Prediction of TRE functionality can be unreliable.  Because we could not 
biochemically test the functionality of each recognized TRE, we refer to 
results as “potential TREs”.  
The average number of potential TREs per gene were found by 
averaging the number of potential TRE sites (repeats) across all genes 
containing that TRE.  Genes lacking a particular TRE in their promoter are 
not included in the average.  Results are shown in Figure 15.  Increased 
incidence of particular transcriptional response elements in the gene 
promoters of significantly affected genes may represent a transcriptional 
mechanism by which PCBs can alter gene transcription.  The TRE occurring 
with the greatest frequency of repeats within affected genes is bound by the 
Nuclear Respiratory 1 Family of transcription factors (NRF1).  GAGA box 
(GABF) TREs also occur in high frequency, and the Early Growth 
Factor/Nerve Growth Factor Induced Protein C family (EGRF) represents the 
third largest category.  Following this TRE, the average frequency of repeats 






















Figure 15.  Transcriptional Response Element (TRE) analysis:  Average # of 
TREs per Gene.  Genomatix GmbH software Gene2Promoter was used to 
extract promoter sequences from the 50 recognized genes with the lowest p-
values.  TREs occurring with the greatest frequency per promoter are shown 
here (>2 per gene).  TRE codes on the X-axis are given in the format of 





Transcription Factors Associated 
with TREs 
 
Transcriptional Response Element Site 
 




Potential TREs common to the 50 most significant recognized genes 
are plotted in figure 16.  The TRE most represented across the 50 tested 
genes was the Ets-1 family (Avian retroviral E-Twenty-Six), which includes 
Elk-1 (Ets-like gene 1) and Nuclear Respiratory Factor 2 (NRF2).  Following 
this, the Homeobox Factor family with moderate activity (HOXF) is found in 
90% of tested genes, and the mammalian equivalent of Drosophila Tinman, 
(NKXH) family of transcription factors is found in 84% of tested genes.  
Following these TREs come CREB, the ubiquitous cAMP-responsive binding 
protein site, the HEAT heat shock factors family TRE, and the SP1F TRE 
site, which is bound by Stimulating Proteins 1 and 2, TGF-beta inducible 








Figure 16. Transcriptional Response Element (TRE) analysis:  % of Gene 
Promoters Containing Each TRE.  Genomatix GmbH software 
Gene2Promoter was used to extract promoter sequences from the 50 
recognized genes with the lowest p-values.  The highest occurring TREs are 
shown here (those occurring in >65% of genes). TRE codes represent 
TRAFAC binding factor sites. 
% Genes Containing TREs 
 
Transcriptional Response Element Site 
 






Dose-response curves of gene transcripts with a p-value < 0.01 were entered 
into cluster analysis using the Adaptive Quality-Based Clustering software 
(http://homes.esat.kuleuven.be/~thijs/Work/Clustering.html).  Results are 
given in Figure 17.  The criteria of 60% probability of fitting a cluster group, 
and a minimum of 4 transcripts per cluster were used.  Transcripts were 
assigned to only one cluster, and dose-response curves that did not fit the 
clustering criteria are not included.  Cluster analysis reveals commonalities 
between expression profiles but does not measure the statistical significance 
of differences between treatment groups.  These results should be 
interpreted in the context of a metaanalysis examining overall trends in 
treatment effects within the data set. 
Of the 405 gene transcripts submitted to analysis, 264 were placed 
within a cluster (~65%), and of these 128 transcripts (48%) were of unknown 
function.  The 11 clusters resulting from analysis, randomly assigned a 
numerical ID, are arranged in Figure 17 according to shape:  inverted U-
shaped, zig-zag down, and U-shaped.  No linear dose-response curves 
emerged as a significant cluster from the analysis parameters employed in 
this study.  
In total, 48 transcripts had an inverted U-shaped dose-response 
profile, which is characterized by the 0.1 and 1 mg/kg PCB groups exhibiting 
increased expression and the 10 mg/kg group exhibiting equal or decreased 
expression compared with control.  Unknown transcripts formed the largest 
portion of this group (n=24) with cell cycle genes forming the next largest 
group (n=5).  40 genes exhibited a zig-zag down curve, wherein the 1 mg/kg 
group showed some recovery from a general trend of depressed gene 
expression.  The largest functional categories in the zig zag down group 
were unknown transcripts (n=15), followed by blood-related transcripts 
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(n=11), and blood-brain barrier-related transcripts (n=4).  By far the largest 
group was the U-shaped dose-response curve. The majority of transcripts in 
this group (n=123) fell into Cluster 1, which was characterized by increased 
gene expression in the 10 mg/kg group (Figure 17). In this group, 88 






Figure 17:  Cluster Analysis Results 
 
 
Figure 17.  Cluster Analysis results for genes with a p-value < 0.01.  Data 
were generated on Adaptive Quality-Based Clustering software.  For a 
cluster membership probability of 60% and a minimum of 4 genes per 
cluster, 11 graphs were generated.  These have been grouped according to 
dose-response curve shape:  Inverted U-shaped, Zig-Zag Down, and U-
shaped.  Data from each transcript is shown as a blue dashed line, and 
averaged curves are given in a solid red line.  The Y-axis is centered around 
a normalized mean of all transcript expression values included in the cluster, 
given as 0.  Deviation from this overall mean is indicated by positive or 
negative deflections from the 0 mark.  The four treatment groups of Control, 
0.1, 1, and 10 mg/kg PCBs are represented, respectively, by the numbers 1-
4 on the X-axis.  Dose-response relationships that do not conform to a 




The present study addressed the question of whether fetal PCB 
treatment caused any permanent alterations in gene expression that would 
be manifested in adulthood. We focused this analysis on the POA, a brain 
region that is important for reproductive physiology and behavior (Uphouse 
and Caldarola-Pastuszka, 1993, Wersinger, et al., 1993, Wheaton, et al., 
1975).  Because relatively low doses of PCB were administered and more 
than 55 days elapsed between treatment to the fetus and tissue collection at 
approximately 7-8 weeks of age, we anticipated subtle effects of PCB 
exposure on gene expression.  In concert with our expectations, we viewed 
the whole genome microarray as a hypothesis-generating tool to explore 
broad changes in patterns of gene expression influenced by environmental 
toxicant exposure.  The large number of genes assayed on the chip 
generates a substantial amount of background noise against which a clear 
signal is difficult to determine. In addition, the frequency of false positive 
results varies directly with the number of tests, and thus the desired level of 
significance should be corrected by the approximately 30,000 transcripts 
assayed.  
Given the conservative nature of statistical correction, the whole 
genome Biochip is not the appropriate tool for stating with quantitative 
certainty which genes have altered expression following intoxication.  
Instead, it provides a valuable service in broadening our investigation of PCB 
effects above and beyond our hypothesis of primarily endocrine-related 
effects, thereby highlighting future directions in which to channel toxicological 
research.  In PCB toxicology, many of the molecular mechanisms of action 
are unknown.  Here, we present results identifying the most differentially 
expressed genes in response to three different doses of PCB treatment.  We 
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believe that studies of this nature provide novel insight into the global 
mechanisms of PCB influences on gene expression. 
 
DIFFERENTIALLY AFFECTED GENES 
 A close look at the genes with the most affected gene expression 
profiles (those with the lowest p-values, p < 0.01) across treatment groups 
can present a more detailed picture of the effects of prenatal toxicant 
exposure.  Aroclor 1221 and its metabolic by-products are well-documented 
endocrine-disrupting chemicals with multiple effects on estrogen signaling, 
including binding the estrogen receptor (Shekhar, et al., 1997) and initiating 
transcription of estrogen-responsive genes (Layton, et al., 2002), inhibiting 
the estrogen synthetic enzyme aromatase (Woodhouse and Cooke, 2004), 
and interfering with estrogen receptor beta gene expression (Salama, et al., 
2003).  Upon close examination, we observed a number of genes involved in 
the estrogen signaling pathway. Namely, MapK15/ERK8, “similar to breast 
cancer membrane protein 101”, “similar to breast cancer associated 
oncogene”/BCA3, “secretoglobin family 3A member 1”/HIN1, OKL38 and 
mac25 showed altered expression following PCB exposure. Many of these 
genes, possibly because of their estrogen sensitivity, are associated with 
breast cancer and development, although we cannot infer that their 
expression is similarly affected in mammary tissues as our current analyses 
were conducted in the POA.   
PCB exposure is associated with disruption of the hypothalamic-
pituitary-adrenal (HPA) axis, and several corticosterone releasing hormone-
related genes were found to have altered expression levels following 
prenatal A1221 exposure.  Methylsulfonyl PCB metabolites have been found 
to alter corticosterone synthesis (Johansson, et al., 1998a), and bind to the 
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glucocorticoid receptor (Johansson, et al., 1998b), and PCB exposure is 
linked with elevated basal corticosterone levels (Miller, et al., 1993).   
Microarray results identified several HPA axis stress regulatory genes 
in the list of differentially expressed genes (p < 0.01), which may be 
attributed to HPA mediation by gonadal steroids in the preoptic area.  The 
preoptic area is involved in the HPA axis, and is associated with stress 
response (Mccormick, et al., 2002, Viau, 2002), specifically with reference to 
signal initiation by the cortex/amygdala (Viau and Meaney, 1996), or signal 
intensity attenuation by sex steroid hormones (Herman and Cullinan, 1997, 
Mccormick, et al., 2002).  In the HPA axis, corticotropin releasing hormone 
(CRH) in the hypothalamus (Cummings, et al., 1983) and preoptic area 
(Mcdonald, et al., 1994) induces release of adrenocorticotropic hormone 
(ACTH) from the pituitary, which then stimulates release of the “stress 
hormone” corticosterone from the adrenals; CRH also acts as a neuropeptide 
within the brain. One of the downregulated genes of interest in this study, 
CRH receptor 2 (CRHR2), is bound with high affinity by the endogenous 
ligands urocortin 2 and 3, and modulates stress response by maintaining 
ACTH release throughout the stressor and then terminating the stress 
response (Reyes, et al., 2001).  It is thus believed to provide an anxiolytic 
effect counter to the anxiogenic properties of CRH receptor 1 (CRHR1) 
(Kishimoto, et al., 2000). CRHR2 ligand urocortin 3 mRNA positive nerve 
terminals project into the hypothalamus and nearby basal forebrain nuclei, 
and urocortin 3 protein expression in the brain was strongest in the median 
preoptic nucleus (Lewis, et al., 2001), which confirms colocalization of the 
ligand with its receptor CRHR2.  Urocortin 3 expression is also rapidly 
upregulated in response to psychological stressors (Valdez, et al., 2004).    
Another gene of interest was also downregulated: corticotropin 
releasing hormone binding protein (CRHBP) which is the only known binding 
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protein with high affinity for a neuropeptide, CRH (Jahn, et al., 2005).  
CRHBP is broadly expressed in the brain, including the hypothalamus and 
preoptic area (Cummings, et al., 1983).  Approximately 50% of whole brain 
corticotropin releasing hormone (CRH) is bound by CRHBP, and thus made 
unavailable to bind  to receptors (Behan, et al., 1995).  CRHBP expression is 
mediated by gonadotropins in primate gonadal tissues (Xu, et al., 2005, Xu, 
et al., 2006), and thus may exhibit similar hormonal regulation in the brain. It 
has been suggested that CRHBP prevents generalized neuronal 
hyperexcitability of CRH (Aldenhoff, et al., 1983), in addition to its role in the 
HPA axis.  This study presents the first documented evidence, to our 
knowledge, of a PCB effect on expression of corticotropin releasing hormone 
binding protein and corticotropin releasing hormone receptors 1 and 2. 
Another notable gene that is affected by A1221 is ELAV-like 1 (HuR), 
a key player in post-translational mRNA stability.  Previous results in our 
laboratory found altered post-transcriptional regulation following A1221 
exposure to an immortalized GnRH cell line (Gore, et al., 2002).  PCBs have 
also been shown to alter mRNA levels by increasing post-trancriptional 
mRNA stability of the steroidogenic enzymes CYP11B1 and CYP11B2 (Lin, 
et al., 2006a).  The role that HuR plays in transcript stability may underlie 
some of the molecular effects of PCB exposure.  In addition, its involvement 
in signal transduction and intracellular messenger cascades may correlate 
with the high number of disrupted intracellular signaling molecule genes, as 
discussed in functional group analysis. 
Several other genes with low p-values are related to 
neurodegenerative and psychiatric diseases, although their roles in the POA 
are not well understood. Both neuregulin 1 and neuregulin 2, cytokines for 
which mutation or altered expression is related to a number of pathologies 
including Alzheimer’s and schizophrenia susceptibility (Esper, et al., 2006, 
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Meeks, et al., 2006), were included amongst the most significantly affected 
genes.  In addition, affected gene spondin 1 is known to interact with 
Alzheimer’s-related protein amyloid beta precursor protein (APP) to inhibit its 
cleavage (Ho and Sudhof, 2004).  To date, few studies have been conducted 
to specifically address the connection between environmental toxicant 
exposure and epidemiology, and thus only slight evidence exists for a role of 
PCBs in neurodegenerative diseases and dementia (Corrigan, et al., 2000, 
Landrigan, et al., 2005, Troster, et al., 1991).  Although PCB exposure is 
believed to increase susceptibility to Parkinson’s Disease (Caudle, et al., 
2006), we did not observe any differential expression of genes related to 
Parkinson’s, possibly because we focused on the POA. 
Although our focus is on implications of altered expression of genes 
affected by PCB exposure (p < 0.01) we stress the necessity for follow-up 
procedures employing a more quantitative procedure.  The interests of our 
laboratory lie in the documented effects of A1221 and other PCBs on female 
sexual development and behavior.  Thus, we selected 27 candidate genes 
for additional analysis to determine which genes to study further with 
quantitative real time PCR.  From the results given in Table 10, we chose the 
following genes showing significant post-hoc treatment effects vs. control, for 
quantitative real time PCR follow up:  estrogen receptor alpha, estrogen 
receptor beta, corticotropin releasing hormone binding globulin, 
hydroxysteroid (17-beta) dehydrogenase, corticotropin releasing hormone 
receptor 2, and nuclear coactivator 6.  In future studies beyond the scope of 







FUNCTIONAL GROUP ANALYSES 
 Overall, both the Gene Ontology and the custom functional group 
analyses were in agreement.  Both methods revealed a preponderance of 
affected genes involved in transcriptional activity and intracellular signaling 
pathways, however, methodological differences between the two approaches 
highlighted several different findings as well.   The GO approach revealed 
the large number of gene products residing in plasma membranes, and 
emphasized the strong presence of genes involved in signal transduction 
and response to external stimuli.  The custom approach, however, provided 
a practical evaluation that revealed the involvement of blood and immune-
related genes with the PCB-derived gene expression phenotype.   
Because of the well-documented effects of A1221 on steroid hormone 
systems, we hypothesized that expression of primarily hormone- and 
neurotransmitter-related genes in the preoptic area would be most affected 
by exposure.  However, functional group analysis did not reveal a large 
number of hormone-related genes.  GeneOntology (GO) chart analysis 
suggests that the most common functional groups affected by PCB exposure 
are plasma membrane and cytoplasmic metabolic proteins, including 
hydrolase enzymes and nucleotide/nucleic acid binding proteins. 
Additionally, it is not surprising that PCBs disrupt so many membrane-related 
proteins, since their lipophilic nature allows them to pass through or reside in 
plasma membranes, thereby disrupting lipid bilayer fluidity (Tan, et al., 
2004a).  Possibly, developmental exposure leads to a permanent reactive 
altered expression of membrane-residing intrinsic proteins.  Custom 
functional group analysis placed hormone-related genes at 8% of all results, 
the fifth largest group.  These results imply that the most common long-
lasting effects of prenatal PCB exposure on adult gene expression are in 
intracellular signaling pathways leading to transcriptional and post-
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transcriptional control of gene expression.  Although few endocrine-related 
genes seem to be affected by prenatal A1221 exposure, this does not 
undermine the important role of hormone-responsive gene products in the 
preoptic area.  
Another common pathway affected in GO chart analysis involves 
receptor, protein, and nucleotide binding, such as for transcriptional 
activation, which may also present a proximal cause of adult gene 
expression disruption following prenatal PCB exposure.  The majority of 
transcription factor transcripts identified in the list of significant genes (p < 
0.01) are not well documented in scientific literature.  Because of this, 
specific transcription factor-protein interactions and transcriptional response 
element binding sites cannot be determined.  However, we speculate that 
because many transcription factors have proto-oncogenic capabilities, the 
altered expression we observed may be related to the increased risk of 
cancer faced by PCB-exposed individuals (Cope, et al., 2003, Ntp, 2006, 
Prince, et al., 2006).  In addition, lightly chlorinated PCBs such as A1221 
may correlate more strongly with breast cancer risk than the more heavily 
chlorinated congeners (Lucena, et al., 2001, Moysich, et al., 1998). 
In the custom functional group analysis, the primary category of 
affected genes (p < 0.01) was blood-related (including alpha and beta 
hemoglobin, and Alas2). PCB exposure can decrease erythrocyte count and 
platelet volume, as well as lower immune response, and alter ratios of T 
helper and suppressor cells (Arnold, et al., 1993). PCBs can bind to 
hemoglobin directly (Rehulka and Minarik, 2004) which may lead to 
premature degradation.  Altered levels of corticotropin releasing hormone-
related genes may also be related to the affected expression of genes 
important in the immune system.  Immunotoxic response is regulated 
partially by corticosterone, and abnormal expression of genes upstream of 
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corticosterone in PCB-treated groups could alter immune-related gene 
expression. 
 
TRANSCRIPTIONAL RESPONSE ELEMENT (TRE) ANALYSIS 
We conducted transcriptional response element (TRE) analysis on the 
list of significant genes (p < 0.01) in order to uncover possible DNA binding 
sites common to genes affected by PCB exposure.  The results of this 
analysis suggest possible transcriptional mechanisms by which A1221 might 
be acting. Several genes that were strongly affected by PCB treatment, 
including CCAAT binding protein epsilon, and similar to CREBP inhibitory 
protein, may serve as a proximal mechanism for observed altered gene 
expression.  Because we are unable to test the functionality of potential 
TREs statistically extracted from published promoter sequences, we cannot 
make definitive conclusions based on these results.  Rather, we here 
examine possible contributions of the top ranking TREs to A1221-derived 
transcriptional influence.  TREs found in > 65% of the top 50 recognized 
genes are discussed. 
Results of TRE analysis fall into three general groups:  blood and 
immune-specific transcription factor families, neurodevelopmental 
transcription factor families, and ubiquitous cell metabolic families. The TRE 
with the highest-ranking gene frequency, the ETS1-Factor (ETSF) plays a 
crucial role in pattern formation during development, mainly through its 
involvement in cell proliferation and differentiation, lymphoid cell 
development, angiogenesis, and apoptosis (Hallikas, et al., 2006, Lelievre, et 
al., 2001, Pei, et al., 2005).  The strong representation of blood and immune-
related functional groups in our data set of the top 50 affected transcripts 
could be related to A1221 influence at this site, or at another of the 
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blood/immune-related TREs, including EVI-1 (Ihle and Askew, 1989), GATA 
(Dai, et al., 2002), and NKXH (Nishida, et al., 2002). 
Several neurodevelopmental TREs were identified from our analysis.  
The HoxF TRE is implicated in telencephalic brain patterning, most notably 
the associated transcription factors Phox2a/2b and Pitx3 which have 
powerful control over noradrenergic neuronal differentiation and tyrosine 
hydroxylase expression, respectively (Lebel, et al., 2001, Seo, et al., 2002).  
Effects of PCBs on decreased brain tissue content of norepinephrine are well 
documented (Meerts, et al., 2004c, Seegal, et al., 1985).  Sp1 and Sp2 are 
common transcription factors for the SP1F TRE, found in cytochrome p450 
steroidogenic enzyme genes, and vasopressin (Hammer, et al., 2004, 
Rabadan-Diehl, et al., 2000) and thereby associated with hormone signaling.   
CREB and HEAT are transcriptional binding element sequences that mediate 
cAMP and heat shock protein signaling, respectively.  Cyclic AMP is 
activated ubiquitously in response to a number of intracellular signaling 
systems, and heat shock proteins mediate protein folding and degradation in 
many cell types.  The high percentage of genes that include these 
transcriptional response elements is not surprising, considering their general 
commonality, however we do not rule out the possibility that A1221 may also 
target those transcriptional pathways.  Finally, a putative estrogen response 
element was found in 42% of tested genes, and the putative androgen 
response element was found in 66% of tested genes. 
 
CLUSTER ANALYSIS 
Non-linear dose-response curves are indicative of steroid hormone 
action, whereby physiologically low or high concentrations elicit some 
response, and median concentrations have the opposite polarity of effect 
(Weltje, et al., 2005).  As predicted, the preponderance of non-linear dose-
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response curves within the data set of significant genes identified by 
microarrays (p < 0.01) suggests that prenatal A1221 is acting overall in a 
steroid-hormone or hormetic like mechanism.  This would be expected if 
higher than normal levels of a hormonally active substance, such as PCBs, 
during a sensitive period of development resulted in desensitization or 
downregulation of downstream transcriptional targets. Possible mechanistic 
explanations for the prevalence of the U-shaped curve include:  (1) direct 
binding of A1221 to steroid hormone receptors, (2) alteration of enzymatic 
activity related to steroid hormone formation or metabolism, (3) direct binding 
of A1221 to orphan nuclear receptors such as AhR, which may result in 
steroid hormone-like dose-response relationships, or (4) interference in 
intracellular signaling cascades in a hormone-rich region of the brain, which 
indirectly alters neuroendocrine levels of steroid hormones.  Because of the 
many known disruptive modes of action for PCBs, it is likely that the 
observed alterations in gene transcription may be ascribed to several non-
exclusive causative mechanisms, as these are not mutually exclusive events.   
Many blood-related genes, including alpha and beta hemoglobin, fell 
into the dose-response curve described by cluster 7, showing depressed 
gene expression in all three treatment groups, suggesting either 
transcriptional coregulation or altered developmental patterning resulting in 
decreased vascularization in treated groups.  Interestingly, immune-related 
genes such as fibrinogens, complement components, and leukocyte-specific 
chemokines, form most of the blood-related genes upregulated in the 10 
mg/kg group (cluster 1), and this same treatment group exhibited decreased 
expression of blood-brain barrier-related genes (clusters 3 and 9).  Because 
not only blood-related genes, but vascular epithelial and smooth-muscle 
genes had compromised transcript levels following PCB exposure, we 
believe that the most heuristic explanation is decreased vascularization of 
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the preoptic area in treated groups, although we acknowledge that multiple 
mechanisms most likely contribute to these observed effects. Steroid 
hormones, including estrogen, regulate blood vessel diameter and 
proliferation in the brain (Krause, et al., 2006), and PCBs have been shown 
to alter estrogen-mediated angiogenic signaling in the umbilical cord 
(Tavolari, et al., 2006). Although the effects of prenatal PCBs on brain 
vascularization have not yet been researched, diethylstilbestrol, an 
estrogenic toxicant, can alter estrogen-induced microvascularization in the 
pituitary (Pawllkowski, et al., 1996, Stehr-Green, et al., 1986).In addition to 
blood-related genes, of the transcripts categorized as transcription 
factors/cofactors, 3 were downregulated by PCB treatment, but 11 were 
upregulated.  Similarly 4 transcripts in the intracellular signaling category 
were downregulated whereas 10 were upregulated. 
Overall, cluster analysis confirmed the hypothesis that prenatal A1221 
elicits non-linear dose-response curves in adult gene expression, suggesting 
that A1221 acts in a hormone-like manner. Whole genome microarray is 
particularly valuable for this method of analysis because it eliminates much 




After examining the effects of prenatal A1221 exposure on adult 
female gene expression in the preoptic area of the brain, we conclude that 
prenatal A1221 likely acts on adult gene expression mostly with a steroid 
hormone-typical non-linear dose response curve.  Prenatal exposure to 
A1221 has greatest effects on blood and immune-related gene expression, 
and alters transcription factor mRNA levels.  Putative steroid hormone 
receptor response elements were not as commonly localized to the most 
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strongly-affected genes, suggesting that the mechanisms for A1221’s 
influence on gene expression probably lie in a complex interaction of 
disruptive effects at multiple levels of molecular interactions.  The results of 
this study have illuminated many avenues for follow-up research 
investigating the connection between prenatal A1221 exposure and adult 
neuroendocrine gene expression.  A1221 likely shares some mechanisms of 
action and patterns of molecular interaction with other endocrine-acting 
toxicants, for which prenatal exposure is a current concern for human health 
and wildlife survival.  The present whole genome microarray study was a 
hypothesis-generating tool to benefit further research on this topic.  The 
current findings may thus have a strong impact on further studies 












As persistent organic pollutants, PCBs represent an acknowledged 
health threat to humans and wildlife, and a warning against future 
development of industrial chemicals that have not been thoroughly tested in 
biological systems.  The limits of PCB toxicity are not currently known, and 
every year new studies reveal previously unknown targets for PCB 
disruption.  Novel findings are dependent on which PCB congener/mixture is 
used, the method of administration, the dose administered, the age at 
administration, the species under study, the endpoints evaluated, and which 
tissues or pathways are under scrutiny.  It is becoming increasingly clear that 
in order to control for a high degree of variability in PCB studies, 
concatenated endpoints are necessary:  all animals are treated identically 
(aside from a single variable), and multiple endpoints are measured from 
each litter.  In this manner, information mined from diverse assays may be 
compared with confidence in order to achieve a clearer image of the 
pharmacological implications of PCB exposure.   
To address these issues, this dissertation research examined the 
effects of low-dose PCB exposure during brain sexual development on 
female reproductive parameters and physiology.  Namely, a range of doses 
(0, 0.1, 1 and 10 mg/kg) of the commercial PCB mixture A1221 was selected 
to mimic human and wildlife exposures.  The selected endpoints include 
developmental, behavioral, physiological, and molecular data that offers a 




Developmental effects of PCBs on two generations of female 
rats 
This dissertation research found that exposure of female rats to 
ecologically-relevant levels of A1221 during a sensitive period for brain 
sexual differentiation had long-term and unexpected results that extended 
into the second generation.  Three possible sources of the observed 
multigenerational effects of PCB exposure are:  altered maternal behaviors in 
the F1, epigenetic imprinting, or mutations to the germ cell genome or 
epigenome. Multigenerational effects on behavior and physiology have been 
observed in studies of maternal care, whereby natural variations in maternal 
care can alter expression of stress-related genes in the offspring, and can 
even modify maternal care by the offspring in adulthood (Meaney, 2001).  
This body of work serves as an example whereby maternal behaviors are the 
source of multigenerational transmission of a particular trait.  Additionally, the 
effects of a single administration of beta-endorphin on peripheral immune 
serotonin production were measured in three generations of rats (Csaba, et 
al., 2005).  As with the current study, the magnitude of effect increased with 
each generation following the exposed dam, and the authors attributed the 
mechanism to gene imprinting.  A third explanation for multigenerational 
manifestation of the effects of toxin exposure can be found in epigenetic 
modification of germ line gametes.  Studies examining exposure to 
vinclozalin, an anti-androgenic fungicide, found transmissible epigenetic 
alteration of the spermatocyte genome (Anway, et al., 2005, Chang, et al., 
2006).   
There are few studies examining the transmission of a single 
toxicological event treatment or experiential effect across multiple 
generations are rare compared with toxicological studies investigating 
chronic exposures across multiple generations.  An elegant series of 
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experiments conducted by the MK Skinner laboratory investigating in utero 
vinclozalin exposure of male rats is a notable exception.  This research 
group found the transmission of disease states or abnormalities in multiple 
organ groups for up to four generations (Anway, et al., 2006).  Experiments 
documenting the effects of mouse prenatal exposure to diethylstilbestrol 
(DES), an estrogenic drug previously prescribed clinically as a  miscarriage 
preventative, also found increased occurrence of gonadal tumors and 
lesions, and upregulation of estrogen-responsive gene transcription in 
multiple generations.  The authors hypothesized that these effects were due 
to epigenetically altered methylation patterns on estrogen-sensitive genes, 
and possible germline mutations (Newbold, et al., 2006);  
It is possible that the different generations following exposure might 
experience different magnitudes of effects.  The research described in this 
dissertation did not directly investigate relative magnitude of effect in multiple 
generations because the F1 and F2 generation females were part of different 
experimental methodologies, and different endpoints were examined.  
Indeed, although data are presented for each generation in the DES and 
vinclozalin research discussed above, there have been no multigenerational 
transmission studies that statistically compare the magnitude of effect across 
multiple generations. 
Whereas no gross morphological differences were observed in PCB-
exposed pups, and no clear differences emerged from observations of 
developmental landmarks of eye opening and puberty onset in either the 
exposed or the second generation, altered steroid hormone levels were 
observed in the F2 generation that were suggestive of a delayed or absent 
preovulatory GnRH/LH surge.  Indeed, the two middle treatment groups (0.1 
and 1 mg/kg PCBs) exhibited relatively little fluctuation in serum LH or 
progesterone levels across the estrous cycle relative to control rats or those 
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exposed to the highest 10 mg/kg dose of A1221.  The GnRH/LH surge is 
typically attributed to escalating levels of estradiol released by ovarian 
granulosa cells during the follicular phase of estrous cycle.  Estradiol then 
stimulates GnRH release from the preoptic area via an unknown mechanism, 
and the GnRH surge is directly attributable for the ensuing LH surge from the 
anterior pituitary.  Normal levels of estrogen in PCB-treated animals were 
apparently insufficient to elicit a normal LH surge, which implicates a central 
mechanism for PCB effects on LH release. In fact, there is evidence linking 
A1221 exposure to altered GnRH gene expression in vivo and in vitro (Gore, 
2001, Gore, et al., 2002).  Although in the microarray assay, the GnRH 
transcript did not have a p-value less than 0.01 and thus was not included in 
analysis, however other affected genes may play a role in the mediation of 
GnRH release. 
In addition to altered serum LH, progesterone levels were 
correspondingly abnormal on the day of proestrus.  Following ovulation, the 
ruptured follicle is transformed into a corpus luteum, which secretes 
progesterone. PCB-treated animals had low serum levels of progesterone on 
proestrus, but normal, high levels on the day of estrus.  This suggests two 
possibilities:  (1) the LH surge in PCB-exposed females was delayed, 
allowing for delayed ovulation and progesterone production, or (2) the LH 
surge is absent, but FSH (also released from the anterior pituitary prior to 
ovulation) induces ovulation in the absence of LH with delayed induction of 
corpus luteal progesterone release.  Although this effect is normally 
attributable to LH, FSH is capable of these effects in the absence of LH 
(Schwartz, 1974).  We did not quantify serum FSH within this dissertation 
research, and thus cannot make a conclusive statement on the mechanisms 
involved.  An additional consideration is that corpus luteum tissues may also 
be responding abnormally to gonadotropins.  These findings have strong 
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implications for fertility, and this is a promising route for follow-up studies on 
the second generation of exposed animals.    
First generation (F1) exposed females did not evince altered 
circulating hormone levels for the hormones tested, however it is important to 
note that second generation (F2) females had entirely normal levels on the 
day of estrus, which is the only day for which F1 female serum was collected.  
Future studies will investigate F1 serum hormones across the estrous cycle.  
Additionally, F1 females showed altered sexual behaviors. Our observation 
of a requirement for more trials to successful mating in F1 females, 
described in detail in the “A1221 Effects on Paced Mating Behaviors” section 
of the Discussion in Research Section 2 is consistent with a dissociation of 
reproductive hormones and suggests that the temporal pattern of 
gonadotropin and sex steroid hormones may also be altered in the F1 
generation. Indeed, in one mating trial not described above, an F1 female 
whose vaginal cytology indicated that she was already past behavioral estrus 
was accidentally used in a mating trial, and to my surprise, she was sexually 




Effects of PCBs on female paced mating behaviors 
The major findings from the paced mating experiment are that PCB-
exposed females are less likely to mate, given the opportunity.  Treated 
females in the 1 mg/kg and 10 mg/kg PCB groups required almost double 
the number of opportunities prior to successful mating.  This is even more 
meaningful considering that in the experimental protocol animals were only 
offered 4 attempts to mate, and in these two higher treatment group some 
females required typically 3 or 4 attempts, or never mated.  This finding is 
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highly relevant to the continued existence and survival of wildlife species in 
increasingly shrinking natural habitats, for which chance mating encounters 
may be scarce.  
Another highly significant and unexpected result of PCB exposure was 
the frequency of audible call emission by PCB-exposed females. Audible 
calls for rats are believed to convey stress and/or pain.  Pain response and 
c-fiber nerve conduction would be excellent endpoints to address in further 
research.  Counterintuitive to the expected “negative” effects of PCB 
exposure, exposed rats in the 1 mg/kg group vocalized less frequently than 
control animals.  Two possible explanations for this phenomenon are (1) 
altered brain circuitry for the vocal production pathway, or, more likely (2) 
altered sensitivity to pain or novel or stressful situations.  While this may 
appear to be an adaptive trait in the modern world, depressed stress 
response is highly maladaptive when considering that the required 
behavioral and physiological reaction to a potentially harmful situation may 
be compromised in exposed individuals.  In future research, direct measure 
of circulating corticosterone levels would help to clarify these issues. 
The two major findings of the sexual behaviors research may appear 
contradictory.  The same females who were loath to mate appeared calmer 
when they did mate.  However, it is important to recognize that the induction 
of mating is carefully orchestrated by the combined systemic activities of 
steroid hormones and central influence of neurotransmitter release, carefully 
timed to the female’s peak in fertility.  In contrast, stress response during 
mating, or in other situations, relies on rapid non-premeditated physiological 
response mediated by the corticotropin releasing hormone-
adrenocorticotropic hormone-corticosterone pathway, and the hypothalamic-
pituitary-adrenal (HPA) axis. Therefor, PCB disruption in these multiple 
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hormone systems may activate opposing signals during the induction of, and 
reaction to, sexual encounters.  
The ability of A1221 to disrupt steroid hormone signaling likely at 
underlies many of the observed effects in the current body of research.  
Steroid hormones are key patterning agents in the developing brain, and can 
interact with multiple signaling pathways, neurotransmitter systems, and 
migratory or proliferative developmental events.  Because of its known 
estrogenic effects, I hypothesized that Aroclor 1221 was acting in an 
estrogenic manner during the period of sexual differentiation of the brain.  
Effects on sexual behaviors, including audible vocalizations, are discussed 
below.  Additionally, because the dopamine neurotransmitter system is a 
common target for PCB disruption, behavior results are interpreted with 
regards to possible dopaminergic disruption.  
Aroclor 1221 has well-documented estrogenic effects (see General 
Introduction), and can also act as an anti-androgen by antagonizing 
activation of the androgen receptor in the presenece of dihydrotestosterone 
(Schrader and Cooke, 2003), or by inhibiting aromatase, the enzyme which 
converts testosterone into the male bioactive brain hormone estrogen 
(Woodhouse and Cooke, 2004). Female rats prenatally exposed to 
androgens exhibit decreased sexual receptivity as adults (Hoepfner and 
Ward, 1988), and similarly, prenatal A1221 in this dissertation research may 
have acted in an estrogenic manner during development with long term 
implications for adult sexual behaviors.  The female rats exposed to A1221 
prenatally in the current body of work exhibited longer mount-return latencies 
as adults, just as female rats treated neonatally with testosterone propionate 
exhibited longer event-return latencies as adults (Gans and Erskine, 2003).  
This could be due to an endocrine disruptive mechanism of A1221 during 
development.   
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The relationship between audible vocalizations as a measure of stress 
or pain suggests that audible vocalization incidence is directly related to 
stress response, however there is a lack of information on mating-related 
stress in the female rat.  Audible vocalizations in the rat are associated with 
stress or pain response (Ardid, et al., 1993, Han, et al., 2005, Jourdan, et al., 
1997, Levine, et al., 1984, Yajima, et al., 1981) and may be mediated by 
endogenous sex hormone fluctuations across the female estrous cycle 
(Kayser, et al., 1996).  Thus it is possible that altered circulating hormone 
levels in PCB-treated rats on the day of mating might explain an altered 
stress response. Indeed, rats prenatally administered 17α-ethinylestradiol 
(Arabo, et al., 2005) or bisphenol A (Fujimoto, et al., 2006), both estrogenic 
chemicals, displayed increased anxiety and a depressive-like demeanor as 
an adult. Future research will directly assay stress response and will 
measure circulating corticosterone levels in female rats directly following 
mating.  
Dopamine in the preoptic area and nucleus accumbens play a role in 
female display of lordosis and in the establishment of place preference and 
reward (Ahlenius, 1993, Becker, et al., 2001, Jenkins and Becker, 2003).  
The only study to investigate the effects of A1221 in vivo on dopaminergic 
endpoints found no immunohistochemical difference in the number of 
dopaminergic cell bodies projecting to the preoptic area (cell bodies stained 
with tyrosine hydroxylase antibody) (Chung, et al., 2001).  No differences in 
lordosis were observed between groups in this dissertation research, 
suggesting little to no effect on tuberoinfundibular dopamine population, 
which is involved in female sexual behaviors.  However, one unreported 
event of repeated spinning behavior in a single rat during a mating trial in my 
study has been previously documented in PCB disruption of the nucleus 
accumbens dopamine system (Chou, et al., 1979).  It is possible that A1221 
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may have differentially affected dopaminergic subpopulations in experimental 
females, but further studies would be necessary to confirm this hypothesis 
because effects of PCBs on dopamine populations that are not involved in 




Effects of PCBs on gene expression in the preoptic area 
The third component of this project tested global changes in gene 
expression across the whole genome, using preoptic area tissues.  Due to 
the nature of the experiment (intact females, euthanized months following 
exposure, using very low exposure levels), subtle results were expected. I 
hypothesized that mainly neuroendocrine-specific genes would be altered by 
exposure, and that a non-linear dose response curve would again be in 
evidence.  Given the neuroendocrine nature of the preoptic area, which is 
responsible for regulation of hormone production and release, there was a 
danger of observing overrepresentation of affected hormone-related genes 
merely due to their overrepresentation in the preoptic area.  On the contrary, 
few hormone-related genes were included in the top list (p < 0.01). 
Nevertheless, disruption of even a few key genes that were members of this 
group have the potential to elicit large physiological effects (e.g. the estrogen 
receptors alpha and beta, corticotropin releasing hormone receptor, etc.) 
Most of the altered genes (p < 0.01) identified by the microarrays 
belonged to cellular metabolism and intercellular communication categories, 
with a strong representation by cytokine and transcriptional signaling 
molecules.  The changes in gene expression observed with this experimental 
protocol reflect adult gene profiles, whereas entirely different gene 
expression profiles are likely in the preoptic area if assayed closer to the 
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timing of exposure.  Because of the known hormone mimic effects of A1221, 
it is probable that the immediate response to PCB exposure is strongly 
hormone related, causing altered development and brain patterning of 
hormone signaling pathways that emerge as altered situational 
responsiveness in the adult.  However, PCBs can work through many other 
avenues, and gene expression in cellular physiology pathways remains 
affected in the adult.  Preoptic areas of P1 culled pups, both male and 
female, were collected and further microarray research would be highly 
beneficial towards further exploration of the relationship between early 
developmental gene expression alteration and later adult expression 
following compensation and maturation. 
Of the hormone-related genes with p < 0.01, three general groups 
emerged: estrogen-related genes, thyroid hormone-related genes, and 
corticotropin-releasing hormone-related genes. All of these hormone systems 
have been documented as affected by PCB exposure in previous research 
(see the Introduction to this dissertation).   In the context of the findings of 
this dissertation research, the observed increase in estrogen receptor 
expression may signify altered circulating estrogen levels, perhaps on the 
day of proestrus—1 day prior to euthanasia, or an altered response to serum 
estrogen.  Serum estrogen on the day of euthanasia was normal, as 
discussed previously, however the transcriptionally-mediated effects of 
estradiol’s downstream activity may take hours to days to present, which 
allows for possible altered estradiol levels on other days of the estrous cycle.   
Altered thyroid hormone receptor-associated protein, and thyrotropin 
releasing hormone receptor 2 expression was observed for the 1 mg/kg and 
10 mg/kg treament groups, respectively.  Whereas in the adult, thyroid 
hormones regulate metabolism, in the fetus they serve an essential role in 
guiding brain development (Anderson, et al., 2003).  Because expression of 
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these thyroid hormone-related genes was altered in the adult, it is possible 
that prenatal thyroid hormone signaling was also affected.  Further research 
on prenatal PCBs  is needed to measure adult serum thyroid hormone levels, 
and to investigate neonatal brain morphology for signs of hypo- or 
hyperthyroidism. 
The downregulation of corticosterone releasing hormone-related 
genes in the 1 mg/kg group is highly relevant considering that this same 
treated group exhibited decreased audible vocalizations, an indicator of the 
stress response during mating trials.  Because tissues were collected the day 
following mating, the two findings are temporally related, and may represent 
a cause-and-effect scenario.  Future research would do well to investigate 
stress response, gene expression, and circulating stress hormone levels for 
animals in both mating and non-mating situations to determine if the 
observed altered stress response is specific to mating situations. 
Results from TRE analysis show that the most common TREs to the 
top 50 genes are either ubiquitous across the genome, or else are blood and 
brain development-related.  This finding mirrors the observed depressed 
expression of blood- and immune-related genes, and of vascular smooth 
muscle-related genes that may signify lower than normal vascularization of 
the preoptic area of the brain in PCB-exposed females.  Upregulation of 
several genes related to blood-brain barrier integrity could be related.  One 
explanation may be that prenatal intoxication caused a reactive 
strengthening of the blood-brain barrier in PCB-exposed animals, and that 
either direct PCB exposure acting at blood-related transcriptional response 
elements or indirect effects of signaling by blood-brain barrier tissues 
possibly altered growth of blood vessels in this region.  Decreased 
vascularization of this region might also have indirect effects on sexual 
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behaviors, if increased metabolic needs of this brain nucleus during sexual 
stimulation are not fulfilled by the delivery of blood and nutrients. 
A number of genes characterized as disease risk factors were 
detected amongst the most significantly affected genes in the microarray 
experiment results.  Clearly, follow-up quantitative real time PCR is required 
to clarify the actual differences in gene expression between treatment 
groups, however the power to generate testable hypotheses from genome-
wide expression patterns is an invaluable tool for guiding future endeavors in 
the study of female sexuality and beyond.  The results of this microarray 
experiment should thus be taken in that context, and a creative outlook 
towards future problem solving of trends in human health and wildlife 
survival, in the context of environmental toxicology. 
 
Non-linear dose-response curves and low-dose exposures 
Non-linear dose-response curves were common to all three research 
areas included in this dissertation:  development & fecundity, sexual 
behaviors, and gene expression.  A hallmark of steroid hormone-like 
endocrine disrupting chemicals, this type of dose-response relationship 
renders it difficult to assign minimum toxic dose levels and to predict medical 
outcomes of toxicant exposure.  In paced mating assays, a commonly 
observed pattern was for the lowest or median treatment to elicit effects in 
one direction and the 10 mg/kg group to elicit effects in the opposite 
direction, resulting in significant differences amongst treatment groups, but 
not with the control group. Differences amongst treated groups were mostly 
omitted from the results of each research section but such differences may 
still be biologically relevant 
Dose-response curve linearity tests represent a considerable 
statistical challenge.  For the developmental and behavioral results, the data 
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sets were not large enough to conduct direct assays of the presence of U-
shaped or inverted U-shaped dose-response curves, which would signifify a 
hormetic or steroid-hormone like mechanism.  Instead, the conservative term 
“non-linear” is employed based on the observed high incidence of strong 
treatment effects at the middle treatment levels across multiple endpoints. 
However, the large number of data points generated by whole genome 
microarray renders it possible to submit a large data set of dose response 
curves to a cluster analysis program in order to find patterns common to the 
largest groupings of genes.  The results of this analysis show that the most 
common dose-response curves are U-shaped, and thus that 1221 has a 
steroid hormone-like mechanism of action on adult gene expression. 
 
Implication of experimental data for “natural” populations 
The overall picture of this dissertation research is to present a global 
biological snapshot of the effects of prenatal PCB exposure on the sexual 
“wellness” of adult female animals.  These females appear normal when 
judging their size and development, however clear abnormalities emerge 
when their physiology and gene expression are closely scrutinized, and 
when they are placed into situations that test their reactive behaviors, such 
as the opportunity to mate.  This experimental protocol was conservative in 
that female pups with the median anogenital distances (a measure of 
masculinization following EDC exposure) were selected as experimental 
animals.  This methodology disincluded females with stronger indications of 
masculinization as might be observed following exposure to an estrogenic 
chemical.   
Low levels of toxicants like those used in this dissertation research are 
likely to affect certain individuals more strongly than others.  Over the spread 
of a large population, such as with humans, PCB exposure will most likely 
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reshape the normal curve instead of creating distinct peaks of an abnormal 
phenotype at the distal edges of the curve.  Thus, the peak will become 
flatter and broader as the incidence of previously rare traits is increased with 
a conjoined decrease in the number of average individuals.  Selecting 
experimental animals known to be grouped close to the mean thus 
represents a conservative approach to investigating the question of low-level 
PCB exposure.  Despite these limitations, I observed significant differences 





In this series of experiments, female rats were exposed to ecologically 
relevant low levels of A1221 during the period of brain sexual differentiation.  
The exposed generation appeared normal in physiology and reproductive 
maturation, although they exhibited reluctance to mate, and decreased 
stress response to mating situations. Gene expression profiles of the POA 
revealed that even two months after prenatal exposure to A1221, a number 
of genes related to immune, blood, and hormone functions were altered. 
Some of these changes may underlie the differences in physiology and 
behavior seen in the F1 generation. The highest percentage of altered genes 
were downregulated in the 0.1 and 1 mg/kg groups compared to control rats, 
whereas in the 10 mg/kg group, more genes were upregulated compared to 
control animals. This finding suggests non-traditional dose-response curves 
and is consistent with the non-linearity of effects of A1221 on reproductive 
physiology and behavior. Altered hormone-related gene expression in the F1 
may be implicated in observed depressed hormone levels of the F2 females 
if an inappropriate hormonal environment was present in the pregnant dam 
during fetal and embryonic development of the F2, or if F1 dams had 
abnormal maternal behaviors towards their F2 offspring. In future studies, 
our laboratory will investigate effects of prenatal PCBs on reproductive 
hormones across the estrous cycles of at least three generations of rats, to 
further understand transgenerational effects, and we will also determine if 
alterations in maternal behavior may occur that may impart epigenetic 
modifications to the offspring, as is well-established for manipulations of the 
HPA axis.  
Current trends in toxicological research focus on PCBs that remain in 
measurable quantities in human tissues and the environment, thereby 
underestimating the impact of toxicants such as A1221. It is not impossible to 
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detect the fingerprint of exposure for A1221 or other endocrine disrupting 
chemicals even after the toxicant is no longer present in measurable 
quantities.  The field of toxicogenomics permits the compilation of gene 
profile libraries documenting global effects of toxicant exposure on gene 
expression within an organism.  This work is being pursued currently for PCB 
effects on amphibians (Jelaso, et al., 2002, Jelaso, et al., 2003), but 
application to mammals is rare.  With this current dissertation research, I 
provide a bank of information including developmental, behavioral, and 
toxicogenomic endpoints to characterize prenatal exposure to one PCB 
mixture at one developmental time point.  The later addition of many more 
studies of this format of toxicological research will greatly benefit both 
science and medicine, as patterns begin to emerge linking toxin exposures 
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